跳到正文
MarketHOT
English
摘要
SEC · EDGAR 财务披露·· 22 小时前精选AI 评分69

Alexandria Real Estate Equities提交截至2026年9月30日季度的10-Q:第三季度净亏损6.385亿美元,房地产减值6.379亿美元

10-Q - ALEXANDRIA REAL ESTATE EQUITIES, INC. (0001035443) (Filer)

AI 导读

Alexandria Real Estate Equities提交截至2026年9月30日季度的10-Q,披露第三季度归属于普通股股东的净亏损为6.385亿美元(每股亏损3.74美元),其中包括6.379亿美元房地产减值。

推荐理由

节选披露了公司季度及九个月业绩、资产减值、租赁表现和融资状况,可用于了解其经营与资产负债表变化。

正文 · 原文

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q 

(Mark One)

    ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

          EXCHANGE ACT OF 1934 

For the quarterly period ended September 30, 2026

OR

    ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission file number 1-12993

ALEXANDRIA REAL ESTATE EQUITIES, INC.

(Exact name of registrant as specified in its charter)

Maryland

95-4502084

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer Identification Number)

 26 North Euclid Avenue, Pasadena, California 91101

(Address of principal executive offices) (Zip code)

(626) 578-0777

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value per share

ARE

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities

Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),

and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and

posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period

that the registrant was required to submit and post such files). Yes ☒  No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting

company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting

company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Smaller reporting company 

☐

Accelerated filer 

☐

Emerging growth company 

☐

Non-accelerated filer

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for

complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

As of October 15, 2026, 174,160,645 shares of common stock, par value $0.01 per share, were outstanding.

i

TABLE OF CONTENTS

Page

PART I – FINANCIAL INFORMATION

Item 1.

FINANCIAL STATEMENTS (UNAUDITED)

Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025 ..................................................

1

Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2026 and 2025:

Consolidated Statements of Operations ...................................................................................................................

2

Consolidated Statements of Comprehensive Income ............................................................................................

3

Consolidated Statements of Changes in Stockholders’ Equity and Noncontrolling Interests ..........................

4

Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 ...................

8

Notes to Consolidated Financial Statements ....................................................................................................................

10

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

OPERATIONS ........................................................................................................................................................................

51

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK .........................................................

129

Item 4.

CONTROLS AND PROCEDURES .....................................................................................................................................

130

PART II – OTHER INFORMATION

Item 1.

LEGAL PROCEEDINGS ......................................................................................................................................................

131

Item 1A.

RISK FACTORS ....................................................................................................................................................................

131

Item 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS ...................................................

131

Item 5.

OTHER INFORMATION .......................................................................................................................................................

131

Item 6.

EXHIBITS ...............................................................................................................................................................................

132

SIGNATURES .................................................................................................................................................................................................

133

ii

GLOSSARY

The following abbreviations or acronyms that may be used in this document

have the meanings set forth below:

ASU

Accounting Standards Update

ATM

At the Market

CAD

Canadian Dollar

CIP

Construction in Progress

EPS

Earnings per Share

FASB

Financial Accounting Standards Board

FFO

Funds From Operations

GAAP

U.S. Generally Accepted Accounting Principles

IRS

Internal Revenue Service

JV

Joint Venture

Nareit

National Association of Real Estate Investment Trusts

NAV

Net Asset Value

NYSE

New York Stock Exchange

REIT

Real Estate Investment Trust

RSF

Rentable Square Feet/Foot

SEC

Securities and Exchange Commission

SF

Square Feet/Foot

SoDo

South of Downtown submarket of Seattle

SOFR

Secured Overnight Financing Rate

U.S.

United States

USD

U.S. Dollar

VIE

Variable Interest Entity

1

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

Alexandria Real Estate Equities, Inc.

Consolidated Balance Sheets

(In thousands)

September 30, 2026

December 31, 2025

(Unaudited)

Assets

Investments in real estate

$28,426,999

$28,689,996

Investments in unconsolidated real estate joint ventures

28,580

30,677

Cash and cash equivalents

508,855

549,062

Restricted cash

4,908

4,693

Tenant receivables

6,168

6,672

Deferred rent

1,210,911

1,179,403

Deferred leasing costs

452,164

458,311

Investments

1,735,673

1,501,249

Other assets

1,677,464

1,661,772

Total assets

$34,051,722

$34,081,835

Liabilities, Noncontrolling Interests, and Equity

Unsecured senior notes payable

$10,820,687

$12,047,394

Junior subordinated notes payable

985,143

—

Unsecured senior line of credit and commercial paper

1,091,166

353,161

Accounts payable, accrued expenses, and other liabilities

2,604,418

2,397,073

Dividends payable

131,999

127,771

Total liabilities

15,633,413

14,925,399

Commitments and contingencies

Redeemable noncontrolling interests

9,119

58,788

Alexandria Real Estate Equities, Inc.’s stockholders’ equity:

Common stock

1,708

1,705

Additional paid-in capital

14,839,182

15,497,760

Accumulated other comprehensive loss

(33,691)

(29,395)

Alexandria Real Estate Equities, Inc.’s stockholders’ equity

14,807,199

15,470,070

Noncontrolling interests

3,601,991

3,627,578

Total equity

18,409,190

19,097,648

Total liabilities, noncontrolling interests, and equity

$34,051,722

$34,081,835

The accompanying notes are an integral part of these consolidated financial statements.

2

Alexandria Real Estate Equities, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Revenues:

Income from rentals

$653,618

$735,849

$1,949,841

$2,216,303

Other income

17,564

16,095

55,147

55,839

Total revenues

671,182

751,944

2,004,988

2,272,142

Expenses:

Rental operations

227,931

239,234

659,409

690,062

General and administrative

40,915

29,224

112,461

89,027

Interest

79,687

54,852

208,613

161,024

Depreciation and amortization

304,419

340,230

914,244

1,028,415

Impairment of real estate

637,904

323,870

865,873

485,630

Total expenses

1,290,856

987,410

2,760,600

2,454,158

Equity in earnings (losses) of unconsolidated real estate joint

ventures

75

201

341

(9,327)

Investment income (losses)

23,990

28,161

152,635

(52,453)

(Loss) gain on early extinguishment of debt

(3,323)

(107)

363,112

(107)

Gain on sales of real estate

—

9,366

—

22,531

Net loss

(598,932)

(197,845)

(239,524)

(221,372)

Net income attributable to noncontrolling interests

(38,754)

(34,909)

(109,292)

(127,323)

Net loss attributable to Alexandria Real Estate Equities, Inc.’s

stockholders

(637,686)

(232,754)

(348,816)

(348,695)

Net income attributable to unvested restricted stock awards

(766)

(2,183)

(2,603)

(7,452)

Net loss attributable to Alexandria Real Estate Equities, Inc.’s

common stockholders

$(638,452)

$(234,937)

$(351,419)

$(356,147)

Net loss per share attributable to Alexandria Real Estate Equities,

Inc.’s common stockholders:

Basic

$(3.74)

$(1.38)

$(2.06)

$(2.09)

Diluted

$(3.74)

$(1.38)

$(2.06)

$(2.09)

The accompanying notes are an integral part of these consolidated financial statements.

3

Alexandria Real Estate Equities, Inc.

Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Net loss

$(598,932)

$(197,845)

$(239,524)

$(221,372)

Other comprehensive (loss) income

Change in foreign currency translation adjustments:

Unrealized foreign currency translation (losses)

gains arising during the period

(664)

(4,788)

(4,273)

14,049

Reclassification of gains

—

—

(23)

—

Unrealized (losses) gains on foreign currency

translation, net

(664)

(4,788)

(4,296)

14,049

Total other comprehensive (loss) income

(664)

(4,788)

(4,296)

14,049

Comprehensive loss

(599,596)

(202,633)

(243,820)

(207,323)

Less: comprehensive income attributable to

noncontrolling interests

(38,754)

(34,909)

(109,292)

(127,323)

Comprehensive loss attributable to Alexandria Real Estate

Equities, Inc.’s stockholders

$(638,350)

$(237,542)

$(353,112)

$(334,646)

The accompanying notes are an integral part of these consolidated financial statements.

4

Alexandria Real Estate Equities, Inc.

Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests

(Dollars in thousands)

(Unaudited)

Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity

Number of

Common

Shares

Common

Stock

Additional

Paid-In

Capital

Retained

Earnings

Accumulated

Other

Comprehensive

Loss

Noncontrolling

Interests

Total

Equity

Redeemable

Noncontrolling

Interests

Balance as of June 30, 2026

170,728,916

$1,707

$15,585,296

$—

$(33,027)

$3,612,263

$19,166,239

$9,119

Net (loss) income

—

—

—

(637,686)

—

38,563

(599,123)

191

Total other comprehensive loss

—

—

—

—

(664)

—

(664)

—

Contributions from and sales of noncontrolling interests

—

—

(976)

—

—

9,945

8,969

—

Distributions to and redemption of noncontrolling interests

—

—

—

—

—

(58,780)

(58,780)

(191)

Issuance pursuant to stock plan

198,617

2

22,114

—

—

—

22,116

—

Taxes related to the net settlement of equity awards

(78,932)

(1)

(4,179)

—

—

—

(4,180)

—

Dividends declared on common stock ($0.72 per share)

—

—

—

(125,387)

—

—

(125,387)

—

Reclassification of net loss and distributions

—

—

(763,073)

763,073

—

—

—

—

Balance as of September 30, 2026

170,848,601

$1,708

$14,839,182

$—

$(33,691)

$3,601,991

$18,409,190

$9,119

The accompanying notes are an integral part of these consolidated financial statements.

5

Alexandria Real Estate Equities, Inc.

Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests

(Dollars in thousands)

(Unaudited)

Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity

Number of

Common

Shares

Common

Stock

Additional

Paid-In

Capital

Retained

Earnings

Accumulated

Other

Comprehensive

Loss

Noncontrolling

Interests

Total

Equity

Redeemable

Noncontrolling

Interests

Balance as of June 30, 2025

170,146,069

$1,701

$17,200,949

$—

$(27,415)

$4,554,156

$21,729,391

$9,612

Net (loss) income

—

—

—

(232,754)

—

34,368

(198,386)

541

Total other comprehensive loss

—

—

—

—

(4,788)

—

(4,788)

—

Contributions from and sales of noncontrolling interests

—

—

—

—

—

36,107

36,107

—

Distributions to and redemption of noncontrolling interests

—

—

(66,317)

—

—

(175,607)

(241,924)

(201)

Transfer of noncontrolling interests

—

—

—

—

—

(48,710)

(48,710)

48,710

Reallocation of capital to joint venture partner

—

—

(20,000)

—

—

20,000

—

—

Issuance pursuant to stock plan

321,057

4

26,995

—

—

—

26,999

—

Taxes related to the net settlement of equity awards

(128,046)

(2)

(10,944)

—

—

—

(10,946)

—

Dividends declared on common stock ($1.32 per share)

—

—

—

(228,127)

—

—

(228,127)

—

Reclassification of net loss and distributions

—

—

(460,881)

460,881

—

—

—

—

Balance as of September 30, 2025

170,339,080

$1,703

$16,669,802

$—

$(32,203)

$4,420,314

$21,059,616

$58,662

The accompanying notes are an integral part of these consolidated financial statements.

6

Alexandria Real Estate Equities, Inc.

Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests

(Dollars in thousands)

(Unaudited)

Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity

Number of

Common

Shares

Common

Stock

Additional

Paid-In

Capital

Retained

Earnings

Accumulated

Other

Comprehensive

Loss

Noncontrolling

Interests

Total

Equity

Redeemable

Noncontrolling

Interests

Balance as of December 31, 2025

170,537,867

$1,705

$15,497,760

$—

$(29,395)

$3,627,578

$19,097,648

$58,788

Net (loss) income

—

—

—

(348,816)

—

108,562

(240,254)

730

Total other comprehensive loss

—

—

—

—

(4,296)

—

(4,296)

—

Contributions from and sales of noncontrolling interests

—

—

5,387

—

—

36,610

41,997

—

Distributions to and redemption of noncontrolling interests

—

—

—

—

—

(170,759)

(170,759)

(50,399)

Issuance pursuant to stock plan

514,603

5

71,775

—

—

—

71,780

—

Taxes related to the net settlement of equity awards

(203,869)

(2)

(10,616)

—

—

—

(10,618)

—

Dividends declared on common stock ($2.16 per share)

—

—

—

(376,308)

—

—

(376,308)

—

Reclassification of net loss and distributions

—

—

(725,124)

725,124

—

—

—

—

Balance as of September 30, 2026

170,848,601

$1,708

$14,839,182

$—

$(33,691)

$3,601,991

$18,409,190

$9,119

The accompanying notes are an integral part of these consolidated financial statements.

7

Alexandria Real Estate Equities, Inc.

Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests

(Dollars in thousands)

(Unaudited)

Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity

Number of

Common

Shares

Common

Stock

Additional

Paid-In

Capital

Retained

Earnings

Accumulated

Other

Comprehensive

Loss

Noncontrolling

Interests

Total

Equity

Redeemable

Noncontrolling

Interests

Balance as of December 31, 2024

172,203,443

$1,722

$17,933,572

$—

$(46,252)

$4,489,447

$22,378,489

$19,972

Net (loss) income

—

—

—

(348,695)

—

126,311

(222,384)

1,012

Total other comprehensive income

—

—

—

—

14,049

—

14,049

—

Contributions from and sales of noncontrolling interests

—

—

73

—

—

132,089

132,162

—

Distributions to and redemption of noncontrolling interests

—

—

(73,365)

—

—

(298,823)

(372,188)

(11,032)

Transfer of noncontrolling interests

—

—

—

—

—

(48,710)

(48,710)

48,710

Reallocation of capital to joint venture partner

—

—

(20,000)

—

—

20,000

—

—

Issuance pursuant to stock plan

472,123

5

87,526

—

—

—

87,531

—

Taxes related to the net settlement of equity awards

(184,193)

(2)

(16,372)

—

—

—

(16,374)

—

Repurchase of common stock

(2,152,293)

(22)

(208,165)

—

—

—

(208,187)

—

Dividends declared on common stock ($3.96 per share)

—

—

—

(684,772)

—

—

(684,772)

—

Reclassification of net loss and distributions

—

—

(1,033,467)

1,033,467

—

—

—

—

Balance as of September 30, 2025

170,339,080

$1,703

$16,669,802

$—

$(32,203)

$4,420,314

$21,059,616

$58,662

The accompanying notes are an integral part of these consolidated financial statements.

8

Alexandria Real Estate Equities, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Nine Months Ended September 30,

2026

2025

Operating Activities:

Net loss

$(239,524)

$(221,372)

Adjustments to reconcile net loss to net cash provided by operating activities:

Depreciation and amortization

914,244

1,028,415

Impairment of real estate

865,873

485,630

Gain on sales of real estate

—

(22,531)

(Gain) loss on early extinguishment of debt

(363,112)

107

Equity in (earnings) losses of unconsolidated real estate joint ventures

(341)

9,327

Distributions of earnings from unconsolidated real estate joint ventures

1,004

1,749

Amortization of loan fees

13,267

13,811

Amortization of debt discounts

1,025

1,009

Amortization of acquired above- and below-market leases

(22,229)

(31,874)

Deferred rent

(21,229)

(59,380)

Stock compensation expense

33,131

32,887

Investment (income) losses

(152,635)

52,453

Changes in operating assets and liabilities:

Tenant receivables

473

12

Deferred leasing costs

(54,052)

(64,259)

Other assets

(28,523)

(37,647)

Accounts payable, accrued expenses, and other liabilities

(71,962)

(86,669)

Net cash provided by operating activities

875,410

1,101,668

Investing Activities:

Proceeds from sales of real estate

236,286

227,105

Additions to investments in real estate

(1,328,092)

(1,538,613)

Sale of interests in unconsolidated real estate joint ventures

1,917

—

Investments in unconsolidated real estate joint ventures

(557)

(11,239)

Change in escrow deposits

—

(7,364)

Return of capital from unconsolidated real estate joint ventures

113

458

Additions to non-real estate investments

(199,266)

(184,952)

Sales of and distributions from non-real estate investments

123,660

77,067

Net cash used in investing activities

$(1,165,939)

$(1,437,538)

9

Alexandria Real Estate Equities, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Nine Months Ended September 30,

2026

2025

Financing Activities:

Borrowings under secured notes payable

$—

$4,031

Repayments of borrowings under secured notes payable

(8,892)

(154,212)

Proceeds from issuance of unsecured senior notes payable

747,592

548,532

Repayments of unsecured senior notes payable

(1,602,203)

(600,000)

Proceeds from issuance of junior subordinated notes payable

1,000,000

—

Proceeds from issuances under commercial paper program

38,494,264

15,378,015

Repayments of borrowings under commercial paper program

(37,755,314)

(13,828,015)

Payments of loan fees

(57,893)

(5,307)

Taxes paid related to net settlement of equity awards

(10,594)

(17,207)

Repurchase of common stock

—

(208,187)

Dividends on common stock

(371,427)

(684,419)

Contributions from and sales of noncontrolling interests

36,604

132,162

Distributions to noncontrolling interests

(171,248)

(186,725)

Purchases and redemptions of noncontrolling interests

(49,822)

(17,818)

Net cash provided by financing activities

251,067

360,850

Effect of foreign exchange rate changes on cash and cash equivalents

(530)

(648)

Net (decrease) increase in cash, cash equivalents, and restricted cash

(39,992)

24,332

Cash, cash equivalents, and restricted cash as of the beginning of period

553,755

559,847

Cash, cash equivalents, and restricted cash as of the end of period

$513,763

$584,179

Supplemental Disclosure and Non-Cash Investing and Financing Activities:

Cash paid during the period for interest, net of interest capitalized

$191,189

$128,808

Accrued construction for current-period additions to real estate

$248,232

$233,622

Transfer of real estate assets and/or equipment from tenants

$405,733

$171,153

Acquisition of real estate and other assets in connection with the assumption of related

secured notes payable of an unconsolidated real estate joint venture

$8,892

$—

Notes receivable issued in connection with sales of real estate

$—

$91,000

Derecognition of net investment in real estate from sales-type lease

$—

$4,677

Reallocation of additional paid-in capital to consolidated joint venture partner’s noncontrolling

interest

$—

$20,000

Exchange of joint venture interests:

Disposition of our interest in Pacific Technology Park

$—

$82,392

Acquisition of our partner’s noncontrolling interest in 199 East Blaine Street

$—

$96,543

The accompanying notes are an integral part of these consolidated financial statements.

10

Alexandria Real Estate Equities, Inc.

Notes to Consolidated Financial Statements

(Unaudited)

1.ORGANIZATION AND BASIS OF PRESENTATION

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® life science REIT, is the pioneer of the life science real estate

niche since its founding in 1994. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative

Megacampus™ ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, San

Diego, the San Francisco Bay Area, Seattle, Maryland, Research Triangle, and New York City. As of September 30, 2026, Alexandria

has a total market capitalization of $21.01 billion and an asset base that includes 36.5 million RSF of operating properties and 1.9

million RSF of Class A/A+ properties undergoing construction. As used in this quarterly report on Form 10-Q, references to the

“Company,” “Alexandria,” “ARE,” “we,” “us,” and “our” refer to Alexandria Real Estate Equities, Inc. and its consolidated subsidiaries.

The accompanying unaudited consolidated financial statements include the accounts of Alexandria Real Estate Equities, Inc. and its

consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated.

We have prepared the accompanying interim consolidated financial statements in accordance with GAAP and in conformity

with the rules and regulations of the SEC. In our opinion, these interim consolidated financial statements presented herein reflect all

adjustments of a normal recurring nature necessary to fairly present the interim consolidated financial statements. The results of

operations for the interim period are not necessarily indicative of the results that may be expected for the year ending December 31,

2026. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial

statements and the notes thereto included in our annual report on Form 10-K for the year ended December 31, 2025. Any references to

our total market capitalization, number or quality of buildings or tenants, quality of location, square footage, number of leases, or

occupancy percentage, and any amounts derived from these values in these notes to consolidated financial statements are outside the

scope of our independent registered public accounting firm’s procedures.

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Consolidation

On an ongoing basis, as circumstances indicate the need for reconsideration, we evaluate each legal entity that is not wholly

owned by us in accordance with the consolidation accounting guidance. Our evaluation considers all of our variable interests, including

equity ownership, as well as fees paid to us for our involvement in the management of each partially owned entity. To fall within the

scope of the consolidation guidance, an entity must meet both of the following criteria:

•The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity

can be in the form of a partnership, limited liability company, or corporation, among others; and

•We have a variable interest in the legal entity — i.e., variable interests that are contractual, such as equity ownership, or

other financial interests that change with changes in the fair value of the entity’s net assets.

If an entity does not meet both criteria above, we apply other accounting literature, such as the equity method of accounting. If

an entity does meet both criteria above, we evaluate such entity for consolidation under either the variable interest model if the legal

entity meets any of the characteristics below to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.

A legal entity is determined to be a VIE if it has any of the following three characteristics:

1)The entity does not have sufficient equity to finance its activities without additional subordinated financial support;

2)The entity is established with non-substantive voting rights (i.e., the entity deprives the majority economic interest

holder(s) of voting rights); or

3)The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion

if they lack any of the following:

•The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence

the entity’s economic performance, as evidenced by:

•Substantive participating rights in day-to-day management of the entity’s activities; or

•Substantive kick-out rights over the party responsible for significant decisions;

•The obligation to absorb the entity’s expected losses; or

•The right to receive the entity’s expected residual returns.

11

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

For an entity, including our real estate joint ventures, structured as a limited partnership or a limited liability company, our

evaluation of whether the equity holders (equity partners other than the general partner or the managing member of a joint venture) lack

the characteristics of a controlling financial interest includes the evaluation of whether the limited partners or non-managing members

(the noncontrolling equity holders) lack both substantive participating rights and substantive kick-out rights, defined as follows:

•Participating rights provide the noncontrolling equity holders the ability to direct significant financial and operating

decisions made in the ordinary course of business that most significantly influence the entity’s economic performance.

•Kick-out rights allow the noncontrolling equity holders to remove the general partner or managing member without cause.

If we conclude that any of the three characteristics of a VIE is met, including that the equity holders lack the characteristics of a

controlling financial interest because they lack both substantive participating rights and substantive kick-out rights, we conclude that the

entity is a VIE and evaluate it for consolidation under the variable interest model.

Variable interest model

If an entity is determined to be a VIE, we evaluate whether we are the primary beneficiary. The primary beneficiary analysis is

a qualitative analysis based on power and benefits. We consolidate a VIE if we have both power and benefits — that is, (i) we have the

power to direct the activities of a VIE that most significantly influence the VIE’s economic performance (power) and (ii) we have the

obligation to absorb losses of or the right to receive benefits from the VIE that could potentially be significant to the VIE (benefits). We

consolidate VIEs whenever we determine that we are the primary beneficiary. Refer to Note 4 – “Consolidated and unconsolidated real

estate joint ventures” and Note 7 – “Investments” to our unaudited consolidated financial statements for information on specific entities

that qualify as VIEs. If we have a variable interest in a VIE but are not the primary beneficiary, we account for our investment using the

equity method.

Voting model

If a legal entity fails to meet any of the three characteristics of a VIE (i.e., insufficiency of equity, existence of non-substantive

voting rights, or lack of a controlling financial interest), we then evaluate such entity under the voting model. Under the voting model, we

consolidate the entity if we determine that we, directly or indirectly, have greater than 50% of the voting shares (or own a majority of the

limited partnership’s kick-out rights through voting interests), and that other equity holders do not have substantive participating rights.

Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements for

information on specific real estate joint ventures that qualify for evaluation under the voting model.

Noncontrolling interests in consolidated real estate joint ventures

Noncontrolling interests represent the third-party interests in consolidated real estate joint ventures in which we have a

controlling interest. Certain of our partners’ noncontrolling interests have the right to require us to redeem their ownership interests in

the respective entities. We classify the ownership interests in these entities as redeemable noncontrolling interests outside of total

equity in our consolidated balance sheets. Redeemable noncontrolling interests are adjusted for additional contributions and

distributions, the proportionate share of net earnings or losses, and other comprehensive income or loss. If the amount of a redeemable

noncontrolling interest is less than the maximum redemption value at the balance sheet date, such amount is adjusted to the maximum

redemption value. Subsequent declines in the redemption value are recognized only to the extent that previous increases have been

recognized.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions

that affect the reported amounts of assets, liabilities, and equity; the disclosure of contingent assets and liabilities as of the date of the

consolidated financial statements; and the amounts of revenues and expenses during the reporting period. Actual results could

materially differ from those estimates.

12

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Investments in real estate

Evaluation of business combination or asset acquisition

We evaluate each acquisition of real estate or in-substance real estate (including equity interests in entities that predominantly

hold real estate assets) to determine whether the integrated set of assets and activities acquired meets the definition of a business and

must be accounted for as a business combination. An acquisition of an integrated set of assets and activities that does not meet the

definition of a business is accounted for as an asset acquisition. If either of the following criteria is met, the integrated set of assets and

activities acquired would not qualify as a business:

•Substantially all of the fair value of the gross assets acquired is concentrated in either a single identifiable asset or a group

of similar identifiable assets; or

•The integrated set of assets and activities is lacking, at a minimum, an input and a substantive process that together

significantly contribute to the ability to create outputs (i.e., revenue generated before and after the transaction).

An acquired process is considered substantive if:

•The process includes an organized workforce (or includes an acquired contract that provides access to an organized

workforce) that is skilled, knowledgeable, and experienced in performing the process;

•The process cannot be replaced without significant cost, effort, or delay; or

•The process is considered unique or scarce.

Generally, our acquisitions of real estate or in-substance real estate do not meet the definition of a business because

substantially all of the fair value is concentrated in a single identifiable asset or group of similar identifiable assets (i.e., land, buildings,

and related intangible assets) or because the acquisition does not include a substantive process in the form of an acquired workforce or

an acquired contract that cannot be replaced without significant cost, effort, or delay. When evaluating acquired service or management

contracts, we consider the nature of the services performed, the terms of the contract relative to similar arm’s-length contracts, and the

availability of comparable vendors in evaluating whether the acquired contract constitutes a substantive process.

Recognition of real estate acquired

We evaluate each acquisition of real estate or in-substance real estate (including equity interests in entities that predominantly

hold real estate assets) to determine whether the integrated set of assets and activities acquired meets the definition of a business and

must be accounted for as a business combination. An acquisition of an integrated set of assets and activities that does not meet the

definition of a business is accounted for as an asset acquisition.

For acquisitions of real estate or in-substance real estate that are accounted for as business combinations, we allocate the

acquisition consideration (excluding acquisition costs) to the assets acquired, liabilities assumed, noncontrolling interests, and

previously existing ownership interests at fair value as of the acquisition date. Assets include intangible assets such as tenant

relationships, acquired in-place leases, and favorable intangibles associated with in-place leases in which we are the lessor. Liabilities

include unfavorable intangibles associated with in-place leases in which we are the lessor. In addition, for acquired in-place finance or

operating leases in which we are the lessee, acquisition consideration is allocated to lease liabilities and related right-of-use assets,

adjusted to reflect favorable or unfavorable terms of the lease when compared with market terms. Any excess (deficit) of the

consideration transferred relative to the fair value of the net assets acquired is accounted for as goodwill (bargain purchase gain).

Acquisition costs related to business combinations are expensed as incurred.

Generally, we expect that acquisitions of real estate or in-substance real estate will not meet the definition of a business

because substantially all of the fair value is concentrated in a single identifiable asset or group of similar identifiable assets (i.e., land,

buildings, and related intangible assets). The accounting model for asset acquisitions is similar to the accounting model for business

combinations, except that the acquisition consideration (including acquisition costs) is allocated to the individual assets acquired and

liabilities assumed on a relative fair value basis. Any excess (deficit) of the consideration transferred relative to the sum of the fair value

of the assets acquired and liabilities assumed is allocated to the individual assets and liabilities based on their relative fair values. As a

result, asset acquisitions do not result in the recognition of goodwill or a bargain purchase gain. Incremental and external direct

acquisition costs related to acquisitions of real estate or in-substance real estate (such as legal and other third-party services) are

capitalized.

13

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

We exercise judgment to determine the key assumptions used to allocate the purchase price of real estate acquired among its

components. The allocation of the consideration to the various components of properties acquired during the year can have an effect on

our net income due to the useful depreciable and amortizable lives applicable to each component and the recognition of the related

depreciation and amortization expense in our consolidated statements of operations. We apply judgment in utilizing available

comparable market information to assess relative fair value. We assess the relative fair values of tangible and intangible assets and

liabilities based on available comparable market information, including estimated replacement costs, rental rates, and recent market

transactions. In addition, we may use estimated cash flow projections that utilize appropriate discount and capitalization rates.

Estimates of future cash flows are based on a number of factors, including the historical operating results, known and anticipated

trends, and market/economic conditions that may affect the property.

The value of tangible assets acquired is based upon our estimation of fair value on an “as if vacant” basis. The value of

acquired in-place leases includes the estimated costs during the hypothetical lease-up period and other costs that would have been

incurred in the execution of similar leases under the market conditions at the acquisition date of the acquired in-place lease. If there is a

bargain fixed-rate renewal option for the period beyond the noncancelable lease term of an in-place lease, we evaluate intangible

factors, such as the business conditions in the industry in which the lessee operates, the economic conditions in the area in which the

property is located, and the ability of the lessee to sublease the property during the renewal term, in order to determine the likelihood

that the lessee will renew. When we determine that the lessee is reasonably certain to exercise such bargain renewal option, we

consider the option in determining the intangible value of such lease and its related amortization period. We also recognize the relative

fair values of assets acquired, the liabilities assumed, and any noncontrolling interest in acquisitions of less than a 100% interest when

the acquisition constitutes a change in control of the acquired entity.

Depreciation and amortization

The values allocated to buildings and building improvements, land improvements, tenant improvements, and equipment are

depreciated on a straight-line basis. For buildings and building improvements, we depreciate using the shorter of the respective ground

lease terms or their estimated useful lives, not to exceed 40 years. Land improvements are depreciated over their estimated useful

lives, not to exceed 20 years. Tenant improvements are depreciated over their respective lease terms or estimated useful lives, and

equipment is depreciated over the shorter of the lease term or its estimated useful life. Right-of-use assets are amortized on a straight-

line basis over the remaining terms of each related lease. The values of acquired in-place leases and associated favorable intangibles

(i.e., acquired above-market leases) are classified in other assets in our consolidated balance sheets and are amortized over the

remaining terms of the related leases as a reduction of income from rentals in our consolidated statements of operations. The values of

unfavorable intangibles (i.e., acquired below-market leases) associated with acquired in-place leases are classified in accounts

payable, accrued expenses, and other liabilities in our consolidated balance sheets and are amortized over the remaining terms of the

related leases as an increase in income from rentals in our consolidated statements of operations.

Capitalized project costs

We capitalize project costs, including pre-construction costs, interest, property taxes, insurance, and other costs directly

related and essential to the development, redevelopment, pre-construction, or construction of a project. Capitalization of development,

redevelopment, pre-construction, and construction costs is required while activities are ongoing to prepare an asset for its intended use.

Fluctuations in our development, redevelopment, pre-construction, and construction activities could result in significant changes to total

expenses and net income. Costs incurred after a project is substantially complete and ready for its intended use are expensed as

incurred. Should development, redevelopment, pre-construction, or construction activity cease, interest, property taxes, insurance, and

certain other costs would no longer be eligible for capitalization and would be expensed as incurred. Expenditures for repairs and

maintenance are expensed as incurred.

Real estate sales

A property is classified as held for sale when all of the following criteria for a plan of sale have been met: (i) management,

having the authority to approve the action, commits to a plan to sell the property; (ii) the property is available for immediate sale in its

present condition, subject only to terms that are usual and customary; (iii) an active program to locate a buyer and other actions

required to complete the plan to sell have been initiated; (iv) the sale of the property is probable and is expected to be completed within

one year; (v) the property is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and

(vi) actions necessary to complete the plan of sale indicate that it is unlikely that significant changes to the plan will be made or that the

plan will be withdrawn. Depreciation of assets ceases upon designation of a property as held for sale.

If the disposal of a property represents a strategic shift that has (or will have) a major effect on our operations or financial

results, such as (i) a major line of business, (ii) a major geographic area, (iii) a major equity method investment, or (iv) other major parts

of an entity, then the operations of the property, including any interest expense directly attributable to it, are classified as discontinued

operations in our consolidated statements of operations, and amounts for all prior periods presented are reclassified from continuing

operations to discontinued operations. The disposal of an individual property generally will not represent a strategic shift and therefore

will typically not meet the criteria for classification as a discontinued operation.

14

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

We recognize gains or losses on real estate sales in accordance with the accounting standard on the derecognition of

nonfinancial assets arising from contracts with noncustomers. Our ordinary output activities consist of the leasing of space to our

tenants in our operating properties, not the sales of real estate. Therefore, sales of real estate (in which we are the seller) qualify as

contracts with noncustomers. In our transactions with noncustomers, we apply certain recognition and measurement principles

consistent with our method of recognizing revenue arising from contracts with customers. Derecognition of the asset is based on the

transfer of control. If a real estate sales contract includes our ongoing involvement with the property, then we evaluate each promised

good or service under the contract to determine whether it represents a separate performance obligation, constitutes a guarantee, or

prevents the transfer of control. If a good or service is considered a separate performance obligation, an allocated portion of the

transaction price is recognized as revenue as we transfer the related good or service to the buyer.

The recognition of gain or loss on the sale of a partial interest also depends on whether we retain a controlling or

noncontrolling interest in the property. If we retain a controlling interest in the property upon completion of the sale, we continue to

reflect the asset at its book value, record a noncontrolling interest for the book value of the partial interest sold, and recognize additional

paid-in capital for the difference between the consideration received and the partial interest at book value. Conversely, if we retain a

noncontrolling interest upon completion of the sale of a partial interest of real estate, we recognize a gain or loss as if 100% of the asset

were sold.

Impairment of long-lived assets

Prior to and subsequent to the end of each quarter, we review current activities and changes in the business conditions of all of

our long-lived assets to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If

triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows, including, if

necessary, a probability-weighted approach if multiple outcomes are under consideration.

Long-lived assets to be held and used, including our rental properties, CIP, land held for development, right-of-use assets

related to operating leases in which we are the lessee, and intangibles, are individually evaluated for impairment when conditions exist

that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be

held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual

disposition of the asset. Triggering events or impairment indicators for long-lived assets to be held and used are assessed by project

and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations,

current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market

factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, projected rental

rates, estimated exit capitalization rates, and anticipated construction costs for projects under construction, which are based on

available market information, current and historical operating results, known trends, current market/economic conditions that may affect

the asset, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes

are under consideration.

Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount of the asset to

its estimated fair value. If an impairment charge is not required to be recognized, the recognition of depreciation or amortization is

adjusted prospectively, as necessary, to reduce the carrying amount of the asset to its estimated disposition value over the remaining

period that the asset is expected to be held and used. We may adjust depreciation of properties that are expected to be disposed of or

redeveloped prior to the end of their useful lives.

We use the held for sale impairment model for our properties classified as held for sale, which is different from the held and

used impairment model. Under the held for sale impairment model, an impairment charge is recognized if the carrying amount of the

long-lived asset classified as held for sale exceeds its fair value less cost to sell. Because of these two different models, it is possible for

a long-lived asset previously classified as held and used to require the recognition of an impairment charge upon classification as held

for sale.

International operations

As of September 30, 2026, in addition to operating properties in the U.S., we had 11 properties in Canada. The functional

currency for our subsidiaries operating in the U.S. is the U.S. dollar. The local currency of a foreign subsidiary serves as its functional

currency. The assets and liabilities of our foreign subsidiaries are translated into U.S. dollars at the exchange rate in effect as of the

financial statement date. Revenue and expense accounts of our foreign subsidiaries are translated using the weighted-average

exchange rate for the periods presented. Gains or losses resulting from the translation are classified in accumulated other

comprehensive income (loss) as a separate component of total equity and are excluded from net income (loss).

15

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Whenever a foreign investment meets the criteria for classification as held for sale, we evaluate the recoverability of the

investment under the held for sale impairment model. We may recognize an impairment charge if the carrying amount of the investment

exceeds its fair value less cost to sell. In determining an investment’s carrying amount, we consider its net book value and any

cumulative unrealized foreign currency translation adjustment related to the investment. The appropriate amounts of foreign exchange

rate gains or losses classified in accumulated other comprehensive income (loss) are reclassified to net income (loss) when realized

upon the sale of our investment or upon the complete or substantially complete liquidation of our investment.

Investments

We hold investments in publicly traded companies and privately held entities primarily involved in the life science industry. As a

REIT, we generally limit our ownership of each individual entity’s voting stock to less than 10%. We evaluate each investment to

determine whether we have the ability to exercise significant influence, but not control, over an investee. We evaluate investments in

which our ownership is equal to or greater than 20%, but less than or equal to 50%, of an investee’s voting stock with a presumption

that we have this ability. For our investments in limited partnerships that maintain specific ownership accounts, we presume that such

ability exists when our ownership interest exceeds 3% to 5%. In addition to our ownership interest, we consider whether we have a

board seat or whether we participate in the investee’s policy-making process, among other criteria, to determine if we have the ability to

exert significant influence, but not control, over an investee. If we determine that we have such ability, we account for the investment

under the equity method, as described below. From time to time, we may hold equity investments in publicly traded companies that are

subject to temporary contractual sale restrictions. We do not recognize a discount related to a contractual sale restriction.

Investments accounted for under the equity method

Under the equity method of accounting, we initially recognize our investment at cost and subsequently adjust the carrying

amount of the investment for our share of earnings or losses reported by the investee, distributions received, and other-than-temporary

impairments. For additional information about our investments accounted for under the equity method, refer to Note 7 – “Investments” to

our unaudited consolidated financial statements.

Investments that do not qualify for the equity method of accounting

For investees over which we determine that we do not have the ability to exercise significant influence or control, we account

for each investment depending on whether it is an investment in a (i) publicly traded company, (ii) privately held entity that reports NAV

per share, or (iii) privately held entity that does not report NAV per share, as described below.

Investments in publicly traded companies

Our investments in publicly traded companies are classified as investments with readily determinable fair values and are

presented at fair value in our consolidated balance sheets, with changes in fair value classified in investment income (losses) in our

consolidated statements of operations. The fair values for our investments in publicly traded companies are determined based on sales

prices or quotes available on securities exchanges.

Investments in privately held companies

Our investments in privately held entities without readily determinable fair values consist of (i) investments in privately held

entities that report NAV per share and (ii) investments in privately held entities that do not report NAV per share. These investments are

accounted for as follows:

Investments in privately held entities that report NAV per share

Investments in privately held entities that report NAV per share, such as our privately held investments in limited partnerships,

are presented at fair value using NAV as a practical expedient, with changes in fair value classified in investment income (losses) in our

consolidated statements of operations. We use NAV per share reported by limited partnerships generally without adjustment, unless we

are aware of information indicating that the NAV reported by a limited partnership does not accurately reflect the fair value of the

investment at our reporting date.

Investments in privately held entities that do not report NAV per share

Investments in privately held entities that do not report NAV per share are accounted for using a measurement alternative

under which these investments are measured at cost, adjusted for observable price changes and impairments, with changes classified

in investment income (losses) in our consolidated statements of operations.

16

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

An observable price arises from an orderly transaction for an identical or similar investment of the same issuer, which is

observed by an investor without expending undue cost and effort. Observable price changes result from, among other things, equity

transactions of the same issuer executed during the reporting period, including subsequent equity offerings or other reported equity

transactions related to the same issuer. To determine whether these transactions are indicative of an observable price change, we

evaluate, among other factors, whether these transactions have similar rights and obligations, including voting rights, distribution

preferences, and conversion rights to the investments we hold.

Impairment evaluation of equity method investments and investments in privately held entities that do not report NAV per share

We monitor equity method investments and investments in privately held entities that do not report NAV per share for new

developments, including operating results, prospects and results of clinical trials, new product initiatives, new collaborative agreements,

capital-raising events, and merger and acquisition activities. These investments are evaluated on the basis of a qualitative assessment

for indicators of impairment by monitoring the presence of the following triggering events or impairment indicators:

(i)a significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee;

(ii)a significant adverse change in the regulatory, economic, or technological environment of the investee;

(iii)a significant adverse change in the general market condition, including the research and development of technology and

products that the investee is bringing or attempting to bring to the market;

(iv)significant concerns about the investee’s ability to continue as a going concern; and/or

(v)a decision by investors to cease providing support or reduce their financial commitment to the investee.

If such indicators are present, we are required to estimate the investment’s fair value and immediately recognize an

impairment charge in an amount equal to the investment’s carrying value in excess of its estimated fair value.

Investment income/loss recognition and classification

We recognize both realized and unrealized gains and losses in our consolidated statements of operations, classified in

investment income (losses) in our consolidated statements of operations. Unrealized gains and losses represent:

(i)changes in fair value for investments in publicly traded companies;

(ii)changes in NAV for investments in privately held entities that report NAV per share;

(iii)observable price changes for investments in privately held entities that do not report NAV per share; and

(iv)our share of unrealized gains or losses reported by our equity method investees.

Realized gains and losses on our investments represent the difference between proceeds received upon disposition of

investments and their historical or adjusted cost basis. For our equity method investments, realized gains and losses represent our

share of realized gains or losses reported by the investee. Impairments are realized losses, which result in an adjusted cost basis, and

represent charges to reduce the carrying values of investments in privately held entities that do not report NAV per share and equity

method investments, if impairments are deemed other than temporary, to their estimated fair value.

Revenues

The table below provides details of our consolidated total revenues for the three and nine months ended September 30, 2026

and 2025 (in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Income from rentals:

Revenues subject to the lease accounting standard:

Operating leases

$641,492

$722,643

$1,911,559

$2,176,999

Direct financing and sales-type leases

686

1,409

2,542

3,308

Revenues subject to the lease accounting standard

642,178

724,052

1,914,101

2,180,307

Revenues subject to the revenue recognition

accounting standard

11,440

11,797

35,740

35,996

Income from rentals

653,618

735,849

1,949,841

2,216,303

Other income

17,564

16,095

55,147

55,839

Total revenues

$671,182

$751,944

$2,004,988

$2,272,142

17

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

During the three and nine months ended September 30, 2026, revenues that were subject to the lease accounting standard

aggregated $642.2 million and $1.91 billion, respectively, and represented 95.7% and 95.5% of our total revenues. During the three and

nine months ended September 30, 2025, revenues that were subject to the lease accounting standard aggregated $724.1 million and

$2.18 billion, respectively, and represented 96.3% and 96.0% of our total revenues. Our other income consisted primarily of

management and other fees and interest income earned during each period presented. For a detailed discussion related to our revenue

streams, refer to “Lease accounting” and “Recognition of revenue arising from contracts with customers” in Note 2 – “Summary of

significant accounting policies” to our unaudited consolidated financial statements.

Lease accounting

Definition and classification of a lease

When we enter into a contract or amend an existing contract, we evaluate whether the contract meets the definition of a lease.

To meet the definition of a lease, the contract must meet all three criteria:

(i)One party (lessor) must hold an identified asset;

(ii)The counterparty (lessee) must have the right to obtain substantially all of the economic benefits from the use of the asset

throughout the period of the contract; and

(iii)The counterparty (lessee) must have the right to direct the use of the identified asset throughout the period of the contract.

We classify our leases as either finance leases or operating leases if we are the lessee, or sales-type, direct financing, or

operating leases if we are the lessor. We use the following criteria to determine if a lease is a finance lease (as a lessee) or sales-type

or direct financing lease (as a lessor):

(i)Ownership is transferred from lessor to lessee by the end of the lease term;

(ii)An option to purchase is reasonably certain to be exercised;

(iii)The lease term is for the major part of the underlying asset’s remaining economic life;

(iv)The present value of lease payments equals or exceeds substantially all of the fair value of the underlying asset; or

(v)The underlying asset is specialized and is expected to have no alternative use at the end of the lease term.

If a lease meets any of the above criteria, we account for it as a finance, a sales-type, or a direct financing lease. If a lease

does not meet any of the criteria, we account for it as an operating lease.

A lease is accounted for as a sales-type lease if it is considered to transfer control of the underlying asset to the lessee. A

lease is accounted for as a direct financing lease if risks and rewards are conveyed without the transfer of control, which is normally

indicated by the existence of a residual value guarantee from an unrelated third party other than the lessee.

This classification will determine the method of recognition of the lease:

•For an operating lease, we recognize income from rentals if we are the lessor, or rental operations expense if we are the

lessee, over the term of the lease on a straight-line basis.

•For a sales-type lease or a direct financing lease, we recognize the income from rentals, or for a finance lease, we

recognize rental operations expense, over the term of the lease using the effective interest method.

•At inception of a sales-type lease or a direct financing lease, if we determine the fair value of the leased property is lower

than its carrying amount, we recognize a selling loss immediately at lease commencement. If fair value exceeds the

carrying amount of a lease, a gain is recognized at lease commencement on a sales-type lease. For a direct financing

lease, a gain is deferred at lease commencement and amortized over the lease term.

18

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Lessor accounting

Costs to execute leases

We capitalize initial direct costs, which represent only incremental costs to execute a lease that would not have been incurred

if the lease had not been obtained. Costs that we incur to negotiate or arrange a lease, regardless of its outcome, such as for fixed

employee compensation, tax or legal advice to negotiate lease terms, and other costs, are expensed as incurred.

Operating leases

We account for the revenue from our lease contracts by utilizing the single component accounting policy. This policy requires

us to account for, by class of underlying asset, the lease component and nonlease component(s) associated with each lease as a single

component if two criteria are met:

(i)The timing and pattern of transfer of the lease component and the nonlease component(s) are the same; and

(ii)The lease component would be classified as an operating lease if it were accounted for separately.

Lease components consist primarily of fixed rental payments, which represent scheduled rental amounts due under our

leases, and contingent rental payments. Nonlease components consist primarily of tenant recoveries representing reimbursements of

rental operating expenses under our triple net lease structure, including recoveries for property taxes, insurance, utilities, repairs and

maintenance, and common area expenses.

If the lease component is the predominant component, we account for all revenues under such lease as a single component in

accordance with the lease accounting standard. Conversely, if the nonlease component is the predominant component, all revenues

under such lease are accounted for in accordance with the revenue recognition accounting standard. Our operating leases qualify for

the single component accounting, and the lease component in each of our leases is predominant. Therefore, we account for all

revenues from our operating leases under the lease accounting standard and classify these revenues as income from rentals in our

consolidated statements of operations.

We commence recognition of income from rentals related to the operating leases at the date the property is ready for its

intended use by the tenant and the tenant takes possession or controls the physical use of the leased asset. When a lease includes

construction of improvements, we determine whether the improvements are landlord or tenant assets. In determining if the

improvements are landlord or tenant improvements, we consider various factors, including, but not limited to, the following:

•Which party retains legal title to the improvements upon lease expiration;

•Whether the improvements are expected to have significant residual value at the end of the lease term;

•Whether the improvements are unique to the tenant;

•What happens to the improvements upon lease expiration (i.e., whether they are removed or preserved for the landlord);

•Which party bears all costs of the improvements (including the risk of cost overruns); and

•Which party supervises the construction of the improvements.

If the improvements are landlord assets, we capitalize such improvements. If the improvements are tenant assets, we do not

capitalize these assets. Improvements that qualify as tenant assets, if funded by us, are accounted for as lease incentives and

amortized as a reduction of revenue over the term of the lease. If the tenant funds improvements without reimbursement from us, and

we determine these improvements to be landlord assets, we consider the amount associated with the improvements to be non-cash

lease payments, which are recognized as incremental revenue over the term of the related lease.

Income from rentals related to fixed rental payments under operating leases is recognized on a straight-line basis over the

respective operating lease terms. We classify amounts expected to be received in later periods as deferred rent in our consolidated

balance sheets. Amounts received currently but recognized as revenue in future periods are classified in accounts payable, accrued

expenses, and other liabilities in our consolidated balance sheets.

Income from rentals related to variable payments includes tenant recoveries and contingent rental payments. Tenant

recoveries, including reimbursements of utilities, repairs and maintenance, common area expenses, real estate taxes and insurance,

and other operating expenses, are recognized as revenue in the period during which the applicable expenses are incurred and the

tenant’s obligation to reimburse us arises. Income from rentals related to other variable payments is recognized when associated

contingencies are removed.

We assess collectibility of future lease payments from our tenants for each of our operating leases. If we determine that

collectibility is probable, we recognize income from rentals based on the methodology described above. If we determine that

collectibility is not probable, we recognize an adjustment to lower our income from rentals. Furthermore, we may recognize a general

allowance at a portfolio level (not the individual level) if we do not expect to collect future lease payments in full.

19

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

For each lease for which we determine that collectibility of future lease payments is not probable, we cease the recognition of

income from rentals on a straight-line basis and limit the recognition of income to the lesser of payments collected from the lessee or

lease income that would have been recognized on a straight-line basis. We do not resume straight-line recognition of income from

rentals for these leases until we determine that the collectibility of future payments related to these leases is probable. We also record a

general allowance related to the deferred rent balances that at the portfolio level (not the individual level) are not expected to be

collected in full through the lease term. As of September 30, 2026 and December 31, 2025, our general allowance balance aggregated

$27.0 million and $14.3 million, respectively.

Direct financing and sales-type leases

Income from rentals related to direct financing and sales-type leases is recognized over the lease term using the effective

interest rate method. At lease commencement, we derecognize the underlying asset classified within investments in real estate and

record net investment in a lease within other assets in our consolidated balance sheets. This initial net investment is determined by

aggregating the present values of the total future lease payments and the estimated residual value of the property, less any unearned

income related to a direct financing lease. Over the lease term, the investment in the lease accretes in value, producing a constant

periodic rate of return on the net investment in the lease. Income from these leases is classified in income from rentals in our

consolidated statements of operations. Lease payments received reduce the net investment in the lease.

We evaluate our net investment in direct financing and sales-type leases for impairment under the current expected credit

losses accounting standard. For additional information, refer to “Provision for expected credit losses” in Note 2 – “Summary of

significant accounting policies” to our unaudited consolidated financial statements.

As a lessor, we classify a lease with variable lease payments that do not depend on an index or a rate as an operating lease

on the commencement date of the lease if both of the following criteria are met:

(i)The lease would have been classified as a sales-type lease or direct financing lease under the current lease accounting

standard; and

(ii)The sales-type lease or direct financing lease classification would have resulted in a selling loss at lease commencement.

We do not derecognize the underlying asset and do not recognize a loss upon lease commencement but continue to

depreciate the underlying asset over its useful life.

Lessee accounting

We have operating lease agreements in which we are the lessee consisting of ground and office leases. At the lease

commencement date (or at the acquisition date if the lease is acquired as part of a real estate acquisition), we are required to recognize

a liability to account for our future obligations under these operating leases, and a corresponding right-of-use asset.

The lease liability is measured based on the present value of the future lease payments, including payments during the term

under our extension options that we are reasonably certain to exercise. The present value of the future lease payments is calculated for

each operating lease using each respective remaining lease term and a corresponding estimated incremental borrowing rate, which is

the interest rate that we estimate we would have to pay to borrow on a collateralized basis over a similar term for an amount equal to

the lease payments. Subsequently, the lease liability is accreted by applying a discount rate established at the lease commencement

date to the lease liability balance as of the beginning of the period and is reduced by the payments made during the period. We classify

the operating lease liability in accounts payable, accrued expenses, and other liabilities in our consolidated balance sheets.

The right-of-use asset is measured based on the corresponding lease liability, adjusted for initial direct leasing costs and any

other consideration exchanged with the landlord prior to the commencement of the lease, as well as adjustments to reflect favorable or

unfavorable terms of an acquired lease when compared with market terms at the time of acquisition. Subsequently, the right-of-use

asset is amortized on a straight-line basis during the lease term. We classify the right-of-use asset in other assets in our consolidated

balance sheets.

Recognition of revenue arising from contracts with customers

We recognize revenues associated with transactions arising from contracts with customers, excluding revenues subject to the

lease accounting standard discussed in “Lease accounting” above, in accordance with the revenue recognition accounting standard. A

customer is distinguished from a noncustomer by the nature of the goods or services that are transferred. Customers are provided with

goods or services that are generated by a company’s ordinary output activities, whereas noncustomers are provided with nonfinancial

assets that are outside of a company’s ordinary output activities.

20

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

We generally recognize revenue representing the transfer of goods and services to customers in an amount that reflects the

consideration to which we expect to be entitled in the exchange. In order to determine the recognition of revenue from customer

contracts, we use a five-step model to (i) identify the contract with the customer, (ii) identify the performance obligations in the contract,

(iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will

not occur, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we

satisfy the performance obligation.

We identify contractual performance obligations and determine whether revenue should be recognized at a point in time or

over time, based on when control of goods and services transfers to a customer. We consider whether we control the goods or services

prior to the transfer to the customer in order to determine whether we should account for the arrangement as a principal or agent. If we

determine that we control the goods or services provided to the customer, then we are the principal to the transaction, and we recognize

the gross amount of consideration expected in the exchange. If we simply arrange but do not control the goods or services being

transferred to the customer, then we are considered to be an agent to the transaction, and we recognize the net amount of

consideration we are entitled to retain in the exchange.

Total revenues subject to the revenue recognition accounting standard and classified within income from rentals in our

consolidated statements of operations for the three and nine months ended September 30, 2026 included $11.4 million and $35.7

million, respectively, primarily related to short-term parking revenues associated with long-term lease agreements. Short-term parking

revenues do not qualify for the single component accounting policy, as discussed in “Lessor accounting” in Note 2 – “Summary of

significant accounting policies,” due to the difference in the timing and pattern of transfer of our parking service obligations and

associated lease components within the same lease agreement. We recognize short-term parking revenues in accordance with the

revenue recognition accounting standard when the service is provided and the performance obligation is satisfied, which normally

occurs at a point in time.

Monitoring of tenant credit quality

During the term of each lease, we monitor the credit quality and any related material changes of our tenants by (i) monitoring

the credit rating of tenants that are rated by a nationally recognized credit rating agency, (ii) reviewing financial statements of the

tenants that are publicly available or that are required to be delivered to us pursuant to the applicable lease, (iii) monitoring news

reports regarding our tenants and their respective businesses, and (iv) monitoring the timeliness of lease payments.

Notes receivable

We carry notes receivable at amortized cost, adjusted for an estimated provision for expected credit losses. Interest income on

notes receivable is recognized using the effective interest rate method and is classified within other income in our consolidated

statements of operations. Direct costs incurred in originating notes, along with any premium or discount, are deferred and amortized as

an adjustment to interest income over the note’s term using the effective interest rate method. Notes receivable are classified within

other assets in our consolidated balance sheets. Refer to Note 8 – “Other assets” to our unaudited consolidated financial statements for

additional details.

Provision for expected credit losses

We are required to estimate and recognize lifetime expected losses, rather than incurred losses, for most financial assets

measured at amortized cost and certain other instruments, including trade, notes, and other receivables (excluding receivables arising

from operating leases), loans, held-to-maturity debt securities, net investments in leases arising from sales-type and direct financing

leases, and off-balance-sheet credit exposures (e.g., loan commitments). The recognition of such expected losses, even if the expected

risk of credit loss is remote, typically results in earlier recognition of credit losses. At each reporting date, we reassess our provision for

expected credit losses, and, if necessary, we recognize an adjustment for our current estimate of expected credit losses. Refer to

Note 5 – “Leases” and Note 8 – “Other assets” to our unaudited consolidated financial statements for additional details.

An assessment of the collectibility of operating lease payments and the recognition of an adjustment to lease income based on

this assessment is governed by the lease accounting standard discussed in “Lease accounting” earlier in Note 2 — “Summary of

significant accounting policies” to our unaudited consolidated financial statements.

Income taxes

We are organized and operate as a REIT pursuant to the Internal Revenue Code (the “Code”). Under the Code, a REIT that

distributes at least 90% of its REIT taxable income to its stockholders annually (excluding net capital gains) and meets certain other

conditions is not subject to federal income tax on its distributed taxable income, but could be subject to certain federal, foreign, state,

and local taxes. We distribute 100% of our taxable income annually; therefore, a provision for federal income taxes is not required. In

addition to our REIT returns, we file federal, foreign, state, and local tax returns for our subsidiaries. We file with jurisdictions located in

the U.S., Canada, and other international locations. Our tax returns are subject to routine examination in various jurisdictions for the

2020 through 2025 calendar years.

21

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Employee and non-employee share-based awards

We have implemented an entity-wide accounting policy to account for forfeitures related to unmet service conditions of share-

based awards granted to employees and non-employees when they occur. Under this policy, when forfeitures occur, any previously

recognized expense related to those forfeited awards is reversed in the period of forfeiture.

Our employee and non-employee share-based awards are measured at fair value on the grant date and recognized over the

recipient’s required service period. For share-based awards with performance conditions, we continue to assess the probability of

achieving the performance conditions and recognize expense only when it becomes probable that the performance targets will be met.

Conversely, for share-based awards with market conditions, expense is recognized regardless of whether the market condition is met.

Dividends paid on share-based awards with nonforfeitable dividends are initially classified in retained earnings and reclassified

to compensation cost only if the underlying awards are forfeited. Conversely, for share-based awards with forfeitable dividends,

declared dividends are initially classified in retained earnings and in dividends payable within our consolidated balance sheets. If the

underlying awards are forfeited, the corresponding accrued dividend is reversed in the period of forfeiture. Upon vesting of the

underlying share-based awards with forfeitable dividends, the accumulated dividend payment is made and the dividend payable liability

is settled.

Forward equity sales agreements

From time to time, we enter into forward equity sales agreements and account for them in accordance with the accounting

guidance governing financial instruments and derivatives. Under the accounting guidance, our forward equity sales agreements are

typically not deemed to be liabilities as they generally do not embody obligations to repurchase our shares, nor do they embody

obligations to issue a variable number of shares for which the monetary value is predominantly fixed, varied with something other than

the fair value of our shares, or varied inversely in relation to our shares. We also evaluate whether the agreements meet the derivatives

and hedging guidance scope exception to be accounted for as equity instruments. Our forward equity sales agreements are classified

as equity contracts based on the following assessment: (i) none of the agreements’ exercise contingencies are based on observable

markets or indices besides those related to the market for our own stock price and operations; and (ii) none of the settlement provisions

preclude the agreements from being indexed to our own stock.

Hedge accounting

From time to time, we utilize derivative instruments to manage our exposure to certain risks, including interest rate and foreign

currency exchange rate risks. We are exposed to foreign currency exchange rate risk related to our net investment in Canada. To

mitigate the impact of fluctuations in the USD-CAD exchange rate associated with our net investment in Canada, we use cross-currency

swap agreements designated and qualifying as net investment hedges under applicable derivatives and hedging standards.

We designate the USD-CAD cross-currency swap agreements as net investment hedges using the spot method to assess

hedge effectiveness. The spot component represents changes in fair value attributable to movements in the USD-CAD spot exchange

rate, which reflects the market exchange rate between the two currencies as of each reporting date. Changes in the fair value of the

designated spot component are recorded in other comprehensive income (loss) as part of the foreign currency translation adjustment,

to the extent the relationship is highly effective, until the net investment is sold or substantially liquidated. The related amounts due from

or due to counterparties are included in other assets or in accounts payable, accrued expenses, and other liabilities, respectively, within

our consolidated balance sheet.

We elected to account for the forward points (the portion of the derivative’s fair value attributable to the difference between the

forward exchange rate and spot exchange rate) as an excluded component in accordance with applicable derivatives and hedging

accounting standards. The excluded component is recognized over the life of the cross-currency swap agreements using a systematic

and rational basis (as interest settlements occur) and is classified within other income in our consolidated statement of operations.

Issuer and guarantor subsidiaries of guaranteed securities

Generally, a parent entity of an issuer that holds guaranteed securities must provide separate subsidiary issuer or guarantor

financial statements, unless it qualifies for disclosure exceptions. A parent entity may be eligible for disclosure exceptions if it meets the

following criteria:

(i)The subsidiary issuer or guarantor is a consolidated subsidiary of the parent company, and

(ii)The subsidiary issues a registered security that is:

•issued jointly and severally with the parent company, or

•fully and unconditionally guaranteed by the parent company.

A parent entity that meets the above criteria may instead present summarized financial information (“alternative disclosures”)

either within the consolidated financial statements or in “Item 2. Management’s discussion and analysis of financial condition and results

of operations” (“Item 2”). We evaluated the criteria and determined that we are eligible for the disclosure exceptions, which allow us to

provide alternative disclosures; as such, we present alternative disclosures in Item 2.

22

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Loan fees

Fees incurred in obtaining long-term financing are capitalized and classified with the corresponding debt instrument appearing

on our consolidated balance sheets. Loan fees related to our unsecured senior line of credit are capitalized and classified within other

assets. Capitalized amounts are amortized over the term of the related loan, and the amortization is classified in interest expense in our

consolidated statements of operations.

Distributions from equity method investments

We use the “nature of the distribution” approach to determine the classification within our consolidated statements of cash

flows of cash distributions received from equity method investments, including our unconsolidated real estate joint ventures and equity

method non-real estate investments. Under this approach, distributions are classified based on the nature of the underlying activity that

generated the cash distributions. If we lack the information necessary to apply this approach in the future, we will be required to apply

the “cumulative earnings” approach as an accounting change on a retrospective basis. Under the cumulative earnings approach,

distributions up to the amount of cumulative equity in earnings recognized are classified as cash inflows from operating activities, and

those in excess of that amount are classified as cash inflows from investing activities.

Restricted cash

We present cash and cash equivalents separately from restricted cash within our consolidated balance sheets. However, we

include restricted cash with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown

in the consolidated statements of cash flows. We provide a reconciliation between the consolidated balance sheets and the

consolidated statements of cash flows, which is required when the balance includes more than one line item for cash, cash equivalents,

and restricted cash. We also provide a disclosure of the nature of the restrictions related to material restricted cash balances.

Recent accounting pronouncements

On November 4, 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which will require

entities to provide enhanced disclosures related to certain expense categories included in line items on the statement of operations.

The ASU aims to increase transparency and provide investors with additional detailed information about the nature of expenses

reported on the face of the income statement. The new standard does not change the requirements for the presentation of expenses on

the face of the statement of operations.

Under this ASU, entities are required to disaggregate, in a tabular format, expense line items presented on the face of the

statement of operations — excluding earnings or losses from equity method investments — if they include any of the following expense

categories: employee compensation, depreciation, intangible asset amortization, depletion, and purchases of inventory. For any

remaining items within each relevant expense line item, entities must provide a qualitative description of the nature of those expenses.

The new ASU is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after

December 15, 2027. Early adoption is permitted. We expect to adopt this ASU on January 1, 2027. Although the adoption is not

expected to have an impact on our financial statements, it is expected to result in incremental disclosures within the notes to our

consolidated financial statements.

23

3.INVESTMENTS IN REAL ESTATE

Our consolidated investments in real estate consisted of the following as of September 30, 2026 and December 31, 2025 (in

thousands):

September 30, 2026

December 31, 2025

Rental properties:

Land (related to rental properties)

$3,677,185

$3,204,479

Buildings and building improvements

21,200,081

19,738,825

Other improvements

4,861,970

4,371,720

Rental properties

29,739,236

27,315,024

Current and future development and redevelopment projects

4,627,533

6,788,464

Gross investments in real estate

34,366,769

34,103,488

Less: accumulated depreciation

(6,521,199)

(5,970,171)

Investments in real estate assets held for sale, less accumulated depreciation(1)

581,429

556,679

Investments in real estate

$28,426,999

$28,689,996

(1)Refer to “Assets held for sale” below.

Assets held for sale

As of September 30, 2026, we had 18 operating properties and one development project aggregating 1.3 million RSF, and land

parcels aggregating 2.1 million SF that were classified as held for sale.

The disposal of the properties classified as held for sale does not represent a strategic shift that has, or will have, a major

effect on our operations or financial results, as the dispositions relate to an individual asset or a group of assets across multiple markets

and do not represent the exit from any significant market. Accordingly, these assets do not meet the criteria for classification as

discontinued operations. We cease depreciation of our properties upon their classification as held for sale.

The following table presents the components of net assets related to real estate investments that met the criteria for

classification as held for sale as of September 30, 2026 and December 31, 2025 (in thousands):

September 30, 2026

December 31, 2025

Investments in real estate, less accumulated depreciation

$581,429

$556,679

Other assets

122,913

37,859

Total assets

704,342

594,538

Total liabilities

(3,767)

(12,235)

Total accumulated other comprehensive loss (income)

2,205

(566)

Net assets classified as held for sale

$702,780

$581,737

For additional information, refer to “Real estate sales” in Note 2 – “Summary of significant accounting policies” to our unaudited

consolidated financial statements.

24

3.INVESTMENTS IN REAL ESTATE (continued)

Sales of real estate assets and impairment of real estate

Our completed dispositions of real estate assets during the nine months ended September 30, 2026 and in October 2026

consisted of the following (dollars in thousands):

Square Footage

Sales Price

(Our Share)

Property

Submarket/Market

Date of

Sale

Interest

Sold

Operating

Land and

Future

Completed during nine months ended September 30, 2026:

3825 and 3875 Fabian Way

Palo Alto/San Francisco Bay Area

7/14/26

100%

228,000

250,000

$163,000

One Hampshire Street

Cambridge/Greater Boston

8/21/26

100%

104,956

—

44,900

3911, 3931, 4025, 4031, 4045, and 4075

Sorrento Valley Boulevard

Sorrento Valley/San Diego

9/23/26

100%

95,814

144,000

26,500

Other

Various

7,350

241,750

(1)

Completed in October 2026:

Campus Point by Alexandria(2)

University Town Center/San Diego

10/23/26

(2)

1,586,697

366,816

475,000

$716,750

(1)Represents the aggregate contractual sales price of our dispositions, which differs from the sum of sales proceeds disclosed in our consolidated statement of cash flows

under “Investing activities” (proceeds from sales of real estate), amounts under “Financing activities” (contributions from and sales of noncontrolling interests), and

amounts under “Supplemental disclosure and non-cash investing and financing activities” (non-cash consideration) primarily due to the timing of payment, closing costs,

and other sales adjustments such as prorations of rents and expenses.

(2)Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for additional details.

Impairment of real estate

During the nine months ended September 30, 2026, we recognized impairment charges aggregating $865.9 million, classified

within impairment of real estate in our consolidated statement of operations, primarily related to the following assets:

Greater Boston market

•During the three months ended June 30, 2026, we recognized an additional impairment charge of $24.8 million related to one

vacant office property, aggregating 104,956 RSF, in the Cambridge submarket of our Greater Boston market, to reduce its

carrying amount to its updated estimated fair value less costs to sell of approximately $43.7 million based on recent

negotiations with a potential buyer. This asset was classified as held for sale in December 2025 following our assessment of

the project’s financial outlook, including the significant capital required to redevelop and lease the property. As a result, we

decided to sell this asset and reinvest the sales proceeds in other projects with greater value-creation opportunities, and

recognized an impairment charge of $105.7 million in December 2025. The sale was completed in August 2026, with no gain

or loss recognized.

•Impairment charge of $343.3 million was recognized to reduce the carrying amount of one development property at 421 Park

Drive in our Fenway submarket, to its estimated fair value less costs to sell of approximately $238.9 million based on recent

negotiations with an institutional user for the sale of 339,668 RSF, representing substantially all of the 392,011 RSF

development project at this location. The asset met the criteria for classification as held for sale as of September 30, 2026,

following our decision to sell and reallocate the substantial near-term capital that the asset would have required to complete

the development toward other projects with greater value-creation opportunities. We expect to complete the sale within the

next 12 months.

San Diego market

•During the three months ended June 30, 2026, an impairment charge of $64.2 million was recognized to reduce the carrying

amount of a land parcel located outside of a Megacampus aggregating 425,000 SF in the Sorrento Mesa submarket of our

San Diego market, to its estimated fair value less costs to sell of approximately $43.3 million. The land parcel met the criteria

for classification as held for sale as of June 30, 2026, following our reevaluation of the capital required to develop the site and

its alignment with our Megacampus strategy, resulting in our decision to monetize the asset and reallocate capital to other

projects with greater value-creation opportunities. The asset is expected to be sold to a residential developer and we expect to

complete the sale within the next 12 months.

•During the three months ended June 30, 2026, an impairment charge of $28.2 million was recognized to reduce the carrying

amounts of five operating properties, primarily comprising non-laboratory space, aggregating 95,814 RSF and one land parcel

aggregating 144,000 SF in the Sorrento Valley submarket of our San Diego market, to their estimated fair values less costs to

sell of approximately $26.7 million. These assets met the criteria for classification as held for sale as of June 30, 2026,

following our evaluation of the significant capital that would have been required to convert these properties through

redevelopment for laboratory use and their lack of alignment with our Megacampus strategy, resulting in our decision to

monetize these assets and reallocate capital to other projects with greater value-creation opportunities. The sale was

completed in September 2026, with no gain or loss recognized.

25

3.INVESTMENTS IN REAL ESTATE (continued)

•Impairment charge of $9.4 million was recognized during the three months ended September 30, 2026 to reduce the carrying

amount of one operating property aggregating 27,689 RSF in the Sorrento Valley submarket of our San Diego market, to its

estimated fair value less costs to sell of approximately $10.9 million. This asset met the criteria for classification as held for

sale as of September 30, 2026, following our evaluation of the asset’s lack of alignment with our Megacampus strategy,

resulting in our decision to sell this asset and reallocate capital to other projects with greater value-creation opportunities. We

expect to complete the sale within the next 12 months.

•During the three months ended September 30, 2026, we recognized an additional impairment charge of $8.5 million related to

four operating properties, aggregating 157,449 RSF in the Sorrento Mesa and Sorrento Valley submarkets of our San Diego

market, to reduce the carrying amounts to their estimated fair values less costs to sell of approximately $54.7 million based on

updated negotiations with prospective buyers. These assets were classified as held for sale as of June 30, 2026, following our

decision to dispose of these properties and reinvest the sales proceeds in other projects with greater value-creation

opportunities, at which time we recognized an impairment charge of $4.2 million. We expect to complete the sales within the

next 12 months.

San Francisco Bay Area market

•During the three months ended June 30, 2026, we recognized an additional impairment charge of $29.3 million related to one

future development project, aggregating 1.1 million SF, in the SoMa submarket of our San Francisco Bay Area market. The

additional impairment charge was recognized to reduce the carrying amount of this asset to its updated estimated fair value

less costs to sell of approximately $41.8 million based on recent negotiations with a potential buyer. The asset was classified

as held for sale in December 2025 following our commitment to dispose of it and reinvest the sales proceeds in other projects

with greater value-creation opportunities, resulting in an impairment charge of $333.4 million recognized in December 2025.

We expect to complete the sale within the next 12 months.

•In June 2026, we entered into a purchase and sale agreement to sell a previously impaired future development project

aggregating 250,000 SF and one operating property aggregating 228,000 RSF in the Palo Alto submarket of our San

Francisco Bay Area market. These assets were classified as held for sale in December 2025, at which time we recognized an

impairment charge of $144.7 million. During the three months ended June 30, 2026, we recognized a $23.3 million partial

reversal of the impairment charge to increase the carrying values of the assets to their aggregate sales price of $163.0 million,

less costs to sell. This adjustment was recorded as a partial offset to impairment of real estate in our consolidated statements

of operations and did not exceed the cumulative impairment previously recognized on these assets. The sale was completed

in July 2026, with no gain or loss recognized.

•Impairment charge of $135.3 million was recognized to reduce the carrying amounts of four vacant office properties,

aggregating 292,746 RSF, located on a non-Megacampus in the Palo Alto submarket of our San Francisco Bay Area market,

to their estimated fair values less costs to sell of approximately $95.3 million. These assets met the criteria for classification as

held for sale as of September 30, 2026. We acquired these office properties in 2022 with the intent to redevelop them into

laboratory space. Following our evaluation of the significant capital that would have been required to convert these properties

and to lease the vacant spaces, we decided to sell these assets and reallocate capital to other projects with greater value-

creation opportunities. We expect to complete the sale within the next 12 months.

•Impairment charge of $79.2 million was recognized to reduce the carrying amounts of six non-Megacampus properties

aggregating 103,325 RSF in the San Carlos submarket of our San Francisco Bay Area market, to their estimated fair values

less costs to sell of approximately $39.4 million. These assets met the criteria for classification as held for sale as of

September 30, 2026. We acquired these office-flex assets in 2021 with the intent to redevelop them into laboratory space.

Following our evaluation of the significant capital that would have been required to convert these properties, we decided to sell

the assets and reallocate the proceeds to other projects with greater value-creation opportunities. We expect to complete the

sale within the next 12 months.

•Impairment charge of $41.6 million was recognized to reduce the carrying amount of one future development project

aggregating 240,000 SF in the Palo Alto submarket of our San Francisco Bay Area market, to its estimated fair value less

costs to sell of approximately $124.2 million. This non-Megacampus asset met the criteria for classification as held for sale as

of September 30, 2026, following our decision to sell the property. Originally acquired in 2018 to support the expansion of our

Megacampus ecosystem, the project was evaluated based on an updated assessment of its financial outlook, including the

capital required to complete the development and lease the property. As a result, we decided to sell the asset and reallocate

the proceeds to other projects with greater value-creation opportunities. We expect to complete the sale within the next 12

months.

Texas market

•Impairment charge of $50.4 million was recognized to reduce the carrying amount of a non-Megacampus land parcel

aggregating 344,000 SF in the Austin submarket of our Texas market, to its estimated fair value less costs to sell of

approximately $11.1 million. The land parcel met the criteria for classification as held for sale as of September 30, 2026,

following our reevaluation of the capital required to develop the site and its alignment with our Megacampus strategy, resulting

in our decision to sell the asset and reallocate capital to other projects with greater value-creation opportunities. We expect to

complete the sale within the next 12 months.

26

3.INVESTMENTS IN REAL ESTATE (continued)

Canada (Non-cluster) market

•During the nine months ended September 30, 2026, we recognized a $55.0 million impairment charge related to a 247,743

RSF non-laboratory property in Canada. The property was classified as held for sale as of June 30, 2026, and written down to

its estimated fair value less costs to sell of approximately $42.5 million. We decided to sell the property rather than make the

significant near-term investment required to redevelop it, and we intend to redeploy the capital to other projects with greater

value-creation opportunities. We expect to complete the sale within the next 12 months.

During the six months ended June 30, 2026, we recognized an additional impairment charge of $27.8 million on our Montreal

portfolio following an amendment to the sales agreement, reducing its carrying amount to its estimated fair value less costs to

sell of approximately $134.5 million. This portfolio had been classified as held for sale since the fourth quarter of 2025, when

we recognized the initial impairment charge of $107.1 million.

During the three months ended September 30, 2026, the sales agreement was terminated and we decided to retain the

portfolio. Accordingly, we reclassified the portfolio from held for sale to held and used and remeasured the assets as required

under GAAP. As a result, we reversed $31.5 million of previously recognized impairment, primarily related to foreign currency

translation losses that were no longer expected to be recognized in earnings. The reversal increased the carrying amount of

the applicable real estate assets and was recorded as a reduction of impairment of real estate in our consolidated statements

of operations.

Other

ARE‑East River Science Park, LLC (“ARE”), a subsidiary of Alexandria Real Estate Equities, Inc., holds an option granted in

2006 to incorporate a land parcel adjacent to and north of the Alexandria Center® for Life Science – New York City campus (the “Option

Parcel”) into the existing ground lease, which would allow for the future development of an additional life science building within the

campus. ARE’s investment in pre‑construction costs related to the Option Parcel aggregated $185.9 million as of September 30, 2026.

On August 6, 2024, ARE filed a lawsuit in the U.S. District Court for the Southern District of New York against New York City

Health + Hospitals Corporation (“H+H”) and the New York City Economic Development Corporation (“EDC”) relating to disputes under

the ground lease and option arrangements governing the Option Parcel. ARE filed an amended complaint on January 24, 2025,

asserting claims for fraudulent inducement, breach of contract, breach of the implied covenant of good faith and fair dealing, and

declaratory relief concerning the continued validity of the option.

On March 27, 2026, the court granted defendants’ partial motion to dismiss the fraud in the inducement and implied covenant

of good faith and fair dealing claims. ARE intends to appeal this order at the appropriate time and to vigorously pursue its claims. The

court did not dismiss ARE’s claim for declaratory relief, which remains pending.

On April 10, 2026, H+H and EDC answered the amended complaint and asserted counterclaims seeking, among other things,

declaratory relief relating to the alleged expiration of the option and entitlement to a $5.0 million security deposit, and damages of at

least $3.8 million. The case remains pending.

As a result of the foregoing matters, the timing of any development of the Option Parcel is currently indeterminate. Excluding

the potential impact of the counterclaims filed by H+H and EDC, this matter exposes us to potential losses ranging from zero to the full

amount of the investment in the project aggregating $185.9 million as of September 30, 2026, depending on the resolution of the

remaining declaratory relief proceedings, the outcome of any appeal, and/or the ability to develop the project. We performed a

probability-weighted recoverability analysis based on initial estimates of various possible outcomes and determined no impairment was

present as of September 30, 2026.

Separately from, and not as part of, the pending litigation related to the Option Parcel, EDC, on behalf of H+H as the landlord

and itself as lease administrator, delivered on April 20, 2026, a notice alleging that ARE is in default of certain information delivery

obligations under the ground lease relating to the existing operating towers at the Alexandria Center for Life Science – New York City

campus, including sublease, tax, and financial information. The notice asserts that the failure to cure the alleged defaults within the

applicable 30-day cure period would result in daily charges of $1,000 increasing thereafter up to $2,000. ARE disputes the allegations

set forth in the notice of default and intends to vigorously defend against them.

On May 12, 2026, ARE filed a lawsuit in the Commercial Division of the New York State Supreme Court against H+H and EDC,

seeking a Yellowstone injunction, a preliminary injunction, and a temporary restraining order to toll all cure periods under the notice of

default and to enjoin EDC and H+H from issuing a notice of termination (the “NYS Action”). The court denied ARE’s request for a

temporary restraining order on May 13, 2026, and denied ARE’s request for a Yellowstone injunction and a preliminary injunction on

June 15, 2026. On June 17, 2026, ARE filed a notice of appeal from the court’s order, dated June 15, 2026. On July 1, 2026, ARE filed

an application for interim relief pending appeal. Following oral arguments before a single justice, the application was denied without

prejudice to determination by a full panel. On September 10, 2026, the Appellate Division, First Department, denied ARE’s request for

relief pending the determination of its merits appeal. ARE’s merits appeal remains pending.

27

3.INVESTMENTS IN REAL ESTATE (continued)

On July 2, 2026, ARE filed an amended complaint in the NYS Action, adding claims for breach of contract, breach of the

implied covenant of good faith and fair dealing, tortious interference, and unfair competition, and is seeking declaratory and injunctive

relief, based on the defendants’ alleged misuse of ARE’s confidential subtenant information and diversion of an ARE subtenant to a

competing City-sponsored project. On August 6, 2026, EDC and H+H moved to dismiss the amended complaint in its entirety, and the

motion has been fully briefed; oral arguments are scheduled for January 15, 2027. The NYS Action remains pending.

28

4.CONSOLIDATED AND UNCONSOLIDATED REAL ESTATE JOINT VENTURES

From time to time, we enter into joint venture agreements through which we own a partial interest in real estate entities that

own, develop, and operate real estate properties. As of September 30, 2026, our real estate joint ventures held the following properties:

Property(1)

Market

Submarket

Our Ownership

Interest

Consolidated real estate joint ventures:

50 and 60 Binney Street

Greater Boston

Cambridge/Inner Suburbs

34.0%

75/125 Binney Street

Greater Boston

Cambridge/Inner Suburbs

40.0%

100 and 225 Binney Street and 300 Third Street

Greater Boston

Cambridge/Inner Suburbs

30.0%

15 Necco Street

Greater Boston

Seaport Innovation District

56.7%

3215 Merryfield Row

San Diego

Torrey Pines

30.0%

Campus Point by Alexandria(2)

San Diego

University Town Center

59.3%

(3)

5200 Illumina Way

San Diego

University Town Center

51.0%

9625 Towne Centre Drive

San Diego

University Town Center

30.0%

SD Tech by Alexandria(4)

San Diego

Sorrento Mesa

50.0%

Summers Ridge Science Park(5)

San Diego

Sorrento Mesa

30.0%

Alexandria Center® for Science and Technology –

Mission Bay(6)

San Francisco Bay Area

Mission Bay

25.0%

211 and 213 East Grand Avenue

San Francisco Bay Area

South San Francisco

30.0%

500 Forbes Boulevard

San Francisco Bay Area

South San Francisco

10.0%

Alexandria Center® for Life Science – Millbrae

San Francisco Bay Area

South San Francisco

48.6%

1201 and 1208 Eastlake Avenue East

Seattle

Lake Union

30.0%

400 Dexter Avenue North

Seattle

Lake Union

30.0%

800 Mercer Street

Seattle

Lake Union

60.0%

Unconsolidated real estate joint ventures:

1655 and 1725 Third Street

San Francisco Bay Area

Mission Bay

10.0%

101 West Dickman Street

Maryland

Beltsville

58.4%

(7)

(1)Refer to the table on the next page that shows the categorization of our real estate joint ventures under the consolidation framework.

(2)Includes 10200, 10290, and 10300 Campus Point Drive and 4135, 4155, 4165, 4224, and 4242 Campus Point Court.

(3)In October 2026, we completed a partial sale of our interest in this joint venture. Refer to “Campus Point by Alexandria Megacampus” within this Note 4 for additional

information.

(4)Includes 9605, 9645, 9675, 9725, 9735, 9805, 9808, 9855, and 9868 Scranton Road and 10055, 10065, and 10075 Barnes Canyon Road.

(5)Includes 9965, 9975, 9985, and 9995 Summers Ridge Road.

(6)Includes 1450, 1500, and 1700 Owens Street, and 455 Mission Bay Boulevard South.

(7)Represents a joint venture with a local real estate operator in which our joint venture partner manages the day-to-day activities that significantly affect the economic

performance of the joint venture.

Our consolidation policy is described under “Consolidation” in Note 2 – “Summary of significant accounting policies” to our

unaudited consolidated financial statements. Consolidation accounting is highly technical, but its framework is primarily based on the

controlling financial interests and benefits of the joint ventures. We generally consolidate a joint venture that is a legal entity we control

(i.e., we have the power to direct the activities of the joint venture that most significantly affect its economic performance) through

contractual rights, regardless of our ownership interest, and where we determine that we have benefits through the allocation of

earnings or losses and fees paid to us that could be significant to the joint venture (the “VIE model”).

We also generally consolidate joint ventures when we have a controlling financial interest through voting rights and where our

voting interest is greater than 50% (the “voting model”). Voting interest differs from ownership interest for some joint ventures. We

account for joint ventures that do not meet the consolidation criteria under the equity method of accounting by recognizing our share of

income and losses.

29

4.CONSOLIDATED AND UNCONSOLIDATED REAL ESTATE JOINT VENTURES (continued)

The table below shows the categorization of our real estate joint ventures under the consolidation framework:

Property

Consolidation

Model

Voting Interest

Consolidation Analysis

Conclusion

50 and 60 Binney Street

VIE model

Not applicable

under VIE

model

Consolidated

75/125 Binney Street

We have:

100 and 225 Binney Street and 300

Third Street

15 Necco Street

(i)

The power to direct the

activities of the joint venture

that most significantly affect its

economic performance; and

3215 Merryfield Row

Campus Point by Alexandria

5200 Illumina Way

9625 Towne Centre Drive

(ii)

Benefits that can be significant

to the joint venture.

SD Tech by Alexandria

Summers Ridge Science Park

Alexandria Center® for Science and

Technology – Mission Bay

211 and 213 East Grand Avenue

Therefore, we are the primary

beneficiary of each VIE

500 Forbes Boulevard

Alexandria Center® for Life Science –

Millbrae

1201 and 1208 Eastlake Avenue East

400 Dexter Avenue North

800 Mercer Street

101 West Dickman Street

We do not control the joint venture

and are therefore not the primary

beneficiary.

Equity method

of accounting

1655 and 1725 Third Street

Voting model

Does not

exceed 50%

Our voting interest is 50% or less.

Consolidated real estate joint ventures

Consolidated VIEs’ balance sheet information

We, together with joint venture partners, hold interests in real estate joint ventures that we consolidate in our financial

statements. These existing joint ventures provide significant equity capital to fund a portion of our future construction spending, and our

joint venture partners may also contribute equity into these entities for financing-related activities.

The table below aggregates the balance sheet information of our consolidated VIEs (in thousands):

September 30, 2026

December 31, 2025

Investments in real estate

$6,122,821

$6,129,668

Cash and cash equivalents

232,764

258,755

Other assets

725,048

712,154

Total assets

$7,080,633

$7,100,577

Secured notes payable

$—

$—

Other liabilities

614,837

324,513

Total liabilities

614,837

324,513

Redeemable noncontrolling interests

—

49,554

Alexandria Real Estate Equities, Inc.’s share of equity

2,863,805

3,098,932

Noncontrolling interests’ share of equity

3,601,991

3,627,578

Total liabilities and equity

$7,080,633

$7,100,577

30

4.CONSOLIDATED AND UNCONSOLIDATED REAL ESTATE JOINT VENTURES (continued)

In determining whether to aggregate the balance sheet information of consolidated VIEs, we considered the similarity of each

VIE, including the primary purpose of these entities to own, manage, operate, and lease real estate properties owned by the VIEs, and

the similar nature of our involvement in each VIE as a managing member. Due to the similarity of the characteristics,  we present the

balance sheet information of these entities on an aggregated basis. As of September 30, 2026, none of our consolidated VIEs’ assets

were subject to restrictions that limit their use to settle specific obligations of the VIEs, no creditors or other partners of our consolidated

VIEs had recourse to our general credit, and our maximum exposure to our consolidated VIEs was limited to our variable interests in

each VIE.

99 Coolidge Avenue

In July 2025, we amended the agreement for our consolidated real estate joint venture at 99 Coolidge Avenue in our

Cambridge/Inner Suburbs submarket. Pursuant to the amendment, the carrying amount of our partner’s noncontrolling interest was

adjusted from $42.0 million to $48.7 million, and the interest was converted into a redeemable noncontrolling interest that accrued a

fixed 4.05% annual preferred return (“distributions”). In January 2026, our partner exercised its option to require us to purchase its

entire preferred interest, and the redemption was completed in January 2026 for $49.7 million, inclusive of unpaid distributions. 

Campus Point by Alexandria Megacampus

As of September 30, 2026, we held a 59.3% ownership interest in a consolidated joint venture that owns substantially all of the

Campus Point by Alexandria Megacampus, comprising seven operating properties aggregating 1.6 million RSF, located in our

University Town Center submarket of our San Diego market.

In October 2026, we completed the sale of an approximately 29% noncontrolling interest in the consolidated real estate joint

venture that owns substantially all of the Campus Point by Alexandria Megacampus for $475.0 million. We expect our new partner’s

initial share of the annual distributions to approximate 5.5% of the $475.0 million contributed capital. Upon completion of the sale, our

ownership interest in the real estate joint venture decreased to approximately 30%. We expect to fund the majority of future construction

costs at the Megacampus, which is expected to increase our ownership interest in the campus over time to over 50%, with the

ownership interests of our new joint venture partner and existing joint venture partner decreasing to below 20% and 30%, respectively.

Our new joint venture partner has the right to require us to purchase its interest after the seventh anniversary of the transaction

in exchange for shares of our common stock, subject to a contractual share issuance limit, or, at our election, in cash or a combination

of cash and shares.

We retained control and therefore continue to consolidate the properties held by the real estate joint venture. Accordingly, we

accounted for the $44.2 million difference between the consideration received and the book value of our interest sold as an increase to

additional paid-in capital, with no gain recognized in earnings.

Noncontrolling interests in consolidated real estate joint ventures

Noncontrolling interests represent the third-party interests in consolidated real estate joint ventures in which we have a

controlling interest. Noncontrolling interests are adjusted for additional contributions and distributions, the proportionate share of the net

earnings or losses, and other comprehensive income or loss. Distributions, profits, and losses related to these entities are allocated in

accordance with the respective operating agreements. During the nine months ended September 30, 2026 and 2025, we distributed

$171.2 million and $186.8 million, respectively, to our consolidated real estate joint venture partners.

Unconsolidated real estate joint ventures

Our investments in unconsolidated real estate joint ventures, accounted for under the equity method and classified in

investments in unconsolidated real estate joint ventures in our consolidated balance sheets, consisted of the following as of

September 30, 2026 and December 31, 2025 (in thousands):

Property

September 30, 2026

December 31, 2025

1655 and 1725 Third Street

$18,719

$19,484

101 West Dickman Street

9,861

9,669

Other

—

1,524

$28,580

$30,677

As of September 30, 2026, our maximum exposure related to our only unconsolidated VIE, 101 West Dickman Street, is

limited to our investment in this joint venture and a guarantee of up to $5.4 million of the outstanding balance related to the VIE’s

secured construction loan.

31

4.CONSOLIDATED AND UNCONSOLIDATED REAL ESTATE JOINT VENTURES (continued)

Below are key terms of unconsolidated real estate joint ventures’ secured loans as of September 30, 2026 (dollars in

thousands):

Interest

Rate(1)

At 100%

Our

Share

Unconsolidated Joint Venture

Maturity Date

Stated Rate

Aggregate

Commitment

Debt

Balance(2)

101 West Dickman Street

10/29/26

(3)

SOFR+1.95%

(4)

5.91%

$26,750

$19,354

58.4%

1655 and 1725 Third Street

2/10/35

6.37%

6.44%

500,000

497,138

10.0%

$526,750

$516,492

(1)Includes interest expense and amortization of loan fees.

(2)Represents outstanding principal, net of unamortized deferred financing costs, as of September 30, 2026.

(3)In October 2026, the unconsolidated real estate joint venture refinanced this debt with a new $22.5 million secured note payable bearing interest at SOFR+1.85% and

maturing in October 2030. As of September 30, 2026, our investment in this unconsolidated real estate joint venture was $9.9 million.

(4)This loan is subject to a SOFR floor of 0.75%.

32

5.LEASES

Refer to “Lease accounting” in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated financial

statements for information about lease accounting standards that set principles for the recognition, measurement, presentation, and

disclosure of leases for both parties to a lease agreement (i.e., lessees and lessors).

Leases in which we are the lessor

As of September 30, 2026, we had 328 properties aggregating 36.5 million operating RSF in key cluster locations, including

Greater Boston, San Diego, the San Francisco Bay Area, Seattle, Maryland, Research Triangle, and New York City. We primarily focus

on developing Class A/A+ properties in AAA life science and advanced technology innovation clusters that offer the scale and strategic

design integral to our Megacampus strategy. Strategically located near top academic and medical research institutions, our

Megacampus ecosystems feature curated amenities and services and convenient access to transit, creating environments that help our

tenants attract and retain top talent.

As of September 30, 2026, all leases in which we are the lessor were classified as operating leases, with the exception of one

direct financing and one sales-type lease. Our leases are described below.

Operating leases

As of September 30, 2026, our 328 properties were subject to operating lease agreements. Five of these properties are

subject to operating lease agreements that each contain a purchase option as described below:

(i)Two of these properties, representing two land parcels in the San Francisco Bay Area market, are subject to lease

agreements that each contain an option for the lessee to purchase the underlying asset from us at fair market value during

each of the 30-day periods commencing on the dates that are 15 years, 30 years, and 74.5 years after the rent

commencement date of October 1, 2017. The remaining lease term related to each of the two land parcels is 66.2 years.

(ii)Two operating properties in the Seattle market, held by a consolidated real estate joint venture, are subject to purchase

options held by our partner in this joint venture, which is also a tenant at these properties. One purchase option allows our

partner to purchase our 30% interest in one property for $40.0 million in 2031. Contingent upon the exercise of this option,

the second purchase option allows our partner to purchase our 30% interest in one property for $69.1 million in 2034. Our

partner’s remaining lease terms for these operating leases are 6.4 years and 18.0 years, respectively.

(iii)One property subject to an operating lease agreement contains a purchase option exercisable at fair market value in

March 2034.

Certain operating leases contain options for tenants to extend their leases at prevailing market rates at the time of expiration.

In addition, certain operating leases contain an early termination option that requires advance notification and payment of an early

termination fee by the tenant.

At the commencement of each lease, we establish the lease term comprising the noncancelable period for each lease together

with periods covered by options to extend or terminate the lease that we determine the lessee is reasonably certain to exercise. Our

assessment of whether a lessee is reasonably certain to exercise or not exercise an option considers all economic factors relevant to

the assessment, including property-based, market-based, and tenant-based factors. We do not reassess the lease term or a lessee

option to purchase the underlying asset unless there is a lease modification that is not accounted for as a separate contract.

Future lease payments to be received under the terms of our operating lease agreements, excluding expense

reimbursements, in effect as of September 30, 2026 are outlined in the table below (in thousands):

Year

Amount

2026

$391,858

2027

1,529,103

2028

1,423,920

2029

1,329,663

2030

1,259,699

Thereafter

8,116,482

Total

$14,050,725

Refer to Note 3 – “Investments in real estate” to our unaudited consolidated financial statements for additional information

about our owned real estate assets, which are the underlying assets under our operating leases.

33

5.LEASES (continued)

Direct financing and sales-type leases

As of September 30, 2026, we have one direct financing lease agreement, with a net investment balance of $43.2 million, for a

parking structure with a remaining lease term of 66.2 years. The lessee has an option to purchase the underlying asset at fair market

value during each of the 30-day periods commencing on the dates that are 15 years, 30 years, and 74.5 years after the rent

commencement date of October 1, 2017.

As of September 30, 2026, we also have one sales-type lease for a property in the Seattle market. As of September 30, 2026,

the net investment in this lease is $16.9 million. At the end of the lease term in 2026, title to the property under this lease will transfer to

the tenant for a sales price of approximately $18.5 million.

As of September 30, 2026, our estimated provision for expected credit losses related to our direct financing and sales-type

leases aggregated $1.8 million, which was predominantly related to our direct financing lease. We estimate the provision for expected

credit losses related to our direct financing lease using a probability of default methodology, which incorporates the borrower’s

investment-grade credit rating from S&P Global Ratings, to evaluate the probability of default. Additionally, we incorporate the projected

value of the real estate securing the investments to estimate potential recoveries in the event of default, among other inputs. The

estimate of the expected credit loss related to our sales-type lease was determined using historical industry losses and transaction-

specific information, including the estimated fair value of the underlying real estate asset securing this transaction, the short-term nature

of this lease, and other available information. For further details, refer to “Provision for expected credit losses” in Note 2 – “Summary of

significant accounting policies” to our unaudited consolidated financial statements.

The components of our aggregate net investment in our direct financing and sales-type leases as of September 30, 2026 and

December 31, 2025 are summarized in the table below (in thousands):

September 30, 2026

December 31, 2025

Gross investment in direct financing and sales-type leases

$264,805

$265,839

Less: unearned income on direct financing lease

(202,985)

(205,037)

Less: provision for expected credit losses

(1,817)

(1,817)

Net investment in leases

$60,003

$58,985

Future lease payments to be received under the terms of our direct financing and sales-type leases as of September 30, 2026

are outlined in the table below (in thousands):

Year

Total

2026

$17,412

2027

2,097

2028

2,160

2029

2,224

2030

2,291

Thereafter

238,621

Total

$264,805

34

5.LEASES (continued)

Income from rentals

Our income from rentals includes revenue related to agreements for the rental of our real estate, which primarily includes

revenues subject to the lease accounting standard and the revenue recognition accounting standard as shown below (in thousands):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Income from rentals:

Revenues subject to the lease accounting standard:

Operating leases

$641,492

$722,643

$1,911,559

$2,176,999

Direct financing and sales-type leases

686

1,409

2,542

3,308

Revenues subject to the lease accounting standard

642,178

724,052

1,914,101

2,180,307

Revenues subject to the revenue recognition accounting

standard

11,440

11,797

35,740

35,996

Income from rentals

$653,618

$735,849

$1,949,841

$2,216,303

Revenues subject to the revenue recognition accounting standard and classified in income from rentals consist primarily of

short-term parking revenues that are not considered lease revenues under the lease accounting standard. Refer to “Revenues” and

“Recognition of revenue arising from contracts with customers” in Note 2 – “Summary of significant accounting policies” to our

unaudited consolidated financial statements for additional information.

Residual value risk management strategy

Our leases do not have guarantees of residual value on the underlying assets. We manage risk associated with the residual

value of our leased assets by (i) evaluating each potential acquisition of real estate to determine whether it meets our business

objective to invest primarily in high-demand markets, (ii) directly managing our leased properties, conducting frequent property

inspections, proactively addressing potential maintenance issues, and/or timely resolving any occurring issues, and (iii) carefully

selecting our tenants and monitoring their credit quality throughout their respective lease terms.

Leases in which we are the lessee

Operating lease agreements

We have ground and office operating lease agreements in which we are the lessee. Certain of these leases have options to

extend or terminate the contract terms upon meeting certain criteria. There are no notable restrictions or covenants imposed by the

leases, nor guarantees of residual value.

We recognize a right-of-use asset, which is classified within other assets in our consolidated balance sheets, and a related

liability, which is classified within accounts payable, accrued expenses, and other liabilities in our consolidated balance sheets, to

account for our future obligations under ground and office lease arrangements in which we are the lessee. Refer to “Lessee accounting”

in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated financial statements.

As of September 30, 2026, the present value of the remaining contractual payments aggregating $754.4 million under our

operating lease agreements, including our extension options that we are reasonably certain to exercise, was $354.0 million. Our

corresponding operating lease right-of-use assets, adjusted for initial direct leasing costs and other consideration exchanged with the

landlord prior to the commencement of the lease, aggregated $686.2 million. As of September 30, 2026, the weighted-average

remaining lease term of operating leases in which we are the lessee was approximately 60 years, including extension options that we

are reasonably certain to exercise, and the weighted-average discount rate was 4.7%. The weighted-average discount rate is based on

the incremental borrowing rate estimated for each lease, which is the interest rate that we estimate we would have to pay to borrow on

a collateralized basis over a similar term for an amount equal to the lease payments.

Ground lease obligations as of September 30, 2026 included leases for 31 of our properties, which accounted for

approximately 9% of our total number of properties. Our ground lease obligations have remaining lease terms ranging from

approximately 28 to 97 years, including extension options that we are reasonably certain to exercise.

35

5.LEASES (continued)

The reconciliation of future lease payments under noncancelable operating leases in which we are the lessee to the operating

lease liability reflected in our unaudited consolidated balance sheet as of September 30, 2026 is in the table below (in thousands):

Year

Total

2026

$4,989

2027

21,003

2028

21,318

2029

20,825

2030

20,743

Thereafter

665,496

Total future payments under our operating leases in which we are the lessee

754,374

Effect of discounting

(400,346)

Operating lease liability

$354,028

Lessee operating costs

Operating lease costs relate to our ground and office leases in which we are the lessee. Ground leases generally require fixed

annual rent payments and may also include escalation clauses and renewal options. For the nine months ended September 30, 2026

and 2025, amounts paid and classified as operating activities in our unaudited consolidated statements of cash flows for leases in which

we are the lessee aggregated $18.0 million and $165.2 million, respectively. The decrease is primarily due to the ground lease

prepayment of $135.0 million made in January 2025 for a 24-year lease term extension to our existing ground lease agreement at the

Alexandria Technology Square® Megacampus in our Cambridge submarket.

Our operating lease obligations related to our office leases have remaining terms of up to 10 years, exclusive of extension

options. For the three and nine months ended September 30, 2026 and 2025, our costs for operating leases in which we are the lessee

were as follows (in thousands):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Gross operating lease costs

$8,006

$11,525

$24,426

$36,743

Capitalized lease costs

(1,027)

(880)

(2,872)

(2,293)

Expenses for operating leases in which we are the lessee

$6,979

$10,645

$21,554

$34,450

6. CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

Cash, cash equivalents, and restricted cash consisted of the following as of September 30, 2026 and December 31, 2025 (in

thousands):

September 30, 2026

December 31, 2025

Cash and cash equivalents

$508,855

$549,062

Restricted cash:

Development escrows

2,102

2,142

Security deposits

1,778

1,729

Other

1,028

822

4,908

4,693

Total

$513,763

$553,755

36

7.INVESTMENTS

We hold investments in publicly traded companies and privately held entities primarily involved in the life science industry. As a

REIT, we generally limit our ownership of each individual entity’s voting stock to less than 10%. We evaluate each investment to

determine whether we have the ability to exercise significant influence, but not control, over an investee. We evaluate investments in

which our ownership is equal to or greater than 20%, but less than or equal to 50%, of an investee’s voting stock with a presumption

that we have this ability. For our investments in limited partnerships that maintain specific ownership accounts, we presume that such

ability exists when our ownership interest exceeds 3% to 5%. In addition to our ownership interest, we consider whether we have a

board seat or whether we participate in the investee’s policy-making process, among other criteria, to determine if we have the ability to

exert significant influence, but not control, over an investee. If we determine that we have such ability, we account for the investment

under the equity method, as described below.

From time to time, we may hold equity investments in publicly traded companies that are subject to temporary contractual sale

restrictions. We do not recognize a discount related to such contractual sale restrictions.

Investments accounted for under the equity method

Under the equity method of accounting, we initially recognize our investment at cost and subsequently adjust the carrying

amount of the investment for our share of earnings or losses reported by the investee, distributions received, and other-than-temporary

impairments.

As of September 30, 2026, we had nine investments in limited partnerships maintaining specific ownership accounts for each

investor, which were accounted for under the equity method. These investments aggregated $394.4 million. Our ownership interest in

each of these nine investments was greater than 5%.

Investments that do not qualify for the equity method of accounting

For investees over which we determine that we do not have the ability to exercise significant influence or control, we account

for each investment depending on whether it is an investment in a (i) publicly traded company, (ii) privately held entity that reports NAV

per share, or (iii) privately held entity that does not report NAV per share, as described below.

Investments in publicly traded companies

Our investments in publicly traded companies are classified as investments with readily determinable fair values and are

presented at fair value in our consolidated balance sheets, with changes in fair value classified in investment income (losses) in our

consolidated statements of operations. The fair values for our investments in publicly traded companies are determined based on sales

prices or quotes available on securities exchanges.

Investments in privately held companies

Our investments in privately held entities without readily determinable fair values consist of (i) investments in privately held

entities that report NAV per share and (ii) investments in privately held entities that do not report NAV per share. These investments are

accounted for as follows:

Investments in privately held entities that report NAV per share

Investments in privately held entities that report NAV per share, such as our privately held investments in limited partnerships,

are presented at fair value using NAV as a practical expedient, with changes in fair value classified in investment income (losses) in our

consolidated statements of operations. We use NAV per share reported by limited partnerships generally without adjustment, unless we

are aware of information indicating that the NAV reported by a limited partnership does not accurately reflect the fair value of the

investment at our reporting date.

Investments in privately held entities that do not report NAV per share

Investments in privately held entities that do not report NAV per share are accounted for using a measurement alternative

under which these investments are measured at cost, adjusted for observable price changes and impairments, with changes classified

in investment income (losses) in our consolidated statements of operations.

An observable price arises from an orderly transaction for an identical or similar investment of the same issuer, which is

observed by an investor without expending undue cost and effort. Observable price changes result from, among other things, equity

transactions of the same issuer executed during the reporting period, including subsequent equity offerings or other reported equity

transactions related to the same issuer. To determine whether these transactions are indicative of an observable price change, we

evaluate, among other factors, whether these transactions have similar rights and obligations, including voting rights, distribution

preferences, and conversion rights to the investments we hold.

37

7.INVESTMENTS (continued)

Impairment evaluation of equity method investments and investments in privately held entities that do not report NAV per share

We monitor equity method investments and investments in privately held entities that do not report NAV per share for new

developments, including operating results, prospects and results of clinical trials, new product initiatives, new collaborative agreements,

capital-raising events, and merger and acquisition activities. These investments are evaluated on the basis of a qualitative assessment

for indicators of impairment by monitoring the presence of the following triggering events or impairment indicators:

(i)a significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee;

(ii)a significant adverse change in the regulatory, economic, or technological environment of the investee;

(iii)a significant adverse change in the general market condition, including the research and development of technology and

products that the investee is bringing or attempting to bring to the market;

(iv)significant concerns about the investee’s ability to continue as a going concern; and/or

(v)a decision by investors to cease providing support or reduce their financial commitment to the investee.

If such indicators are present, we are required to estimate the investment’s fair value and immediately recognize an

impairment charge in an amount equal to the investment’s carrying value in excess of its estimated fair value.

Investment income/loss recognition and classification

We recognize both realized and unrealized gains and losses in our consolidated statements of operations, classified in

investment income (losses) in our consolidated statements of operations. Unrealized gains and losses represent:

(i)changes in fair value for investments in publicly traded companies;

(ii)changes in NAV for investments in privately held entities that report NAV per share;

(iii)observable price changes for investments in privately held entities that do not report NAV per share; and

(iv)our share of unrealized gains or losses reported by our equity method investees.

Realized gains and losses on our investments represent the difference between proceeds received upon disposition of

investments and their historical or adjusted cost basis. For our equity method investments, realized gains and losses represent our

share of realized gains or losses reported by the investee. Impairments are realized losses, which result in an adjusted cost basis, and

represent charges to reduce the carrying values of investments in privately held entities that do not report NAV per share and equity

method investments, if impairments are deemed other than temporary, to their estimated fair value.

Funding commitments to investments in privately held entities that report NAV

We are committed to funding approximately $317.5 million for our investments in privately held entities that report NAV. Our

funding commitments expire at various dates over the next 11 years, with a weighted-average expiration of 7.8 years as of September

30, 2026. These investments are not redeemable by us, but we may receive distributions from these investments throughout their

terms. Our investments in privately held entities that report NAV generally have expected initial terms in excess of 10 years. The

weighted-average remaining term during which these investments are expected to be liquidated was 5.4 years as of September 30,

2026.

The following tables summarize our investments as of September 30, 2026 and December 31, 2025 (in thousands):

September 30, 2026

Cost

Unrealized

Gains

Unrealized

Losses

Carrying

Amount

Publicly traded companies

$105,921

$56,294

$(24,638)

$137,577

Entities that report NAV

507,978

215,565

(43,100)

680,443

Entities that do not report NAV:

Entities with observable price changes

77,062

50,568

(10,785)

116,845

Entities without observable price changes

406,415

—

—

406,415

Investments accounted for under the equity method

N/A

N/A

N/A

394,393

Total investments

$1,097,376

$322,427

$(78,523)

$1,735,673

38

7.INVESTMENTS (continued)

December 31, 2025

Cost

Unrealized

Gains

Unrealized

Losses

Carrying

Amount

Publicly traded companies

$54,752

$44,319

$(4,143)

$94,928

Entities that report NAV

460,160

89,514

(37,298)

512,376

Entities that do not report NAV:

Entities with observable price changes

82,252

50,601

(9,615)

123,238

Entities without observable price changes

413,324

—

—

413,324

Investments accounted for under the equity method

N/A

N/A

N/A

357,383

Total investments

$1,010,488

$184,434

$(51,056)

$1,501,249

Cumulative gains and losses (realized and unrealized) on investments in privately held entities that do not report NAV still held

as of September 30, 2026 aggregated to a loss of $137.8 million, which consisted of upward adjustments aggregating $50.6 million,

downward adjustments aggregating $10.8 million, and impairments aggregating $177.6 million.

Our investment income (losses) for the three and nine months ended September 30, 2026 and 2025 consisted of the following

(in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Realized gains

$2,427

(1)

$9,646

$9,471

(1)

$19,115

Unrealized gains (losses)

21,563

18,515

143,164

(71,568)

Investment income (losses)

$23,990

(2)

$28,161

$152,635

(2)

$(52,453)

(1)Consists of realized gains of $16.0 million and $44.5 million, partially offset by impairment charges of $13.6 million and $35.0 million during the three and nine months

ended September 30, 2026, respectively.

(2)Investment income of $24.0 million and $152.6 million included $340 thousand of equity in losses and $28.2 million of equity in earnings of our equity method

investments during the three and nine months ended September 30, 2026, respectively.

Additional details on our non-real estate investments still held as of the end of each period are presented below (in thousands):

Nine Months Ended September 30,

2026

2025

Investments in privately held entities that do not report NAV still held as of the end of

each period:

Upward adjustments

$15,821

$14,939

Downward adjustments and impairments

(50,930)

(94,034)

$(35,109)

$(79,095)

Unrealized gains on non-real estate investments still held as of the end of each period

(excluding equity method investments)

$127,209

$16,592

Refer to “Investments” in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated financial

statements for additional information.

39

8. OTHER ASSETS

The following table summarizes the components of other assets as of September 30, 2026 and December 31, 2025 (in

thousands):

September 30, 2026

December 31, 2025

Acquired in-place leases

$158,803

$204,008

Deferred compensation plan

62,540

53,529

Deferred financing costs – unsecured senior line of credit

63,027

39,406

Deposits

28,043

28,618

Furniture, fixtures, equipment, and software

77,295

70,311

Net investment in leases

60,003

58,985

Notes receivable

276,808

258,033

Operating lease right-of-use assets

686,159

697,865

Other assets

92,031

87,036

Prepaid expenses

44,850

33,718

Property, plant, and equipment

127,905

130,263

Total

$1,677,464

$1,661,772

Notes receivable

Our notes receivable as of September 30, 2026 and December 31, 2025 consisted of the following (dollars in thousands):

September 30, 2026

Weighted-Average

Notes Receivable

Effective

Interest Rate

Maturity

Date

Balance

December 31, 2025

Secured by real estate assets in San Diego

9.9%

1/10/29

$262,023

$240,476

Secured by real estate assets in Greater Boston

6.2%

12/16/29

15,317

18,089

Less: provision for expected credit losses

(532)

(532)

Notes receivable

$276,808

$258,033

Our notes receivable represent held-to-maturity debt securities carried at amortized cost and are generally secured by real

estate. Under the current expected credit losses accounting standard, we are required to estimate and, if necessary, recognize a

provision for expected credit losses related to these notes. We do not have a history of losses on such securities; therefore, we utilize

available information on historical losses for the commercial real estate industry. We determine expected credit losses for our notes

receivable using historical industry losses and considering loan-specific information, including credit ratings of the borrowers, estimated

fair values of underlying real estate assets, loan-to-value ratios, the presence of guarantors, and/or other available information. During

the three and nine months ended September 30, 2026, no adjustment to the provision for expected credit losses related to our notes

receivable was required. The provision is evaluated on an ongoing basis, with any necessary adjustments recognized in the

corresponding period.

40

9.FAIR VALUE MEASUREMENTS

We provide fair value information about all financial instruments for which it is practicable to estimate fair value. We measure

and disclose the estimated fair value of financial assets and liabilities by utilizing a fair value hierarchy that distinguishes between data

obtained from sources independent of the reporting entity and the reporting entity’s own assumptions about market participant

assumptions. This hierarchy consists of three broad levels, as follows: (i) quoted prices in active markets for identical assets or liabilities

(Level 1), (ii) significant other observable inputs (Level 2), and (iii) significant unobservable inputs (Level 3). Significant other observable

inputs can include quoted prices for similar assets or liabilities in active markets, as well as inputs that are observable for the asset or

liability, such as interest rates, foreign exchange rates, and yield curves. Significant unobservable inputs are typically based on an

entity’s own assumptions, since there is little, if any, related market activity. In instances in which the determination of the fair value

measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the

entire fair value measurement falls is based on the lowest level of input that is significant to the fair value measurement in its entirety.

Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers

factors specific to the asset or liability.

Assets and liabilities measured at fair value on a recurring basis

The following table sets forth the assets and liabilities that we measure at fair value on a recurring basis by level in the fair

value hierarchy as of September 30, 2026 and December 31, 2025 (in thousands). There were no transfers of assets measured at fair

value on a recurring basis to or from Level 3 in the fair value hierarchy during the nine months ended September 30, 2026.

Fair Value Measurement Using

Description

Total

Quoted Prices in

Active Markets

for Identical Assets

(Level 1)

Significant

Other

Observable Inputs

(Level 2)

Significant

Unobservable

Inputs

(Level 3)

Assets:

Investments in publicly traded companies:

As of September 30, 2026

$137,577

$137,577

$—

$—

As of December 31, 2025

$94,928

$94,928

$—

$—

Cross-currency swap agreements:

As of September 30, 2026

$3,634

$—

$3,634

$—

Liabilities:

Cross-currency swap agreements:

As of December 31, 2025

$928

$—

$928

$—

Our investments in publicly traded companies represent investments with readily determinable fair values, and are carried at

fair value, with changes in fair value classified in investment income (losses) in our consolidated financial statements. We also hold

investments in privately held entities, which consist of (i) investments that report NAV and (ii) investments that do not report NAV, as

further described below.

Our investments in privately held entities that report NAV, such as our privately held investments in limited partnerships, are

carried at fair value using NAV as a practical expedient, with changes in fair value classified in net income. As of September 30, 2026

and December 31, 2025, the carrying values of investments in privately held entities that report NAV aggregated $680.4 million and

$512.4 million, respectively. These investments are excluded from the fair value hierarchy above as required by the fair value

accounting standard. We estimate the fair value of each of our investments in limited partnerships based on the most recent NAV

prepared by the general partner and reported by each limited partnership. As a result, the determination of fair values of our

investments in privately held entities that report NAV generally does not involve significant estimates, assumptions, or judgments on our

part.

Our cross-currency swap agreements are recognized at fair value. Refer to Note 2 – “Summary of significant accounting

policies” and Note 11 – “Hedge agreements” to our unaudited consolidated financial statements for additional information.

41

9.FAIR VALUE MEASUREMENTS (continued)

Assets and liabilities measured at fair value on a nonrecurring basis

The following table sets forth our assets measured at fair value on a nonrecurring basis, categorized by level within the fair

value hierarchy, as of September 30, 2026 and December 31, 2025 (in thousands).

Fair Value Measurement Using

Description

Carrying

Amount

Quoted Prices in

Active Markets

for Identical Assets

(Level 1)

Significant

Other

Observable Inputs

(Level 2)

Significant

Unobservable

Inputs

(Level 3)

Real estate assets with carrying values adjusted

based on fair values during the:

Nine months ended September 30, 2026

$882,223

(1)

$—

$—

$882,223

Year ended December 31, 2025

$581,737

(1)

$—

$—

$581,737

Investments in privately held entities that do not

report NAV with carrying values adjusted based on

fair values during the:

Nine months ended September 30, 2026

$79,653

$—

$65,424

(2)

$14,229

(3)

Year ended December 31, 2025

$68,738

$—

$62,261

(2)

$6,477

(3)

(1)These amounts represent the aggregate carrying amounts of real estate assets for which adjustments based on nonrecurring fair value measurements were recognized

during the respective periods, including assets for which impairment losses or reversals of previously recognized impairment losses were recorded. These assets

primarily include a subset of our total real estate assets classified as held for sale as of September 30, 2026 and December 31, 2025. The fair values for these real

estate assets were estimated based on executed purchase and sale agreements, letters of intent, valuations provided by third-party real estate brokers, or market

comparables from recent transactions. Refer to “Investments in real estate” in Note 2 – “Summary of significant accounting policies” and “Assets held for sale” in Note 3

– “Investments in real estate” to our unaudited consolidated financial statements for additional information.

(2)These amounts represent the carrying amounts of our equity investments in privately held entities with observable price changes for which adjustments based on

nonrecurring fair value measurements were recognized during the respective periods. These amounts are included in the investment balances of $1.74 billion and $1.50

billion in our unaudited consolidated balance sheets as of September 30, 2026 and December 31, 2025, respectively, disclosed in Note 7 – “Investments” to our

unaudited consolidated financial statements.

(3)These amounts are included in the investments in privately held entities without observable price changes balances aggregating $406.4 million and $413.3 million as of

September 30, 2026 and December 31, 2025, respectively, disclosed in Note 7 – “Investments” to our unaudited consolidated financial statements, and represent the

carrying amounts of investments in privately held entities that do not report NAV for which impairments have been recognized during the respective periods in

accordance with the measurement alternative guidance described in “Investments” in Note 2 – “Summary of significant accounting policies” to our unaudited

consolidated financial statements.

Investments in privately held entities that do not report NAV

Our investments in privately held entities that do not report NAV are measured at cost, adjusted for observable price changes

and impairments, with changes recognized in net income (loss). These investments are adjusted based on the observable price

changes in orderly transactions for the identical or similar investment of the same issuer. Further adjustments are not made until

another observable transaction occurs. Therefore, the determination of fair values of our investments in privately held entities that do

not report NAV does not involve significant estimates and assumptions or subjective and complex judgments.

We also subject our investments in privately held entities that do not report NAV to a qualitative assessment for indicators of

impairment. If indicators of impairment are present, we are required to estimate the investment’s fair value and immediately recognize

an impairment charge in an amount equal to the investment’s carrying value in excess of its estimated fair value.

The estimates of fair value typically incorporate valuation techniques that include an income approach reflecting a discounted

cash flow analysis, and a market approach that includes a comparative analysis of acquisition multiples and pricing multiples generated

by market participants. In certain instances, we may use multiple valuation techniques for a particular investment and estimate its fair

value based on an average of multiple valuation results.

Refer to Note 7 – “Investments” to our unaudited consolidated financial statements for additional information.

Assets and liabilities not measured at fair value in the statement of financial position but for which the fair value is disclosed

The fair values of our unsecured senior notes payable, junior subordinated notes payable, and the amounts outstanding on our

unsecured senior line of credit and commercial paper program were estimated using widely accepted valuation techniques, including

discounted cash flow analyses using significant other observable inputs such as available market information on discount and

borrowing rates with similar terms, maturities, and credit ratings. Because the valuations of our financial instruments are based on these

types of estimates, the actual fair value of our financial instruments may differ materially if our estimates do not prove to be accurate.

Additionally, the use of different market assumptions or estimation methods may have a material effect on the estimated fair value

amounts.

42

9.FAIR VALUE MEASUREMENTS (continued)

As of September 30, 2026 and December 31, 2025, the book and estimated fair values of our unsecured senior notes payable,

junior subordinated notes payable, and the amounts outstanding under our unsecured senior line of credit and commercial paper

program, including the level within the fair value hierarchy for which the estimates were derived, were as follows (in thousands):

September 30, 2026

Book Value

Fair Value Hierarchy

Estimated

Fair Value

Quoted Prices in

Active Markets

for Identical Assets

(Level 1)

Significant

Other

Observable Inputs

(Level 2)

Significant

Unobservable

Inputs

(Level 3)

Liabilities:

Unsecured senior notes payable

$10,820,687

$—

$9,323,013

$—

$9,323,013

Junior subordinated notes payable

$985,143

$—

$969,100

$—

$969,100

Unsecured senior line of credit

$—

$—

$—

$—

$—

Commercial paper program

$1,091,166

$—

$1,091,605

$—

$1,091,605

December 31, 2025

Book Value

Fair Value Hierarchy

Estimated

Fair Value

Quoted Prices in

Active Markets

for Identical Assets

(Level 1)

Significant

Other

Observable Inputs

(Level 2)

Significant

Unobservable

Inputs

(Level 3)

Liabilities:

Unsecured senior notes payable

$12,047,394

$—

$10,675,433

$—

$10,675,433

Unsecured senior line of credit

$—

$—

$—

$—

$—

Commercial paper program

$353,161

$—

$353,189

$—

$353,189

The carrying values of cash and cash equivalents, restricted cash, tenant receivables, deposits, notes receivable, accounts

payable, accrued expenses, and other short-term liabilities approximate their fair value.

43

10.SECURED AND UNSECURED SENIOR DEBT

The following table summarizes our outstanding indebtedness and respective principal payments remaining as of September 30, 2026 (dollars in thousands):

Stated 

Rate

Interest

Rate(1)

Maturity

Date(2)

Principal Payments Remaining for the Periods Ending December 31,

Unamortized

(Deferred

Financing

Cost),

(Discount)/

Premium

Debt

2026

2027

2028

2029

2030

Thereafter

Principal

Total

Unsecured senior notes payable

3.95%

4.13%

1/15/27

$—

$350,000

$—

$—

$—

$—

$350,000

$(167)

$349,833

Unsecured senior notes payable

3.95%

4.07

1/15/28

—

—

425,000

—

—

—

425,000

(569)

424,431

Unsecured senior notes payable

4.50%

4.60

7/30/29

—

—

—

300,000

—

—

300,000

(637)

299,363

Unsecured senior notes payable

2.75%

2.87

12/15/29

—

—

—

400,000

—

—

400,000

(1,346)

398,654

Unsecured senior notes payable

4.70%

4.81

7/1/30

—

—

—

—

450,000

—

450,000

(1,408)

448,592

Unsecured senior notes payable

4.90%

5.05

12/15/30

—

—

—

—

700,000

—

700,000

(3,359)

696,641

Unsecured senior notes payable

3.375%

3.48

8/15/31

—

—

—

—

—

750,000

750,000

(3,219)

746,781

Unsecured senior notes payable

2.00%

2.12

5/18/32

—

—

—

—

—

900,000

900,000

(5,347)

894,653

Unsecured senior notes payable

1.875%

1.97

2/1/33

—

—

—

—

—

1,000,000

1,000,000

(5,586)

994,414

Unsecured senior notes payable

2.95%

3.07

3/15/34

—

—

—

—

—

800,000

800,000

(5,905)

794,095

Unsecured senior notes payable

4.75%

4.88

4/15/35

—

—

—

—

—

500,000

500,000

(4,155)

495,845

Unsecured senior notes payable

5.50%

5.66

10/1/35

—

—

—

—

—

550,000

550,000

(5,852)

544,148

Unsecured senior notes payable

5.25%

5.41

3/15/36

—

—

—

—

—

750,000

750,000

(10,601)

739,399

Unsecured senior notes payable

5.25%

5.38

5/15/36

—

—

—

—

—

400,000

400,000

(3,508)

396,492

Unsecured senior notes payable

4.85%

4.93

4/15/49

—

—

—

—

—

300,000

300,000

(2,670)

297,330

Unsecured senior notes payable

4.00%

3.95

2/1/50

—

—

—

—

—

390,801

390,801

5,419

396,220

Unsecured senior notes payable

3.00%

3.16

5/18/51

—

—

—

—

—

352,398

352,398

(4,373)

348,025

Unsecured senior notes payable

3.55%

3.70

3/15/52

—

—

—

—

—

475,406

475,406

(6,127)

469,279

Unsecured senior notes payable

5.15%

5.26

4/15/53

—

—

—

—

—

500,000

500,000

(7,204)

492,796

Unsecured senior notes payable

5.625%

5.71

5/15/54

—

—

—

—

—

600,000

600,000

(6,304)

593,696

Unsecured senior notes payable weighted-

average interest rate/subtotal

4.04

—

350,000

425,000

700,000

1,150,000

8,268,605

10,893,605

(72,918)

10,820,687

Junior subordinated notes payable

7.25%

(3)

7.37

(3)

2/15/57

(3)

—

—

—

—

—

1,000,000

1,000,000

(14,857)

985,143

Unsecured senior line of credit and

commercial paper program(4)

(4)

4.40

(4)

1/22/32

(4)

—

—

—

—

—

1,092,450

1,092,450

(1,284)

1,091,166

Weighted-average interest rate/total

4.33%

$—

$350,000

$425,000

$700,000

$1,150,000

$10,361,055

$12,986,055

$(89,059)

$12,896,996

(1)Represents the weighted-average interest rate as of the end of the applicable period, including amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.

(2)Reflects any extension options that we control.

(3)Refer to footnote 3 on the following page.

(4)Refer to footnote 4 on the following page. In September 2026, we amended and restated our $5.0 billion unsecured senior line of credit, which, among other changes, extended the maturity date from January 22, 2030 to January 22, 2032,

including extension options that we control. In addition, the amendment reduces the applicable borrowing rate to SOFR plus 0.725% from SOFR plus 0.835%.

44

10.SECURED AND UNSECURED SENIOR DEBT (continued)

The following table summarizes our debt outstanding as of September 30, 2026 (dollars in thousands):

Fixed-Rate

Debt

Variable-Rate

Debt

Weighted-Average

Interest

Remaining

Term

(in years)

Total

Percentage

Rate(1)

Unsecured senior notes payable

$10,820,687

$—

$10,820,687

83.9%

4.04%

10.6

Junior subordinated notes payable

985,143

—

985,143

7.6

7.37

(3)

30.4

(3)

Unsecured senior line of credit(2) and

commercial paper program

—

1,091,166

1,091,166

8.5

4.40

5.3

(4)

Total/weighted average

$11,805,830

$1,091,166

$12,896,996

100.0%

4.33%

11.6

(4)

Percentage of total debt

91.5%

8.5%

100%

(1)Represents the weighted-average interest rate as of the end of the applicable period, including expense/income related to the amortization of loan fees, amortization of

debt premiums (discounts), and other bank fees.

(2)As of September 30, 2026, we had no outstanding balance on our unsecured senior line of credit.

(3)Our junior subordinated notes will initially bear interest at 7.250% per year through, but excluding, February 15, 2032. Thereafter, the interest rate will reset every five

years to the five-year U.S. Treasury rate plus 2.889%, subject to a minimum interest rate of 7.250%. In addition, we may redeem the notes at 100% of principal plus

accrued and unpaid interest during the period beginning November 17, 2031 and ending on February 15, 2032, and thereafter on any interest payment date.

(4)We calculate the weighted-average remaining term of our commercial paper notes by using the maturity date of our unsecured senior line of credit. Using the maturity

date of our outstanding commercial paper notes, the consolidated weighted-average maturity of our debt is 11.2 years. The commercial paper notes sold during the nine

months ended September 30, 2026 were issued at a weighted-average yield to maturity of 4.19% and had a weighted-average maturity term of 14 days. Our total

weighted-average remaining term also assumes the full maturity of our junior subordinated notes payable due in 2057.

Issuance and repayments of unsecured senior notes payable

In February 2026, we completed tender offers to repurchase an aggregate debt principal amount of approximately $1.33 billion

of a portion of our outstanding 4.00% Senior Notes due 2050, 3.00% Senior Notes due 2051, and 3.55% Senior Notes due 2052. Cash

consideration paid was $952.2 million. The repurchase was primarily funded through the issuance of $750.0 million of 5.25% unsecured

senior notes due 2036, and approximately $200 million of short-term borrowings under our commercial paper program. In connection

with the debt repurchase, we recognized a gain on early extinguishment of debt aggregating $366.4 million, including the write-off of

unamortized debt issuance costs and other transaction-related costs.

In January 2026, we repaid $300.0 million of 4.30% unsecured senior notes payable upon maturity. No gain or loss was

incurred in connection with this repayment.

In April 2026, we repaid $350.0 million of 3.80% unsecured senior notes payable upon maturity. No gain or loss was incurred

in connection with this repayment.

Issuance of junior subordinated notes payable

In August 2026, we completed a public offering of $1.00 billion aggregate principal amount of 7.250% Series A fixed-to-fixed

reset rate junior subordinated notes due 2057. The notes will initially bear interest at 7.250% per year through, but excluding,

February 15, 2032. Thereafter, the interest rate will reset every five years to the five-year U.S. Treasury rate plus 2.889%, subject to a

minimum interest rate of 7.250%. We may elect to defer interest payments for up to five consecutive years, subject to the terms of the

notes, including certain restrictions on paying dividends and repurchasing equity. The notes may be redeemed at our option in whole or

in part at 100% of principal plus accrued and unpaid interest during the period beginning November 17, 2031 and ending on

February 15, 2032, and thereafter on any interest payment date. The notes may also be redeemed in whole, but not in part, at 100% of

principal plus accrued and unpaid interest upon certain tax events and at 102% of principal plus accrued and unpaid interest upon

certain rating agency events.

$5.0 billion unsecured senior line of credit

In September 2026, we amended and restated our $5.0 billion unsecured senior line of credit which, among other changes,

extended the maturity date from January 22, 2030 to January 22, 2032, including extension options that we control. The amendment

also reduced the applicable borrowing rate to SOFR plus 0.725% from SOFR plus 0.835% and eliminated the existing sustainability-

linked pricing adjustments. The facility fee was revised to 0.15% from 0.14%. In connection with the amendment, we recognized a loss

on early extinguishment of debt of approximately $3.3 million for the partial write-off of unamortized loan fees.

As of September 30, 2026, our unsecured senior line of credit, which matures in 2032, including extension options under our

control, had aggregate commitments of $5.0 billion, and bore an interest rate of SOFR plus 0.725%. In addition to the cost of borrowing,

the unsecured senior line of credit is subject to an annual facility fee of 0.15% based on the aggregate commitments outstanding. As of

September 30, 2026, we had no outstanding balance on our unsecured senior line of credit.

45

10.SECURED AND UNSECURED SENIOR DEBT (continued)

$2.50 billion commercial paper program

Our commercial paper program allows us to issue up to $2.50 billion of commercial paper notes that bear interest at short-term

fixed rates with a maturity of generally 30 days or less and a maximum maturity of 397 days from the date of issuance. This program is

back-stopped by our unsecured senior line of credit, and at all times we expect to retain a minimum undrawn amount of borrowing

capacity under our unsecured senior line of credit equal to the amount of commercial paper notes outstanding. We use the net

proceeds from the issuances of the notes for general working capital and other general corporate purposes, which may include, but are

not limited to, the repayment of other debt and selective development, redevelopment, or acquisition of properties. During the nine

months ended September 30, 2026, the notes were issued at a weighted-average yield to maturity of 4.19% and had a weighted-

average maturity term of 14 days. As of September 30, 2026, we had $1.09 billion outstanding under our commercial paper program.

Interest expense

The following table summarizes interest expense for the three and nine months ended September 30, 2026 and 2025 (in

thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Interest incurred

$142,609

$140,943

$415,225

$409,603

Capitalized interest

(62,922)

(86,091)

(206,612)

(248,579)

Interest expense

$79,687

$54,852

$208,613

$161,024

11. HEDGE AGREEMENTS

We have fixed-to-fixed cross-currency swap agreements designated as net investment hedges to mitigate the impact of

fluctuations in the USD–CAD exchange rate on our real estate investments in Canada. Under the terms of these agreements, USD

fixed interest amounts are payable to us and CAD fixed interest amounts are payable to the counterparty.

On April 30, 2026, our cross-currency swap agreements with an aggregate notional amount of CAD $340.0 million matured.

No amounts were reclassified from accumulated other comprehensive income to earnings because the related net investment had not

been sold or substantially liquidated.

During the three months ended June 30, 2026, we entered into new fixed-to-fixed cross-currency swap agreements

designated as net investment hedges with an aggregate notional amount of CAD $270.0 million. During the three months ended

September 30, 2026, we terminated these agreements and entered into new fixed-to-fixed cross-currency swap agreements with the

same aggregate CAD notional amount, designated as net investment hedges, which were deemed effective on the commencement

date. These agreements mature on January 31, 2028.

As of September 30, 2026, our outstanding cross-currency swap agreements had an aggregate notional amount of CAD

$270.0 million, or approximately USD $194.1 million, and were highly effective.

Unrealized gains or losses on these agreements are recognized in accumulated other comprehensive income and will be

reclassified into net income upon complete or substantially complete liquidation of our investment in Canada. Refer to “Hedge

accounting” in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated financial statements for additional

information.

The tables below summarize the fair value of our cross-currency swap agreements designated as net investment hedges and

the effect on our consolidated financial statements. Amounts are presented in USD (in thousands).

Fair value of cross-currency swap agreements designated as net investment hedges

Balance Sheet Location

September 30, 2026

December 31, 2025

Other assets

$3,634

$—

Accounts payable, accrued expenses, and other liabilities

$—

$928

46

11. HEDGE AGREEMENTS (continued)

Effect on consolidated other comprehensive income

Effect Recognized

(in thousands)

Location in Consolidated Statement

of Comprehensive Income

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Total unrealized (losses) gains

recognized in other

comprehensive income

Unrealized (losses) gains on foreign

currency translation, net

$(26)

$2,970

$8,040

$2,970

Effect on consolidated statements of operations

Effect Recognized

(in thousands)

Location in Consolidated

Statement of Operations

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Total gain recognized in net

income(1)

Other income

$641

$748

$4,289

$748

(1)Represents net interest settlements and interest rate forward points excluded from assessment of hedge effectiveness. Refer to “Hedge accounting” in Note 2 –

“Summary of significant accounting policies” to our unaudited consolidated financial statements for additional information.

12. ACCOUNTS PAYABLE, ACCRUED EXPENSES, AND OTHER LIABILITIES

The following table summarizes the components of accounts payable, accrued expenses, and other liabilities as of

September 30, 2026 and December 31, 2025 (in thousands):

September 30, 2026

December 31, 2025

Accounts payable and accrued expenses

$507,754

$510,580

Accrued construction

261,727

314,836

Acquired below-market leases

109,551

133,033

Conditional asset retirement obligations

29,700

34,342

Deferred rent liabilities

24,483

14,659

Operating lease liability

354,028

360,543

Unearned rent and tenant security deposits

1,174,022

876,252

Other liabilities

143,153

152,828

Total

$2,604,418

$2,397,073

As of September 30, 2026 and December 31, 2025, our conditional asset retirement obligations primarily consisted of the soil

and groundwater remediation liabilities associated with certain properties. Some of our properties may contain asbestos or may be

subjected to other hazardous or toxic substances, which, under certain conditions, require remediation. We engage independent

environmental consultants to conduct Phase I or similar environmental assessments at our properties. This type of assessment

generally includes a site inspection, interviews, and a public records review; asbestos, lead-based paint, and mold surveys; subsurface

sampling; and other testing. We recognize a liability for the fair value of a conditional asset retirement obligation when the fair value of

the liability can be reasonably estimated. In addition, environmental laws and regulations subject our tenants, and potentially us, to

liability that may result from our tenants’ routine handling of hazardous substances and wastes as part of their operations at our

properties. As of September 30, 2026, we are not aware of any additional environmental liability that we believe would require additional

disclosures or recognition in our consolidated financial statements.

47

13.EARNINGS PER SHARE

We grant two types of restricted stock awards: (i) restricted stock awards with nonforfeitable dividends and (ii) restricted stock

awards with forfeitable dividends.

Unvested restricted stock awards (“RSAs”) with nonforfeitable dividends are considered participating securities and included in

the computation of EPS using the two-class method. Under this method, we allocate net income (after amounts attributable to

noncontrolling interests) to common stockholders and these RSAs by using the weighted-average shares of each class outstanding for

quarter-to-date and year-to-date periods independently, based on their respective participation rights to dividends declared (or

accumulated) and undistributed earnings.

Unvested RSAs with forfeitable dividends do not qualify as participating securities under the two-class method because the

dividends are forfeited if the awards do not vest. As a result, undistributed earnings are not allocated to these awards prior to vesting,

and these awards have no effect on the computation of basic EPS while unvested. Once these awards vest, they are included in the

denominator of basic EPS, weighted for the portion of the reporting period they were vested. Prior to vesting, these awards are included

in the denominator of diluted EPS if they are dilutive, which is determined using the treasury stock method. Under this method,

incremental shares are calculated as the difference between the total unvested shares and the number of shares that could

hypothetically be repurchased using the assumed proceeds (including unrecognized compensation cost related to these awards).

These incremental shares are weighted for the portion of the reporting period they were unvested and are included in the diluted EPS

denominator only if their inclusion reduces EPS (i.e., if they are not antidilutive).

In addition, from time to time, we enter into forward equity sales agreements. We consider the potential dilution resulting from

the forward equity sales agreements on the EPS calculations. At inception, the agreements do not have an effect on the computation of

basic EPS as no shares are delivered until settlement. The common shares issued upon the settlement of the forward equity sales

agreements, weighted for the period these common shares were outstanding, are included in the denominator of basic EPS. To

determine the dilution resulting from the forward equity sales agreements during the period of time prior to settlement, we calculate the

number of weighted-average shares outstanding – diluted using the treasury stock method. As of September 30, 2026, no forward

equity sales agreements were outstanding.

The table below reconciles the numerators and denominators of the basic and diluted EPS computations for the three and nine

months ended September 30, 2026 and 2025 (in thousands, except per share amounts):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Net loss

$(598,932)

$(197,845)

$(239,524)

$(221,372)

Net income attributable to noncontrolling interests

(38,754)

(34,909)

(109,292)

(127,323)

Net income attributable to unvested RSAs with nonforfeitable

dividends

(766)

(2,183)

(2,603)

(7,452)

Numerator for basic and diluted EPS – net loss attributable to

Alexandria Real Estate Equities, Inc.’s common stockholders

$(638,452)

$(234,937)

$(351,419)

$(356,147)

Denominator for basic EPS – weighted-average shares of

common stock outstanding

170,751

170,181

170,689

170,278

Dilutive effect of unvested RSAs with forfeitable dividends

—

—

—

—

Denominator for diluted EPS – weighted-average shares of

common stock outstanding

170,751

170,181

170,689

170,278

Net loss per share attributable to Alexandria Real Estate

Equities, Inc.’s common stockholders:

Basic

$(3.74)

$(1.38)

$(2.06)

$(2.09)

Diluted

$(3.74)

$(1.38)

$(2.06)

$(2.09)

48

14.STOCKHOLDERS’ EQUITY

Common equity transactions

Common stock repurchase program

On December 8, 2025, we announced that our Board of Directors authorized a new common stock repurchase program that

allows for the repurchase of up to $500.0 million of our common stock through December 31, 2026. This new program replaced our

prior stock repurchase program. As of the date of this report, no repurchases have been made under the new program and

$500.0 million remains available for future share repurchases.

ATM common stock offering program

In February 2024, we entered into an ATM common stock offering program that allows us to sell up to an aggregate of

$1.50 billion of our common stock.

During the nine months ended September 30, 2026, we had no activity under our ATM program. As of September 30, 2026,

the remaining aggregate amount available under our ATM program for future sales of common stock was $1.47 billion.

Dividends

During the three months ended March 31, 2026, we declared cash dividends on our common stock aggregating $125.5 million,

or $0.72 per share.

During the three months ended June 30, 2026, we declared cash dividends on our common stock aggregating $125.4 million,

or $0.72 per share.

During the three months ended September 30, 2026, we declared cash dividends on our common stock aggregating

$125.4 million, or $0.72 per share.

Accumulated other comprehensive loss

The change in accumulated other comprehensive loss attributable to Alexandria Real Estate Equities, Inc.’s stockholders for

the nine months ended September 30, 2026 was due to net unrealized losses of $4.3 million, and included $12.3 million of unrealized

foreign currency translation losses related to our operations in Canada, partially offset by $8.0 million of unrealized gains resulting from

the changes in the fair value of our cross-currency swap agreements due to the weakening of the Canadian dollar. Refer to Note 11 –

“Hedge agreements” to our unaudited consolidated financial statements for additional information.

Common stock, preferred stock, and excess stock authorizations

Our charter authorizes the issuance of 400.0 million shares of common stock, of which 170.8 million shares were issued and

outstanding as of September 30, 2026. Our charter also authorizes the issuance of up to 100.0 million shares of preferred stock, none

of which were issued and outstanding as of September 30, 2026. In addition, 200.0 million shares of “excess stock” (as defined in our

charter) are authorized, none of which were issued and outstanding as of September 30, 2026.

49

15.SEGMENT INFORMATION

We are a life science REIT focused on developing, redeveloping, and operating properties that provide space for lease to

tenants primarily in the life science industry. Our properties are leased predominantly through triple-net lease agreements and share

key characteristics, including generic and reusable improvements, consistent lease structures, and business and financial strategy. All

properties are located within North America, predominantly in the U.S., and operate within a comparable regulatory environment.

Operating segments

Our Chief Operating Decision Maker (“CODM”), represented by our Executive Chairman and our Chief Executive Officer,

evaluates operating results at the geographic market level to assess performance and allocate resources. Our operating segments align

with our markets, including Greater Boston, San Diego, the San Francisco Bay Area, and Seattle, among others. Regular market

performance updates are provided directly to the CODM. These updates include each market’s net operating income (“NOI”), which

serves as the profit or loss measure used by the CODM for performance assessment and resource allocation. NOI provides useful

information regarding performance of each market as it reflects income and expenses incurred in connection with real estate operations

in each market. This metric enables the CODM to evaluate the profitability and performance of each market on a consistent and

comparable basis, supporting decisions on capital resource allocation, including in connection with development, redevelopment,

acquisition, and disposition activities in each market.

Evaluation of economic similarity and aggregation of operating segments

In accordance with the segment reporting accounting standard, we evaluate the economic similarity of our operating

segments. Seven of our nine operating segments exhibit consistent long-term economic characteristics, including similar historical long-

term NOI margins, which are also expected to remain similar in the future. Additionally, these markets share similar operational

characteristics, including nature of services provided (i.e., leasing, operating, developing, and redeveloping life science properties),

tenant base (i.e., a variety of tenants involved in the life science industry), methods of operation (i.e., consistent lease structures,

property management practices, and business strategies), and nature of the regulatory environment (consistent across North America,

where all our operating segments are located). Based on shared economic characteristics, we have aggregated our seven operating

segments into one reportable segment for segment reporting purposes. The remaining operating segments, which do not meet the

aggregation criteria and individually do not meet the quantitative thresholds to qualify as reportable segments, were included in the “all

other” category in the tables below.

The following table presents the reportable segment profit or loss measure, NOI, for the three and nine months ended

September 30, 2026 and 2025 (in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Reportable segment revenues:

Revenues from external customers

$647,777

$700,635

$1,898,710

$2,103,291

Other income

21,102

7,764

48,498

24,779

Reportable segment total revenues

668,879

708,399

1,947,208

2,128,070

Reportable segment total rental operating expenses

(224,477)

(222,441)

(648,469)

(647,279)

Reportable segment net operating income (reportable

segment profit or loss)

$444,402

$485,958

$1,298,739

$1,480,791

Significant expenses included in the reportable segment profit or loss measure (i.e., NOI) are represented by the reportable

segment total rental operating expenses and are disclosed in the table above. These expenses primarily include property taxes, utilities,

repairs and maintenance, engineering, janitorial, and other costs.

50

15.SEGMENT INFORMATION (continued)

Presented below is the reconciliation of the reportable segment total revenues to the consolidated revenues, the reportable

segment total rental operating expenses to consolidated rental operations, and the reportable segment NOI to the consolidated net

income (in thousands):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Reconciliation of reportable segment revenues to

consolidated total revenues:

Reportable segment total revenues

$668,879

$708,399

$1,947,208

$2,128,070

All other revenues

2,303

43,545

57,780

144,072

Consolidated total revenues

$671,182

$751,944

$2,004,988

$2,272,142

Reconciliation of reportable segment total rental operating

expenses to consolidated rental operations:

Reportable segment total rental operating expenses

$(224,477)

$(222,441)

$(648,469)

$(647,279)

All other rental operating expenses

(3,454)

(16,793)

(10,940)

(42,783)

Consolidated rental operations

$(227,931)

$(239,234)

$(659,409)

$(690,062)

Reconciliation of reportable segment net operating income

to consolidated net (loss) income:

Reportable segment net operating income (reportable

segment profit or loss)

$444,402

$485,958

$1,298,739

$1,480,791

All other revenues

2,303

43,545

57,780

144,072

All other rental operating expenses

(3,454)

(16,793)

(10,940)

(42,783)

Other items not allocated to segments:

General and administrative

(40,915)

(29,224)

(112,461)

(89,027)

Interest expense

(79,687)

(54,852)

(208,613)

(161,024)

Depreciation and amortization

(304,419)

(340,230)

(914,244)

(1,028,415)

Impairment of real estate

(637,904)

(323,870)

(865,873)

(485,630)

Equity in earnings (losses) of unconsolidated real

estate joint ventures

75

201

341

(9,327)

Investment income (losses)

23,990

28,161

152,635

(52,453)

(Loss) gain on early extinguishment of debt

(3,323)

(107)

363,112

(107)

Gain on sales of real estate

—

9,366

—

22,531

Consolidated net loss

$(598,932)

$(197,845)

$(239,524)

$(221,372)

The following table reconciles reportable segment investments in real estate to consolidated total assets (in thousands).

Reportable segment investments in real estate constitute the total assets of our reportable segment. Consolidated assets not allocated

to segments represent all asset line items presented in our consolidated balance sheets other than consolidated investments in real

estate.

September 30, 2026

December 31, 2025

Reportable segment investments in real estate

$26,872,264

$27,510,082

All other investments in real estate

1,554,735

1,179,914

Consolidated investments in real estate

28,426,999

28,689,996

Consolidated assets not allocated to segments

5,624,723

5,391,839

Consolidated total assets

$34,051,722

$34,081,835

16.SUBSEQUENT EVENTS

Sale of a partial interest in October 2026

In October 2026, we completed the sale of an approximately 29% noncontrolling interest in the consolidated real estate joint

venture that owns substantially all of Campus Point by Alexandria Megacampus for $475.0 million. Refer to Note 4 – “Consolidated and

unconsolidated real estate joint ventures” to our unaudited consolidated financial statements for additional information.

51

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-looking statements

Certain information and statements included in this quarterly report on Form 10-Q, including, without limitation, statements

containing the words “forecast,” “guidance,” “goals,” “projects,” “estimates,” “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,”

“seeks,” “should,” “targets,” or “will,” or the negative of those words or similar words, constitute “forward-looking statements” within the

meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as

amended. Forward-looking statements involve inherent risks and uncertainties regarding events, conditions, and financial trends that

may affect our future plans of operations, business and financial strategy, results of operations, and financial position. A number of

important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking

statements, including, but not limited to, the following:

•Operating factors, such as a failure to operate our business successfully in comparison to market expectations or in

comparison to our competitors, our inability to obtain capital when desired or refinance debt maturities when desired, and/

or a failure to maintain our status as a REIT for federal tax purposes;

•Market and industry factors, such as adverse developments concerning the life science industry and/or our tenants;

•Government factors, such as any unfavorable effects resulting from federal, state, local, and/or foreign government

policies, laws, and/or funding levels;

•Global factors, such as negative economic, social, political, financial, credit market, banking conditions, and/or regional

armed hostilities; and

•Other factors, such as climate change, cyber intrusions, and/or changes in laws, regulations, and financial accounting

standards.

This list of risks and uncertainties is not exhaustive. Additional information regarding risk factors that may affect us is included

under Part I, “Item 1A. Risk factors”; and Part II, “Item 7. Management’s discussion and analysis of financial condition and results of

operations” in our annual report on Form 10-K for the year ended December 31, 2025, and under respective sections in this quarterly

report on Form 10-Q. Readers of this quarterly report on Form 10-Q should also read our other documents filed publicly with the SEC

for further discussion regarding such factors.

52

Overview

We are a Maryland corporation formed in October 1994 that has elected to be taxed as a REIT for federal income tax

purposes. Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science

REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate

niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in

AAA life science and advanced technology innovation cluster locations, including Greater Boston, San Diego, the San Francisco Bay

Area, Seattle, Maryland, Research Triangle, and New York City. As of September 30, 2026, Alexandria has a total market capitalization

of $21.01 billion and an asset base that includes 36.5 million RSF of operating properties and 1.9 million RSF of Class A/A+ properties

undergoing construction.

We develop dynamic Megacampus ecosystems that enable and inspire some of the world’s most brilliant minds and innovative

companies to create life-changing scientific and technological innovations. We believe in the utmost professionalism, humility, and

teamwork. Our tenants include multinational pharmaceutical companies; life science product, service, and device companies; public

and private biotechnology companies; advanced technologies companies; biomedical institutions; U.S. government institutions; and

others. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and

collaborative Megacampus environments that enhance our tenants’ ability to successfully recruit and retain world-class talent and

inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science

companies through our venture capital platform.

As of September 30, 2026:

•Investment-grade or publicly traded large cap tenants represented 57% of our annual rental revenue;

•Approximately 97% of our leases (on an annual rental revenue basis) contained effective annual rent escalations

approximating 3% that were either fixed or indexed based on a consumer price index or other index;

•Approximately 91% of our leases (on an annual rental revenue basis) were triple net leases, which require tenants to pay

substantially all real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and other

operating expenses (including increases thereto) in addition to base rent;

•Approximately 91% of our leases (on an annual rental revenue basis) provided for the recapture of capital expenditures

(such as HVAC maintenance and/or replacement, roof replacement, and parking lot resurfacing) that we believe would

typically be borne by the landlord in traditional office leases; and

•74% of our leasing activity during the last twelve months was generated from our existing tenant base.

A key element of our business and financial strategy is our unique focus on Class A/A+ properties primarily located in

collaborative Megacampus ecosystems in AAA life science and advanced technology innovation clusters. Our Megacampus

ecosystems are designed for optionality and scalability, offering our tenants a clear path to address their growth requirements, including

through our future developments and redevelopments. Strategically located near top academic and medical research institutions and

equipped with curated amenities and services and convenient access to transit, our Megacampus ecosystems are designed to support

our tenants in attracting and retaining top talent and in meeting our tenants’ growth needs, which we believe is a key driver of tenant

demand for our properties. Our strategy also includes drawing upon our deep, broad, and long-standing real estate and life science

industry relationships in order to retain tenants, identify and attract new and leading tenants, and source additional real estate.

53

Executive summary

Operating results

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Net loss attributable to Alexandria’s common

stockholders – diluted:

In millions

$(638.5)

(1)

$(234.9)

$(351.4)

$(356.1)

Per share

$(3.74)

$(1.38)

$(2.06)

$(2.09)

Funds from operations attributable to Alexandria’s

common stockholders – diluted, as adjusted:

In millions

$264.4

$377.8

$856.5

$1,166.3

Per share

$1.54

$2.22

$5.00

$6.85

(1)Includes $637.9 million of real estate impairment charges related to assets held for sale for the three months ended September 30, 2026. Refer to Note 3 – “Investments

in real estate” to our unaudited consolidated financial statements in Item 1 for additional details.

For additional information, refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria

Real Estate Equities, Inc.’s common stockholders” under “Definitions and reconciliations.”

A best-in-class REIT with a high-quality and diverse tenant base, strong margins, and long lease terms

(As of or for the three months ended September 30, 2026, unless stated otherwise)

Occupancy of operating properties

87.1%

Occupancy of operating properties, including executed leases with future occupancy

90.8%

Percentage of total annual rental revenue in effect from Megacampus platform

80%

Percentage of total annual rental revenue in effect from investment-grade or publicly traded large cap tenants

57%

Operating margin

66%

Adjusted EBITDA margin

65%

Percentage of leases containing annual rent escalations

97%

Weighted-average remaining lease term:

All tenants

7.7

years

Top 20 tenants

10.0

years

Strong tenant collections:

Rents and receivables for the three months ended September 30, 2026, collected as of the date of this report

99.9%

Strong and flexible balance sheet with significant liquidity; top 20% credit rating ranking among all publicly traded U.S. REITs; long-

duration remaining debt term (as of September 30, 2026)

•$21.01 billion in total market capitalization.

•$8.11 billion in total equity capitalization.

•Net debt and preferred stock to Adjusted EBITDA:

•Target for the three months ending December 31, 2026, annualized: 5.6x–6.2x.

•For the three months ended September 30, 2026 annualized: 6.9x; 6.6x on a pro forma basis reflecting the October 2026

closing of the sale of our partial interest in the Campus Point by Alexandria joint venture.

•Significant liquidity of $4.56 billion and closed extension of our $5.0 billion unsecured senior line of credit to 2032.

•Only 6% of our total debt matures through 2028.

•11.6-year weighted-average remaining debt term, the longest among S&P 500 REITs.

•Total debt and preferred stock, as adjusted, to gross assets of 30%.

•Intermediate-term goal for leverage: mid-5x range.

54

Solid 3Q26 total leasing volume exceeding 1.2 million RSF; highest total quarterly volume since 4Q24

•Total leasing volume surpassed 1.2 million RSF during the three months ended September 30, 2026, exceeding the average

quarterly leasing volume of 979,822 RSF for the period from the first quarter of 2025 through the second quarter of 2026 by

approximately 256,000 RSF, and representing the highest quarterly volume since the fourth quarter of 2024.

•Includes 450,961 RSF of leasing of previously vacant space, the second-highest quarterly amount in company history.

•74% of our leasing activity during the last twelve months was generated from our existing tenant base.

Three Months Ended

Nine Months Ended

September 30, 2026

September 30, 2026

June 30, 2026

March 31, 2026

Leasing volume in RSF:

Leasing of previously vacant space

450,961

329,148

148,734

928,843

Leasing of development and

redevelopment space

—

68,771

117,935

186,706

450,961

397,919

266,669

1,115,549

Lease renewals and re-leasing of space

785,069

640,998

380,687

1,806,754

Total leasing volume

1,236,030

1,038,917

647,356

2,922,303

Lease renewals and re-leasing of space:

Rental rate changes

(2.4)%

(0.7)%

(15.0)%

(5.1)%

Rental rate changes (cash basis)

(3.3)%

(4.3)%

(15.8)%

(6.9)%

Ongoing execution of Alexandria’s capital recycling strategy

We plan to continue funding a significant portion of our capital requirements for the year ending December 31, 2026 through

dispositions of land, non-core dispositions, and sales of partial interests. In October 2026, we completed the sale of an approximately

29% noncontrolling interest in Campus Point by Alexandria Megacampus for $475.0 million to a new joint venture partner.

Sources of capital: transactions

Sales Price

(dollars in millions)

Non-core and land dispositions

$242

Sales of partial interests

475

Completed as of the date of this report

717

Pending transactions subject to:

Non-refundable deposits

355

Signed letters of intent and/or purchase and sale agreement late-stage negotiations

1,548

2,620

Proceeds from dispositions and sales of partial interests in excess of 2026 guidance midpoint which may be

deferred into 2027

(720)

2026 guidance midpoint for dispositions and sales of partial interests

$1,900

Occupancy of operating properties and leasing progress on temporary vacancy

Occupancy of operating properties as of June 30, 2026

86.9%

Key changes in occupancy:

Reclassification of 339,020 RSF at 311 Arsenal Street from redevelopment to operating in 3Q26, including

167,543 RSF of executed leases and leases under negotiation for space not yet delivered

(0.9)

(1)

Reclassification of held-for-sale properties with vacancy

0.6

Net increase in occupancy primarily due to lease commencements during 3Q26

0.5

Occupancy of operating properties as of September 30, 2026

87.1

Vacant operating space with executed leases and future occupancy

3.7

(2)

Occupancy of operating properties as of September 30, 2026, including executed leases with future occupancy

90.8%

(1)Refer to “Resolution of certain construction projects under evaluation and reduction of capital spend and funding needs” within this section for additional details.

(2)Represents executed leases aggregating 1.3 million RSF within our operating portfolio, with occupancy expected upon completion of building and/or tenant

improvements. The weighted-average expected occupancy date is approximately June 2027, with expected annual rental revenue of approximately $52 million. We

expect 32% of the total 1.3 million RSF to be occupied by December 31, 2026.  The RSF presented excludes 686 thousand RSF of pre-leased space related to

development and redevelopment projects under construction with future delivery. Refer to “New Class A/A+ development and redevelopment properties: under

construction” in Item 2 for additional details.

55

Key operating metrics

•Same property net operating income changes

•Decreased by 6.7% and 2.8% (cash basis) for the three months ended September 30, 2026, compared to the three

months ended September 30, 2025.

•Decreased by 9.2% and 8.4% (cash basis) for the nine months ended September 30, 2026, compared to the nine months

ended September 30, 2025.

•The decline was due to a decrease in same property occupancy, primarily driven by previously disclosed key lease

expirations with expected downtime aggregating 282,878 RSF and 1.2 million RSF in the three and nine months ended

September 30, 2026, respectively, with weighted-average lease expiration dates of August 2026 and April 2026,

respectively.

•Same properties average occupancy:

•88.1% for the three months ended September 30, 2026, compared to 91.7% same properties average occupancy for the

three months ended September 30, 2025.

•88.6% for the nine months ended September 30, 2026, compared to 92.8% same properties average occupancy for the

nine months ended September 30, 2025.

Resolution of certain construction projects under evaluation and reduction of capital spend and funding needs

•We entered into a purchase and sale agreement with an institutional user for the sale of 421 Park Drive on the Alexandria

Center® for Life Science – Fenway Megacampus, aggregating 339,668 RSF, which represents substantially all of our

development project at this location. The disposition is expected to generate significant sales proceeds and to reduce future

potential construction spend by approximately $136 million, with closing anticipated in the fourth quarter of 2026.

•We have executed leases of 66,859 RSF and have additional leases under negotiation of 100,684 RSF for advanced

technology use at our project at 311 Arsenal Street in The Arsenal on the Charles Megacampus. This activity enables us to

pivot the redevelopment project to a lower-cost advanced technology use, reducing future potential construction spend by

approximately $220 million. As a result of this leasing progress, the entire project aggregating 339,020 RSF was reclassified

from redevelopment to operating as of September 30, 2026.

•We continue to evaluate the business and financial strategy for three remaining projects aggregating 667,002 RSF, including

options that could further reduce future construction funding requirements.

•Non-income-producing assets as of September 30, 2026 are 12% of gross assets, a reduction of 800 bps since December 31,

2024.

Alexandria’s development and redevelopment pipeline delivered incremental annual net operating income of $40 million during 3Q26,

with an additional $85 million expected from projects to be delivered by 4Q28

•During the three months ended September 30, 2026, we placed into service 529,061 RSF of development and redevelopment

projects across multiple submarkets. The projects were 84% occupied at delivery and generated incremental annual net

operating income aggregating $40 million. Key deliveries for the three months ended September 30, 2026 included:

•198,992 RSF to Novo Nordisk for its R&D Center at 60 Sylvan Road on the Alexandria Center® for Life Science –

Waltham Megacampus.

•174,662 RSF at 99 Coolidge Avenue located on a Megacampus in Watertown.

•Annual net operating income (cash basis) from recently delivered projects is expected to increase by $67 million upon the

burn-off of initial free rent, which has a weighted-average remaining period of approximately four months.

•80% of the RSF in our total development and redevelopment pipeline is within our Megacampus ecosystems.

Development and Redevelopment Projects

Incremental

Annual Net

Operating Income

RSF

Occupied/Leased/

Negotiating

Percentage

(dollars in millions)

Placed into service:

Six months ended June 30, 2026

$58

532,219

91%

Three months ended September 30, 2026

40

529,061

84

Placed into service during nine months ended September 30, 2026

$98

(1)

1,061,280

87%

Expected to be placed into service:(2)

Fiscal year 2027

$24

905,582

77%

Fiscal year 2028

61

$85

(1)Excludes future incremental annual net operating income from spaces placed into service that were vacant and/or unleased at delivery.

(2)Excludes 667,002 RSF of redevelopment projects currently under evaluation.

56

Continued successful management of general and administrative expenses

•For the trailing twelve months ended September 30, 2026, general and administrative expenses represented 7.5% of net

operating income, nearly half the average of other S&P 500 REITs for 2023–2025.

•Compared to 2024, we continue to expect approximately $76 million of cumulative general and administrative expense savings

for the two-year period 2025 and 2026 (based on the midpoint of our 2026 guidance range). Some of the cost savings in 2025

were temporary, and approximately half of the cost reductions achieved in 2025 are expected to continue in 2026 (based on

the midpoint of our 2026 guidance range).

Key capital events

•In August 2026, we completed a public offering of $1.00 billion aggregate principal amount of 7.250% Series A fixed-to-fixed

reset rate junior subordinated notes due 2057. The notes will initially bear interest at 7.250% per year through, but excluding,

February 15, 2032. Thereafter, the interest rate will reset every five years to the five-year U.S. Treasury rate plus 2.889%,

subject to a minimum interest rate of 7.250%. We may elect to defer interest payments for up to five consecutive years, subject

to the terms of the notes, including certain restrictions on paying dividends and repurchasing equity. We may also redeem at

100% of principal plus accrued and unpaid interest during the period beginning November 17, 2031 and ending on

February 15, 2032, and thereafter on any interest payment date. This issuance supports our liquidity, capital structure and

deleveraging objectives while receiving 50% equity treatment from key rating agencies for purposes of the computations of

leverage, fixed charges, and other credit metrics.

•In September 2026, we closed our amended and restated $5.0 billion unsecured senior line of credit, which, among other

changes, extended the maturity date from January 22, 2030 to January 22, 2032, including extension options that we control.

The amendment also reduced the applicable borrowing rate to SOFR plus 0.725% from SOFR plus 0.835%. In connection with

the amendment, we recognized a loss on early extinguishment of debt of approximately $3.3 million related to the partial write-

off of unamortized loan fees.

•Under our common stock repurchase program authorized in December 2025, we may repurchase up to $500.0 million of our

common stock through December 31, 2026. As of the date of this report, no shares have been repurchased under this

program and $500.0 million remains available for future share repurchases.

Dividend strategy to share net cash flows from operating activities with stockholders while retaining a significant portion for reinvestment

•Common stock dividend declared of $0.72 per share for the three months ended September 30, 2026, consistent with the

preceding quarter. The declared dividend per common share reflects our commitment to maintaining the strength of our

balance sheet, enhancing financial flexibility, supporting liquidity, and sharing cash flows with our stockholders.

•Significant net cash provided by operating activities, as adjusted, retained for reinvestment aggregating $2.55 billion for the

years ended December 31, 2022 through 2025 and the midpoint of our 2026 guidance range.

•Dividend yield of 6.1% as of September 30, 2026 and dividend payout ratio of 47% for the three months ended September 30,

2026.

Investments

•As of September 30, 2026:

•Our non-real estate investments aggregated $1.74 billion.

•Unrealized gains presented in our consolidated balance sheet were $243.9 million, comprising gross unrealized gains and

losses aggregating $322.4 million and $78.5 million, respectively.

•Investment income of $24.0 million for the three months ended September 30, 2026, presented in our consolidated statement

of operations, consisted of $16.0 million of realized gains, $21.6 million of unrealized gains, and $13.6 million of impairment

charges.

57

Trends that may affect our future results

Currently identified key market trends and uncertainties that had or may have a negative effect on our business are discussed

below. Although we seek to minimize the risks posed by these trends and uncertainties as discussed in the mitigating factors section

below, there can be no assurance that these measures will be successful in preventing or mitigating material impacts on our future

results of operations, financial position, and cash flows. Refer to “Item 1A. Risk factors” in Part I of our annual report on Form 10-K for

the year ended December 31, 2025 for discussion of additional risks we face.

New and existing supply and reduced demand for life science space may continue to negatively affect our rental rates,

occupancy, and operating results.

•Influx of supply. During and after the COVID-19 pandemic, the shift toward hybrid and remote work arrangements as well as

exceptionally strong demand for life science space, driven by public health urgency and supported by historically low interest

rates, prompted certain office and other real estate investors to repurpose underutilized office spaces into laboratory facilities,

initiating a wave of new development activity across the sector. Our success and the success of other laboratory operators

prompted new and existing developers to commence speculative redevelopment and/or development laboratory projects in

anticipation of demand for such facilities. These conversion and speculative development projects have contributed to a

significant influx of new laboratory properties in our top three markets—Greater Boston, San Diego, and San Francisco Bay

Area. Life science real estate availability in these top markets—measured as the percentage of life science RSF available

relative to total life science RSF—rose to approximately 29% during 2025, from approximately 4% in 2021. This surge created

supply that materially exceeded current demand. As pandemic-driven urgency faded, the amount of available space became

the dominant factor influencing tenant activity, with absorption unable to match the influx of supply.

•Decrease in demand. Adding to these challenges, life science tenant demand—after reaching historically high levels in 2021—

has moderated significantly. The average tenant demand, measured by life science tenants’ RSF requirements, declined by

more than 60% in 2025 compared to 2021 across our top three markets: Greater Boston, San Diego, and San Francisco Bay

Area. This reflected a shift from extraordinary tenant demand driven by pandemic-related urgency to levels more consistent

with historical pre-pandemic norms, particularly those observed during 2016-2018. Importantly, this shift occurred amid

substantially higher available supply, as discussed above, further negatively impacting occupancy and rental rates in top life

science markets.

Exacerbating the recent demand trend, the life science industry faced an unusual convergence of macroeconomic, regulatory,

policy, and political challenges in 2025 that continued to affect the sector during 2026. These included consequential shifts in

leadership at the U.S. Department of Health and Human Services (“HHS”), tariff-related measures, operational, leadership,

and staff disruptions at the NIH and the FDA, threatened reductions in NIH funding of biomedical research and proposals to

limit NIH funding of indirect grant costs, heightened scrutiny of pharmaceutical pricing, and increased global competition from

China, discussed below. Collectively, these factors, including those described below, increased uncertainty, leading tenants to

defer leasing commitments and expansion decisions pending greater clarity. As a result, absorption of available space has

been notably slower.

◦Prolonged biotech bear market and capital constraints. The life science sector experienced the fifth consecutive year

of a broad-based biotech bear market in 2025. Life science venture capital fundraising declined to its lowest level since

2016, reducing overall levels of venture capital funds available to deploy in the future. Life science venture funds also

continued to be highly risk averse, focusing investments on clinical-stage and asset-based opportunities that may not

drive significant laboratory space needs. The initial public offering market for biotech companies remained largely closed

in 2025, eliminating a key source of liquidity and growth capital, but began to reopen in 2026. Elevated financing costs and

broader economic and regulatory uncertainty continued to constrain access to debt and equity financing. These factors

slowed company formation, reduced headcount growth, and delayed laboratory expansion decisions, directly impacting

leasing demand for specialized life science space. Although capital markets and leasing activity showed early signs of

improvement in 2026, the recovery remained uneven, and laboratory demand continued to be constrained by disciplined

capital allocation and significant excess supply.

◦Regulatory and policy factors affecting absorption. At the same time, the regulatory environment experienced

significant disruption. The FDA saw more than 50% turnover in senior leadership during the first half of 2025,

accompanied by employee layoffs and delays in regulatory review decisions. Leadership turnover continued in 2026,

including the departure of the FDA Commissioner in May 2026. Changing expectations related to clinical trial requirements

and flexibility for rare diseases with large unmet needs created additional uncertainty around development timelines for

certain regulated products. These conditions have reduced some tenants’ near-term confidence in expansion and capital

investment decisions.

Biomedical research institutions faced increased uncertainty around federal funding policies throughout 2025. The

proposed 15% cap on NIH institutional indirect grant spending, subsequently ruled unlawful by an appellate court, raised

concerns for biomedical research institutions about the ability to recover infrastructure and operating costs, which

materially constrained incremental real estate demand among certain federally supported entities.

58

In April 2026, the Trump administration discontinued its legal effort to implement the proposed 15% cap on NIH indirect

cost reimbursements, allowing the federal court ruling blocking the policy to become final. Existing negotiated

reimbursement rates remain in effect. Accordingly, NIH-funded research institutions continue to operate under the current

reimbursement framework.

Further, government actions aimed at reducing U.S. prescription drug prices have heightened uncertainty regarding future

returns on pharmaceutical and biotechnology investments. This has weighed on risk appetite across the sector and

constrained investment into some areas of research and development. As a result, some tenants have delayed or scaled

back expansion plans, reducing leasing activity and occupancy levels.

At the same time, global competition for life science research has intensified, with certain foreign markets, especially

China, rapidly gaining ground as biotechnology leaders through centralized funding and faster regulatory approval

timelines. Coupled with immigration-related restrictions implemented in the U.S. during 2025 that limit access to

international research talent, these policy actions not only affect current activities but also pose a significant threat to the

long-term viability of the U.S. biomedical industry. The cumulative effect of these developments may significantly reduce

tenant demand for U.S. life science real estate. Refer to “Item 1A. Risk factors” in our annual report on Form 10-K for

additional details.

•Impact on our business. The surge in supply and decrease in demand for life science space have led to industry-wide elevated

vacancy rates, slower leasing activity, pressure on rental rates, higher lease concessions, and increased competition for

tenants. Our operating occupancy declined from 90.9% as of December 31, 2025 to 87.1% as of September 30, 2026, and we

project our operating occupancy to be approximately 87.0% as of December 31, 2026, representing the midpoint of our

guidance range for occupancy percentage in North America as of December 31, 2026.

To remain competitive, we have realized lower rental rate changes on renewed and re-leased spaces and have offered more

tenant improvement allowances or additional tenant concessions, including free rent, to retain existing tenants or attract new

tenants. We project our rental rate on renewed and re-leased spaces to decrease by approximately 5.0% for the year ending

December 31, 2026, representing the midpoint of our guidance range. Furthermore, to maintain long-term tenant relationships

and sustain occupancy levels within our core assets, our existing operating properties may require additional revenue- and

non-revenue-enhancing capital expenditures earlier than typically expected.

The table below reflects a trend of increasing revenue- and non-revenue-enhancing capital expenditures, including tenant

improvement expenditures. The table also presents the trend, on a per RSF basis, of increasing tenant improvement

allowance, leasing commissions, and free rent concessions, and of less favorable changes in rental rates related to our

renewed/re-leased spaces, as well as decreases in our operating occupancy (dollars in thousands, except per RSF amounts):

Revenue- and

Non-Revenue-

Enhancing

Capital

Expenditures

Tenant

Improvements/

Leasing

Commissions

per RSF

Free Rent

Concessions per

Annum

(leases executed in

trailing 12 months)

Rental Rate

Changes

(on renewed/

re-leased

spaces)

Operating

Occupancy

(as of each

period end)

2024

$273,377

$46.89

0.7 months

16.9%

94.6%

2025

$324,293

$55.34

1.5 months

7.0%

90.9%

Nine months ended September 30, 2026

$430,365

$46.45

2.0 months

(5.1)%

87.1%

Midpoint of 2026 guidance range

$510,000

N/A

(5.0)%

87.0%

Additionally, we have key lease expirations with expected downtime in 2027 aggregating 1.4 million RSF as of September 30,

2026 with a weighted-average lease expiration date of March 2027. These spaces are expected to become vacant at lease

expiration and re-leased to new tenants. We expect downtime on the 1.4 million RSF to be approximately 9 to 24 months on a

weighted-average basis. In addition, we have identified 717,546 RSF of key lease expirations in 2028 that are expected to

have downtime of approximately 9 to 24 months on a weighted-average basis. Considering elevated laboratory supply, there

can be no assurance that we will be able to re-lease some or all of this space on acceptable terms, without significant capital

expenditures, or within anticipated time frames, even at reduced rates.

As of September 30, 2026, we anticipate that 905,582 RSF of our projects undergoing construction will be placed into service

from October 1, 2026 through 2028 and will generate $85 million in future incremental annual net operating income. These

projects are 77% leased or under lease negotiations as of September 30, 2026. Furthermore, we have an additional 667,002

RSF of projects under evaluation which are 8% leased or under lease negotiations. For these projects, we are evaluating the

business and financial strategy, including continuing construction, repositioning for advanced technology or other non-

laboratory use, selling, or pausing development or redevelopment. If we decide to sell or pause, such actions could negatively

impact our FFO and operating metrics. Alternatively, if we decide to invest limited capital, we may place some or all of these

projects into operation, which could temporarily reduce our operating occupancy until the projects are leased and occupied.

Landlord-funded tenant improvement allowances have increased significantly for first-generation space, including development

and redevelopment projects, with most space in shell condition requiring landlords to fund the full build-out cost. This trend

59

places additional pressure on projected returns and overall economics, and further challenges our ability to attract and secure

tenants for the remaining unleased RSF related to these projects at the expected rates, or at all, which could result in a

shortfall or delay in the commencement of the projected incremental annual net operating income.

Unfavorable macroeconomic and capital market conditions may continue to adversely affect the value of our real estate and

non-real estate portfolios, which could result in additional significant impairments and may impact our ability to raise capital

efficiently to further our business objectives.

The effective execution of our development and redevelopment activities is contingent on access to the capital required to fund

these projects. We expect construction spending in 2026 to aggregate $1.75 billion at the midpoint of our 2026 guidance

range. This includes significant remaining construction costs to complete our active pipeline and anticipated increases in both

revenue- and non-revenue-enhancing capital expenditures in our operating portfolio. As a result, our capital plan and leverage

management strategy have increased our reliance on real estate dispositions and sales of partial interests to generate capital.

However, current real estate market conditions, including lower property valuations, increased capitalization rates, and higher

short-term and long-term interest rates, will likely adversely affect the timing and pricing of such transactions.

For 2027, we are continuing to apply a disciplined approach to reduce construction spending and expect construction spending

in 2027 will be primarily comprised of (i) revenue- and non-revenue-enhancing capital expenditures primarily to support the

leasing of vacant space and renewals and re-leasing of space at our operating properties and (ii) amounts required to

complete our development and redevelopment projects that are expected to stabilize through 2028 and are 77% leased/

negotiating.

•Lower property valuations and increased capitalization rates. A portion of our projected construction spending and other uses

of capital is expected to be funded through dispositions, sales of partial interests, and other capital sources (including junior

subordinated notes). Real estate investments are generally less liquid than many other investment types, which can present

challenges in selling our properties in a timely manner or at desirable prices, especially in an environment of oversupply and

high interest rates.

In addition to the factors discussed above specifically affecting demand for life science space, broader real estate demand has

also been impacted by macroeconomic conditions, particularly elevated interest rates. Following the onset of the COVID-19

pandemic, the U.S. Federal Reserve reduced the federal funds target range to 0%–0.25% in March 2020 and maintained that

near-zero range until March 2022. To address inflation concerns, the U.S. Federal Reserve then increased the target range

rapidly, reaching 5.25%–5.50% in July 2023, where it remained for an extended period. Although the U.S. Federal Reserve

reduced the federal funds target range to 4.25%–4.50% during 2024 and further to 3.50%–3.75% during 2025, interest rates

remain elevated. In September 2026, the U.S. Federal Reserve increased the target range to 3.75%–4.00%. Due to a variety

of factors, the yield on the 10-year U.S. Treasury note increased significantly in October 2026, exceeding 5% and reaching its

highest level since 2002. This continues to limit access to debt and/or equity financing for prospective buyers of real estate

assets. All other aspects being equal, such challenges for buyers contribute to an excess of properties available for sale, which

exerts downward pressure on property valuations and elevates capitalization rates, adversely impacting the sales proceeds we

can generate from our real estate asset sales.

The oversupply of life science real estate assets, discussed above, combined with high interest rates and reduced market

liquidity, has contributed to a prolonged period of lower property valuations and higher capitalization rates, resulting in

significant real estate impairments and making it more challenging to execute asset sales within the expected timelines and at

favorable pricing. In 2026, we expect to complete dispositions and sales of partial interests of approximately $1.90 billion at the

midpoint of our 2026 guidance range. However, we may not be able to achieve this and/or other targets disclosed in our 2026

guidance as a result of the uncertainties discussed in this section as well as in “Item 1A. Risk factors” in Part I of our annual

report on Form 10-K for the year ended December 31, 2025.

The table below presents trends in total dispositions and impairments of real estate and capitalization rates associated with

dispositions and sales of partial interests in our real estate assets over the last several years (dollars in thousands), partly

attributable to the quality of core and non-core assets sold during each period.

Aggregate Sales Price of

Dispositions and Sales of

Partial Interests

Impairment of

Real Estate

Capitalization

Rates(1)

Capitalization

Rates

(Cash Basis)(1)

2024

$1,382,453

$223,068

7.7%

6.5%

2025

$1,813,778

$2,202,818

7.7%

(2)

7.5%

(2)

Nine months ended September 30, 2026

$241,750

$865,873

N/A

Midpoint of 2026 guidance range

$1,900,000

(3)

(1)Capitalization rates are calculated only for stabilized operating assets sold. Refer to “Capitalization rates” under “Definitions and reconciliations” for additional

information.

(2)Represents the weighted-average capitalization rate for stabilized operating assets sold in 2025, which accounted for only 20% of the aggregate sales price

of dispositions and sales of partial interests in 2025.

(3)We are not able to forecast impairments or capitalization rates for future periods without unreasonable effort due to the inherent difficulty of forecasting the

timing and amount of transactions that depend on market conditions outside of our control.

60

For additional information about our dispositions and real estate impairments recognized during the three and nine months

ended September 30, 2026, refer to “Sales of real estate assets and impairment of real estate” in Note 3 – “Investments in real

estate” to our unaudited consolidated financial statements in Item 1.

For 2026, we have established a disposition and joint venture program aggregating approximately $1.90 billion at the midpoint

of our 2026 guidance range for dispositions and sales of partial interests. We may utilize multiple sources of capital, including

land and non-core dispositions, sales of partial interests, and the issuance of $1.00 billion junior subordinated notes offering

completed during the three months ended September 30, 2026, to fund (i) construction focused on highly leased

developments and lease-up of vacant space, and (ii) repayment of senior unsecured debt sufficient to achieve our net debt

and preferred stock to Adjusted EBITDA – fourth quarter of 2026 annualized target of 5.6x to 6.2x. We continue to evaluate

available alternatives and expect to execute on cost-efficient sources of capital under prevailing market conditions. We do not

anticipate the issuance of any common equity during the year ending December 31, 2026.

In 2026, we are committed to dispose of certain assets classified as held for sale with an aggregate book value of

$702.8 million as of September 30, 2026. To achieve the midpoint of our 2026 guidance range of $1.90 billion for dispositions

and sales of partial interests, we continue to evaluate a broad range of opportunities, including non-core operating properties,

both stabilized and unstabilized, and land parcels.

Under GAAP, real estate assets are evaluated for impairment upon an indication of potential impairment:

•For real estate assets held and used, impairments are recognized if the sum of expected future undiscounted cash

flows, including estimated proceeds from eventual disposition, is less than the carrying amount. In such cases, the

carrying amount is reduced to estimated fair value.

•For real estate assets held for sale, impairments are recognized if fair value less costs to sell is less than the carrying

amount.

•In evaluating potential disposition targets that do not meet the criteria for held for sale classification, we apply a

probability-weighted approach, and in each case, no impairment charge is currently required.

If circumstances change, including changes in expected cash flows, capitalization rates, or market conditions, we may incur

additional material real estate impairments in 2026. For additional information on accounting for real estate impairments, refer

to “Impairment of long-lived assets” in Note 2 – “Summary of significant accounting policies” to our unaudited consolidated

financial statements in Item 1.

We are focused on our large-scale non-core disposition program in 2026, although some of these dispositions could close in

2027. As of September 30, 2026, 80% of our annual rental revenue is from our Megacampus platform, and we expect this

percentage to continue to grow over time, in part through our disposition program.

•Increased cost and limited availability of capital. Our 2026 guidance assumes a reduction of our outstanding unsecured debt

by approximately $675.0 million, at the midpoint of our 2026 guidance range.

•In August 2026, we completed a public offering of $1.0 billion aggregate principal amount of 7.250% junior

subordinated notes due 2057. The notes will initially bear interest at 7.250% per year through, but excluding,

February 15, 2032. Thereafter, the interest rate will reset every five years to the five-year U.S. Treasury rate plus

2.889%, subject to a minimum interest rate of 7.250%. We may elect to defer interest payments for up to five

consecutive years, subject to the terms of the notes, including certain restrictions on paying dividends and

repurchasing equity. We may also redeem at 100% of principal plus accrued and unpaid interest during the period

beginning November 17, 2031 and ending on February 15, 2032, and thereafter on any interest payment date. This

issuance supports our capital structure and deleveraging objectives while receiving 50% equity treatment from key

rating agencies.

•In February 2026, we completed tender offers to repurchase an aggregate debt principal amount of $1.33 billion

across a portion of our outstanding 4.00% Senior Notes due 2050, 3.00% Senior Notes due 2051, and 3.55% Senior

Notes due 2052. The tender offers were completed at an average discount of approximately 28%, for a total cash

payment of $952.2 million, resulting in the extinguishment of approximately $380 million of debt. We funded the

$952.2 million payment through the issuance of $750.0 million of 5.25% unsecured senior notes due 2036 and

approximately $200 million of short-term borrowings under our commercial paper program.

•In January 2026 and April 2026, we repaid, upon maturity, $300.0 million of 4.30% unsecured senior notes and

$350.0 million of 3.80% unsecured senior notes, respectively. These repayments, aggregating $650 million, were

temporarily funded through borrowings under our commercial paper program.

Achievement of our targeted $675.0 million net unsecured debt reduction remains dependent on our ability to generate

proceeds during 2026 from planned real estate dispositions and sales of partial interests.

61

These expectations assume our ability to execute these transactions on acceptable terms. If we are unable to sell real estate

assets at our targeted prices or within our expected timeframes, we may need to reduce the projected amount of debt

repayment, delay the timing of such repayment, and/or increase our reliance on additional debt financing to fund the

approximately $1.75 billion of construction spending, based on the midpoint of our 2026 guidance range. Elevated interest

rates may result in debt financing options that are costlier, less accessible, or even unavailable, potentially limiting our ability to

complete our development and redevelopment projects on schedule and thereby delaying our expected incremental annual

net operating income generation.

The table below reflects interest rates related to unsecured senior notes payable and junior subordinated notes payable that

we have issued over the last several years and in 2026 (dollars in thousands). There is no assurance that high debt costs will

not continue into the future.

Unsecured Senior

Notes Payable Issued

Junior Subordinated

Notes Payable Issued

Interest Rate(1)

2024

$1,000,000

$—

5.57%

2025

$550,000

$—

5.66%

February 2026 issuance

$750,000

$—

5.41%

August 2026 issuance

$—

$1,000,000

7.37%

(1)Includes amortization of loan fees, amortization of debt premiums (discounts), and other bank fees.

•Capitalized Interest.

The table below presents gross interest expense, capitalized interest, and interest expense (in thousands):

Gross Interest Expense

Capitalized Interest

Interest Expense

2024

$516,799

$(330,961)

$185,838

2025

$557,122

$(330,424)

$226,698

Nine months ended September 30, 2026

$415,225

$(206,612)

$208,613

Midpoint of 2026 guidance range

$520,000

$(240,000)

$280,000

For 2026, we expect capitalized interest of approximately $240 million at the midpoint of our guidance range. The decrease

compared to 2025 reflects our actions taken in response to the market conditions, including re-evaluating certain projects,

ceasing or pausing certain pre-construction activities on land and uncommitted projects to conserve capital, and disposing of

certain assets. As a result, we expect our interest expense to increase to approximately $280 million (at the midpoint of our

2026 guidance range) in 2026 from $226.7 million in 2025. Continued macroeconomic and capital market pressures may

necessitate further reevaluation of our plans, including temporary suspension of our construction projects, delay of future

projects, or the sale of non-income-producing assets, which could further reduce our capitalized interest and increase interest

expense.

•Volatility in the valuation of non-real estate investments. We hold strategic investments in publicly traded companies and

privately held entities primarily involved in the life science industry. These investments are subject to market- and sector-

specific risks that can substantially affect their valuation. Like many other industries, the life science industry is susceptible to

macroeconomic challenges, such as ongoing economic and geopolitical uncertainty and a tighter capital environment. These

factors may lead to increased volatility in the valuation of our non-real estate investments.

In such an environment, distributions from our investments—which we may receive as dividends, as liquidation distributions

from our investments in limited partnerships, or as a result of mergers and acquisitions involving our privately held investees—

may be limited and could result in lower realized gains. Gross unrealized gains related to our non-real estate investments held

as of September 30, 2026, December 31, 2025, and December 31, 2024 aggregated to $322.4 million, $184.4 million, and

$228.1 million, respectively. These unrealized amounts are subject to market fluctuations and may not ultimately be realized.

We may not receive distributions from our investments or may face difficulties in monetizing our non-real estate investments at

optimal prices. There can be no assurance that we will be able to realize gains in the future. In periods with limited or no

realized gains, our FFO per share, as adjusted, may be adversely affected.

62

For the nine months ended September 30, 2026, we recognized $44.5 million in realized gains on non-real estate investments

and are projecting realized gains of $65 million in 2026 at the midpoint of our guidance range. During the nine months ended

September 30, 2026, we also recognized impairment charges and unrealized gains that reflect continued valuation pressures.

The table below presents components of investment income (losses) on our non-real estate investments (in thousands):

Realized

Gains

Significant

Realized Losses

Impairments

Unrealized

(Losses) Gains

Investment

(Losses) Income

2024

$117,214

$—

$(58,090)

$(112,246)

$(53,122)

2025

$115,722

$(103,329)

$(95,716)

$26,980

$(56,343)

Nine months ended September

30, 2026

$44,497

$—

$(35,026)

$143,164

$152,635

Midpoint of 2026 guidance range

$65,000

N/A(1)

(1)We are not able to forecast investment income (losses) of future periods without unreasonable effort and therefore do not provide the information on a

forward-looking basis. This is due to the inherent difficulty of forecasting the timing and/or amount of items that depend on market conditions outside of our

control.

Unfavorable market conditions could also lead to additional impairments of our investments in privately held entities that do not

report NAV per share, as well as other‑than‑temporary impairments of our non‑real estate investments accounted for under the

equity method.

The realization of any of the foregoing risks could continue to have material adverse impacts on our revenues and operating

performance, including, but not limited to, our income from rentals, net operating income, results of operations, funds from operations,

operating margins, initial stabilized yields (unlevered) on new or existing construction projects, occupancy, rental rates, EPS, FFO per

share, FFO per share, as adjusted, and net cash provided by operating activities, as adjusted. These impacts have adversely affected,

and could continue to adversely affect, our Adjusted EBITDA, which in turn may continue to negatively impact our key metrics such as

Adjusted EBITDA margin, net debt and preferred stock to Adjusted EBITDA, and fixed-charge coverage ratios. This may also impact

our credit ratings and credit rating outlooks. To preserve liquidity and mitigate an increase to our net debt and preferred stock to

Adjusted EBITDA ratio resulting from declines in Adjusted EBITDA, we may seek additional capital by pursuing additional sales of real

estate and non-real estate investments, or through equity offerings, which could be dilutive to existing stockholders. A reduction in

earnings and/or net cash provided by operating activities, as adjusted, could potentially necessitate or make advisable a reduction in

our dividends per share, as determined by our board of directors. Any of the foregoing could further negatively affect our business and

the market value of our common stock. 

•Mitigating factors:

•Reinforcing the Megacampus platform as our core growth engine. We believe our Megacampus strategy represents

our most powerful competitive advantage in an oversupplied life science real estate market. Our Megacampus

ecosystems are large-scale environments designed to meet the evolving needs of the world’s leading scientific and

technological organizations, located in life science innovation hubs in close proximity to top academic and medical

research institutions. This proximity is a key driver of tenant demand. These campuses are used in two distinct ways: (i) to

house the research operations of our tenants, and (ii) to recruit and retain the best talent available from a limited pool,

which underscores why their scale, strategic design, and location are critical. With our Megacampus ecosystems, we aim

to provide a superior set of amenities, services, and access to transit. With inspiring design and people-centric amenities,

we believe these campuses enhance our tenants’ confidence in using these spaces as effective recruiting tools. In

contrast, we believe that a significant amount of the competitive supply in the market today consists of isolated facilities

that provide operational space but lack the scale and strategic design that our Megacampus ecosystems deliver.

Our Megacampus ecosystems, which offer both high visibility and a clear path for growth, are designed for scalability to

accommodate our tenants’ growth. Our future development and redevelopment projects aggregate 19.5 million RSF as of

September 30, 2026, of which 80% is concentrated within our Megacampus ecosystems. Their strategic locations and

path for growth serve as powerful incentives for tenants to lease space from us.

We believe our Megacampus strategy has enabled us to capture a greater share of available leasing demand relative to

competitors in our core life science markets, even as overall supply has increased. The strength of this strategy is

reflected in the 2026 performance metrics below, achieved despite challenging macroeconomic, regulatory, policy, and

geopolitical environments:

•Our occupancy of 87.1% as of September 30, 2026:

•Additional 3.7% occupancy is expected from 1.3 million RSF (3.7% of total operating RSF) of leased space that

was temporarily vacant as of September 30, 2026. These spaces are expected to become occupied upon

completion of building and/or tenant improvements, with a weighted‑average expected occupancy date of June

2027, and are expected to generate annual rental revenue of approximately $52 million upon lease

commencement. We expect 32% of the total 1.3 million RSF to be occupied by December 31, 2026.

63

•During the nine months ended September 30, 2026, we placed into service development and redevelopment projects

aggregating 1.1 million RSF that are 87% occupied in various submarkets and delivered incremental annual net

operating income of $98 million.

•Expected incremental annual net operating income from projects anticipated to be placed into service by the end of

2028:

•$24 million from 2027 deliveries.

•$61 million from 2028 deliveries.

•Strength of our brand. As a recognized leader in the life science and real estate sectors, Alexandria has successfully

built a diverse and high-quality tenant base. Over the past three decades, we have fostered long-standing relationships

and strategic partnerships with our tenants, which have enabled us to maintain strong occupancy levels and leasing

volume, generate growth in net operating income and cash flows, and effectively navigate various economic cycles. Key

indicators of our brand strength include the following:

•As of September 30, 2026, 74% of our leasing activity during the last twelve months was from our existing tenant

base.

•As of September 30, 2026, 84% of our top 20 tenant annual rental revenue was derived from investment-grade or

publicly traded large cap companies.

•Our tenant collections have remained consistently high, averaging 99.9% from the beginning of 2021 to

September 30, 2026.

•Prudent financial management. Our strong and flexible balance sheet and prudent balance sheet management are key

factors in our ability to navigate macroeconomic uncertainties and capitalize on new opportunities. The strength of our

financial position is highlighted by several key indicators:

•Our significant liquidity of $4.56 billion as of September 30, 2026 provides us the flexibility to address our operational

needs and to pursue strategic opportunities.

•We expect to fund a large portion of our capital requirements through the following sources in 2026:

•$525 million in net cash provided by operating activities, as adjusted, at the midpoint of our 2026 guidance range.

•$105.0 million in capital contributions to fund construction expected from our existing consolidated real estate

joint venture partners from October 1, 2026 through 2027 and beyond.

•$1.90 billion from real estate dispositions and sales of partial interests at the midpoint of our 2026 guidance

range.

•Issuance of $1.00 billion of 7.250% Series A fixed-to-fixed reset rate junior subordinated notes due 2057, which

was completed in August 2026.

•As of September 30, 2026, our credit ratings from S&P Global Ratings and Moody’s Ratings were BBB+ and Baa2,

respectively, which rank in the top 20% among all publicly traded U.S. REITs.

•Net debt and preferred stock to Adjusted EBITDA ratio target: 5.6x to 6.2x for the fourth quarter of 2026, annualized.

•As of September 30, 2026, our fixed-rate debt represents 91.5% of our total debt, which provides predictability in debt

servicing costs. Since 2022, our quarter-end fixed-rate debt has averaged 95.5%.

•Our debt maturity schedule is well laddered, which provides us with financial flexibility and reduces short-term

refinancing risks. As of September 30, 2026, only 6% of our debt matures through 2028.

•As of September 30, 2026, the weighted-average remaining term of our debt is 11.6 years, which is the longest

among S&P 500 REITs, and demonstrates our strategic approach to debt management and our focus on maintaining

manageable annual debt maturities.

•Operational excellence of our team. Alexandria focuses on operational excellence in the direct asset management and

operations of our Labspace® asset base. Our asset management and operations team is composed of highly experienced,

educated, and professionally credentialed facilities specialists. This expertise, essential in ensuring a secure and efficient

environment for groundbreaking scientific research, has been cultivated and maintained over many years.

The demanding nature of laboratory-based scientific research requires strict adherence to safety standards set by local,

state, and federal regulatory bodies. Key compliance aspects include good manufacturing practices (“GMP”) and Clinical

Laboratory Improvement Amendments (“CLIA”) certifications, adherence to national biosafety level guidelines, proper

permitting and handling of hazardous waste generation and chemical storage, maintenance of safety stations, effective

management of ultra-low temperature freezers, and careful licensing and management of radioactive materials.

•Other mitigating factors

•Improvement in office market. The increase in demand for premium office space since 2024, primarily driven by the

technology sector, particularly companies focused on AI, absorbed some of the market’s supply that was previously

anticipated for life science use and is now being repositioned back into office space. High ceilings, improved

ventilation systems, and abundant natural light, which are all features of life science real estate, have become highly

desirable, appealing to office and advanced technology tenants. We expect this trend may lead to the exit from the

life science sector of inexperienced life science real estate developers and expedite the resolution of the oversupply

impacting the sector.

64

•Proactive reduction in capital spending and funding needs. To address higher capital costs and slower market

absorption, we implemented a disciplined reduction in construction spending. Based on the midpoint of our 2026

guidance range, our average annual construction spending is expected to decrease to approximately $1.74 billion for

2024–2026, representing a reduction of approximately $1.02 billion, or 37%, compared to the 2021–2023 average.

Our 2026 construction spending is primarily focused on:

•Leasing vacant space at operating properties

•Completing active committed construction projects

•Limiting future pipeline pre-construction activity

This strategy supports a more cost-efficient capital plan while preserving flexibility for future growth opportunities.

•Decrease in general and administrative expenses. Over the past several years, we have implemented comprehensive

measures to reduce our expenditures across our organization, including our general and administrative expenses,

through a variety of cost-control and efficiency initiatives, including, but not limited to:

•Personnel-related matters, including:

•Reduction in headcount over the last two years.

•Restructuring of various compensation plans.

•Streamlining of business processes:

•Implementation of systems upgrades, process improvements, and smarter technology.

•Renegotiation of contracts related to legal, technology, and operational support services, and

elimination of redundancies through better alignment and consolidation of roles.

As a result, we have achieved the following outcomes:

•We expect $76 million of cumulative savings in 2025 and 2026 (based upon the midpoint of our guidance

range for 2026 general and administrative expenses), compared to 2024.

•For the trailing twelve months ended September 30, 2026, our general and administrative expenses were

7.5% of net operating income, approximately half the 2023–2025 average of other S&P 500 REITs.

We believe the mitigating factors discussed above will help us manage prolonged market volatility while maintaining the

flexibility to act on strategic opportunities. Through disciplined execution of non-core asset recycling, targeted capital

allocation, continued focus on our Megacampus platform, moderated construction spending, and preservation of balance sheet

strength, we are building a resilient platform designed to deliver sustainable future growth and value creation across multiple

cycles. We believe these actions position us to emerge from the current cycle in a position of strength.

65

Operating summary

Same Property Performance:

Net Operating Income Changes

Occupancy of Operating Properties

8246337209768

(1)

8246337209805

(1)

8246337209880

Refer to “Same properties” and “Definitions and reconciliations” in Item 2 for additional details. “Definitions and reconciliations” contains the definitions of “Adjusted EBITDA,”

“Fixed-charge coverage ratio,” “Net debt and preferred stock to Adjusted EBITDA,” and “Net operating income” and their respective reconciliations from the most directly

comparable financial measures presented in accordance with GAAP.

(1)Refer to footnote 1 under “Same properties” in Item 2 for additional details.

66

Rental Rate Changes:

Renewed/Re-leased Space

Favorable Lease Structure(1)

Strategic Lease Structure by Owner and Operator

of Collaborative Megacampus Ecosystems

Increasing cash flows

Percentage of leases containing annual

rent escalations

97%

Stable cash flows

Percentage of triple net leases

91%

Lower capex burden

Percentage of leases providing for the

recapture of capital expenditures

91%

8246337209904

8246337209966

Margins(2)

Operating

Adjusted EBITDA

66%

65%

(1)Percentages calculated based on our annual rental revenue in effect as of September 30, 2026.

(2)For the three months ended September 30, 2026.

67

Stable Cash Flows From Our High-Quality and Diverse Tenants

1

2199023256393

(1)

(2)

(3)

Percentage of ARE’s Annual Rental Revenue

Investment-Grade or

Publicly Traded Large Cap Tenants

57%

84%

of ARE’s Total

Annual Rental Revenue

of ARE’s Top 20 Tenant

Annual Rental Revenue

Weighted Average

Remaining Term(4)

7.7 Years

10 Years

All Tenants

Top 20 Tenants

As of September 30, 2026. Annual rental revenue represents amounts in effect as of September 30, 2026. Refer to “Definitions and reconciliations” in Item 2 for additional

information.

(1)Represents the percentage of our annual rental revenue generated by professional services, finance, construction/real estate companies, and retail-related tenants.

(2)89% of our annual rental revenue from advanced technologies tenants is from investment-grade or publicly traded large cap tenants.

(3)80% of our annual rental revenue from biomedical institutions is from investment-grade or publicly traded large cap tenants.

(4)Represents the weighted-average remaining term based on annual rental revenue in effect as of September 30, 2026.

68

Leasing activity

The following table summarizes our leasing activity at our properties:

Three Months Ended

Nine Months Ended

Year Ended

September 30, 2026

September 30, 2026

December 31, 2025

(Dollars per RSF)

Including

Straight-Line Rent

Cash

Basis

Including

Straight-Line Rent

Cash

Basis

Including

Straight-Line Rent

Cash

Basis

Leasing activity:

Renewed/re-leased space(1)

Rental rate changes

(2.4)%

(3.3)%

(5.1)%

(6.9)%

7.0%

3.5%

New rates

$49.15

$47.59

$45.71

$46.71

$52.71

$53.66

Expiring rates

$50.34

$49.21

$48.18

$50.19

$49.27

$51.87

RSF

785,069

1,806,754

2,543,473

Tenant improvements/leasing

commissions

$40.64

$46.45

$55.34

Weighted-average lease term

11.2 years

9.7 years

9.0 years

Previously vacant/developed/

redeveloped space leased

New rates

$58.33

$58.60

$48.30

$48.32

$72.30

(2)

$67.56

(2)

Previously vacant RSF

450,961

(3)

928,843

944,362

Developed/redeveloped RSF(4)

—

(3)

186,706

704,821

(2)

Weighted-average lease term

11.9 years

12.2 years

13.8 years

Leasing activity summary (totals):

New rates

$52.50

$51.61

$46.70

$47.33

$60.42

$59.13

RSF

1,236,030

2,922,303

4,192,656

Weighted-average lease term

11.5 years

10.9 years

11.9 years

Lease expirations(1)

Expiring rates

$52.13

$54.53

$53.30

$57.21

$54.22

$55.56

RSF

1,102,282

(5)

3,612,133

4,460,081

Leasing activity includes 100% of results for properties in which we have an investment.

(1)Excludes month-to-month leases aggregating 272,378 RSF and 58,516 RSF as of September 30, 2026 and December 31, 2025, respectively. During the trailing twelve

months ended September 30, 2026, we granted free rent concessions averaging 2.0 months per annum. This includes a lease concession for a 20-year lease with a non-

life science tenant in the Research Triangle market executed during the three months ended September 30, 2026. Excluding this lease, free rent concessions were 1.1

months per annum.

(2)Includes the largest life science lease in company history, executed in July 2025 with Novartis AG. The 16-year expansion build-to-suit lease aggregates 466,598

RSF and is located at the Campus Point by Alexandria Megacampus in our University Town Center submarket. Excluding this lease, previously vacant/developed/

redeveloped rental rates would have been $58.31 and $58.70 (cash basis) and development/redevelopment leasing volume would have been 238,223 RSF, for the

year ended December 31, 2025.

(3)During the three months ended September 30, 2026, we executed leases of 66,859 RSF and have additional leases under negotiation of 100,684 RSF for advanced

technology use at our project at 311 Arsenal Street in our Greater Boston market, all of which will be reflected as leasing of previously vacant space. This activity

enabled us to pivot the redevelopment project to a lower-cost advanced technology use, reducing future potential construction spend by approximately $220 million.

As a result of this leasing progress, the entire project aggregating 339,020 RSF was reclassified from redevelopment to operating as of September 30, 2026.

(4)Refer to “New Class A/A+ development and redevelopment properties: summary of pipeline” in Item 2 for additional information, including total project costs.

(5)Includes previously disclosed key lease expirations aggregating 282,878 RSF that became vacant during the three months ended September 30, 2026, with a

weighted-average lease expiration date of August 2026.

69

Contractual lease expirations

The following tables summarize the contractual lease expirations as of September 30, 2026:

Year

RSF

Percentage of

Occupied RSF

Annual Rental Revenue

(per RSF)(1)

Percentage of

Annual Rental Revenue

2026

(2)

481,770

1.6%

$39.19

1.0%

2027

3,054,723

9.9%

$57.27

9.4%

2028

3,701,167

(3)

12.0%

$50.94

10.1%

2029

2,150,332

7.0%

$41.53

4.8%

2030

2,653,670

8.6%

$43.44

6.2%

2031

3,510,598

11.4%

$53.88

10.1%

2032

1,067,200

3.5%

$56.34

3.2%

2033

2,400,457

7.8%

$46.43

6.0%

2034

2,627,230

8.6%

$65.93

9.3%

2035

1,158,790

3.8%

$55.45

3.4%

Thereafter

7,916,798

25.8%

$85.89

36.5%

Market

2026 Contractual Lease Expirations (in RSF)

Annual

Rental

Revenue

(per RSF)(1)

2027 Contractual Lease Expirations (in RSF)

Annual

Rental

Revenue

(per RSF)(1)

Leased

Negotiating

Early Tenant

Discussions

Marketing/

Remaining

Total(2)

Leased

Negotiating

Early Tenant

Discussions

Marketing/

Remaining

Total

Greater Boston

93,181

—

—

37,384

130,565

$29.94

90,664

—

24,259

112,178

227,101

$44.93

San Diego

—

49,603

5,520

10,274

65,397

62.16

—

141,838

82,641

136,502

360,981

41.97

San Francisco Bay Area

12,719

—

2,927

—

15,646

22.45

32,944

40,996

24,694

68,536

167,170

78.12

Seattle

25,552

12,335

—

5,692

43,579

40.59

18,205

116,459

153,984

38,241

326,889

33.02

Maryland

—

—

—

2,796

2,796

14.95

—

35,465

25,766

103,250

164,481

30.28

Research Triangle

13,385

5,506

—

2,690

21,581

25.94

43,238

14,870

140,150

46,314

244,572

34.56

New York City

—

—

—

33,634

33,634

113.67

—

72,428

5,894

26,332

104,654

96.32

Texas

—

—

—

—

—

—

—

—

—

26,160

26,160

27.74

Non-cluster/other markets

—

—

—

—

—

—

—

—

—

54,755

54,755

15.21

Subtotal

144,837

67,444

8,447

92,470

313,198

46.37

185,051

422,056

457,388

612,268

1,676,763

44.36

Key lease expirations with

expected downtime

—

12,801

77,775

77,996

168,572

25.86

—

305,643

521,300

551,017

1,377,960

(3)

72.92

Total

144,837

80,245

86,222

170,466

481,770

$39.19

185,051

727,699

978,688

1,163,285

3,054,723

$57.27

Percentage of expiring leases

30%

17%

18%

35%

100%

6%

24%

32%

38%

100%

Contractual lease expirations for properties classified as held for sale as of September 30, 2026 are excluded from the information on this page.

(1)Amounts in effect as of September 30, 2026.

(2)Excludes month-to-month leases aggregating 272,378 RSF as of September 30, 2026. Refer to “Leasing activity” in Item 2 for additional details.

(3)See tables below for additional details.

(4)Includes 317,385 RSF of key lease expirations from Bristol Myers Squibb across four properties, generating $24.0 million of annual rental revenue with a weighted-average expiration date of April 2027. Upon lease expiration, Bristol Myers

Squibb is expected to relocate to 4135 Campus Point Court, a 426,927 RSF R&D facility delivered in June 2026. We expect the vacated space to experience a period of downtime and are currently under negotiation for 190,085 RSF.

(5)Refer to the footnote for Novartis AG under "Top 20 tenants" in Item 2 for additional details.

2027 Key Lease Expirations with Expected Downtime

2028 Key Lease Expirations with Expected Downtime

Total

Annual Rental

Revenue(1)

Weighted Average

Expiration Date

Weighted Average

Expected Downtime

Total

Annual Rental

Revenue(1)

Weighted Average

Expiration Date

Weighted Average

Expected Downtime

1,377,960 RSF

$100.5M

March 2027

9 to 24 months

717,546 RSF

$60.4M

April 2028

9 to 24 months

Reason for Expected Downtime

(Based on RSF)

Reason for Expected Downtime

(Based on RSF)

2199023256201

2199023256190

Relocation to Other

ARE Properties(4)

Leases at Assets Originally

Acquired for Redevelopment

Other

Relocation to Other

ARE Properties

Leases at Assets Originally

Acquired for Redevelopment

100 Technology Square(5)

Other

Current Leasing Status

(Based on RSF) 

Current Leasing Status

(Based on RSF) 

2199023256329

2199023256318

Negotiating

Early Tenant Discussions

Marketing/Remaining

Early Tenant

Discussions

Marketing/Remaining

70

Contractual lease expirations (continued)

The following table summarizes our key contractual lease expirations in 2027 as of September 30, 2026 (dollars in thousands):

Expiration

Date

Annual

Rental

Revenue

RSF

Campus

Negotiating

Early Tenant

Discussions

Marketing/

Remaining

Total

Campus Point by Alexandria/San Diego – University Town Center

March 2027

$18,776

190,085

—

61,775

251,860

(1)

Alexandria Center® for Life Science – Waltham/Greater Boston – Route 128

January 2027

27,045

—

232,902

—

232,902

(2)

Alexandria Center® for Advanced Technologies – South San Francisco/San

Francisco Bay Area – South San Francisco

January 2027

8,805

—

—

129,501

129,501

199 East Blaine Street/Seattle – Lake Union

June 2027

7,177

—

66,464

43,505

109,969

Sequence District by Alexandria/San Diego – Sorrento Mesa

January 2027

3,282

90,000

—

—

90,000

(2)

Alexandria Center® for Advanced Technologies – South Lake Union/Seattle –

Lake Union

March 2027

4,089

—

50,946

32,144

83,090

(2)

3033 Science Park Road/San Diego – Torrey Pines

March 2027

5,258

—

—

65,525

65,525

(1)

Alexandria Technology Square®/Greater Boston – Cambridge/Inner Suburbs

January 2027

5,652

—

37,960

22,951

60,911

(1)

ARE Torrey Ridge/San Diego – Torrey Pines

March 2027

2,889

—

—

59,248

59,248

The Arsenal on the Charles/Greater Boston – Cambridge/Inner Suburbs

February 2027

4,732

—

54,109

—

54,109

(1)

Alexandria Center® for Advanced Technologies – Canyon Park/Seattle – Bothell

July 2027

1,725

—

—

50,297

50,297

(2)

Alexandria Center® for Life Science – Shady Grove/Maryland – Rockville

January 2027

1,599

—

—

48,500

48,500

(1)

10970 Alexandria Way/San Diego – Torrey Pines

November 2027

2,675

—

—

36,172

36,172

Other

Various

6,781

25,558

78,919

1,399

105,876

March 2027

(3)

$100,485

305,643

521,300

551,017

1,377,960

22%

38%

40%

(1)Relocation to other ARE properties.

(2)Leases at assets originally acquired for redevelopment or repositioning.

(3)Represents the weighted-average expiration date based on annual rental revenue as of September 30, 2026.

71

Top 20 tenants

84% of Top 20 Tenant Annual Rental Revenue Is From Investment-Grade

or Publicly Traded Large Cap Tenants(1)

Our properties are leased to a high-quality and diverse group of tenants, with no individual tenant accounting for greater than

8.6% of our annual rental revenue in effect as of September 30, 2026. The following table sets forth information regarding leases with our

20 largest tenants in North America based upon annual rental revenue in effect as of September 30, 2026 (dollars in thousands, except

average market cap amounts):

Remaining

Lease

Term(1)

(in Years)

Aggregate

RSF

Annual

Rental

Revenue(1)

Percentage

of Annual

Rental

Revenue(1)

Investment-Grade

Credit Ratings

Average

Market

Cap

(in billions)

Tenant

Moody’s

S&P

1

Bristol Myers Squibb Company

8.3

1,654,290

$

162,062

8.6%

A2

A

$115.74

2

Eli Lilly and Company

8.7

1,054,241

92,120

4.9

Aa3

AA-

$985.81

3

Moderna, Inc.

12.2

462,100

71,445

3.8

—

—

$23.15

4

AstraZeneca PLC

5.5

611,326

56,683

(2)

3.0

A1

A+

$280.03

5

Takeda Pharmaceutical Company Limited

10.1

386,111

41,673

2.2

Baa1

BBB+

$52.65

6

Eikon Therapeutics, Inc.(3)

12.8

299,638

38,907

2.1

—

—

$0.59

7

Intellia Therapeutics, Inc.(4)

6.9

283,272

35,090

1.9

—

—

$1.64

8

Illumina, Inc.

5.1

792,687

29,977

1.6

Baa3

BBB

$23.02

9

United States Government

3.9

414,499

29,435

(5)

1.6

Aaa

AA+

$—

10

Novo Nordisk A/S

11.3

262,382

28,876

1.5

Aa3

AA

$209.80

11

Uber Technologies, Inc.

56.0

(6)

1,009,188

27,879

1.5

Baa1

BBB+

$161.24

12

Boston Children's Hospital

14.0

309,231

26,294

1.4

Aa2

AA

$—

13

Novartis AG

1.7

(7)

321,743

25,111

1.3

Aa3

AA-

$303.20

14

Sanofi

4.3

267,278

22,045

1.2

Aa3

AA

$112.32

15

New York University

5.8

218,983

21,073

1.1

Aa2

AA-

$—

16

Massachusetts Institute of Technology

3.3

242,428

20,529

1.1

Aaa

AAA

$—

17

Merck & Co., Inc.

7.6

300,930

18,895

1.0

Aa3

A+

$287.66

18

Vaxcyte, Inc.

8.3

230,755

18,656

1.0

—

—

$7.45

19

Charles River Laboratories, Inc.

9.1

189,549

18,467

1.0

—

—

$9.85

20

Altos Labs, Inc.(8)

14.5

158,990

18,408

1.0

—

—

$—

Total/weighted-average

10.0

(6)

9,469,621

$

803,625

42.8%

Annual rental revenue and RSF include 100% of each property managed by us. Refer to “Annual rental revenue” and “Investment-grade or publicly traded large cap tenants”

under “Definitions and reconciliations” in Item 2 for additional details, including our methodology of calculating annual rental revenue from unconsolidated real estate joint

ventures and average market capitalization, respectively.

(1)Based on annual rental revenue in effect as of September 30, 2026.

(2)Of the $56.7 million of annual rental revenue generated by this tenant, $27.0 million relates to a 232,902 RSF lease at our Alexandria Center® for Life Science – Waltham

Megacampus, which expires in the first quarter of 2027. This lease is included in the 1.4 million RSF of 2027 key lease expirations with expected downtime disclosed under

“Contractual lease expirations” in Item 2. We do not expect the tenant to renew its lease and are actively marketing the space.

(3)Eikon Therapeutics, Inc. is a public biotechnology company led by Roger Perlmutter, a biopharmaceutical executive who previously served as an executive vice president

of Merck & Co., Inc. As of June 30, 2026, the company held $531 million in cash and marketable securities.

(4)Intellia Therapeutics, Inc. is an established, publicly traded clinical-stage biotechnology company focused on CRISPR-based gene-editing therapies. The company reported

positive Phase 3 clinical results in 2026 and reported cash, cash equivalents and marketable securities of $628.4 million as of June 30, 2026. Additionally, on September 4,

2026, the company announced it secured a non-dilutive senior secured term loan facility for up to $400 million.

(5)Includes leases, which are not subject to annual appropriations, with governmental entities such as the NIH and the General Services Administration. Approximately 2% of

the annual rental revenue derived from our leases with the United States Government is cancelable prior to the lease expiration date.

(6)Includes (i) ground leases for land at 1455 and 1515 Third Street (two buildings aggregating 422,980 RSF) and (ii) leases at 1655 and 1725 Third Street (two buildings

aggregating 586,208 RSF) in our Mission Bay submarket owned by our unconsolidated real estate joint venture in which we have an ownership interest of 10%. Annual

rental revenue is presented using 100% of the annual rental revenue from our consolidated properties and our share of annual rental revenue from our unconsolidated real

estate joint ventures. Excluding these ground leases, the weighted-average remaining lease term for our top 20 tenants was 8.4 years as of September 30, 2026.

(7)Includes one direct lease at 100 Technology Square at Alexandria Technology Square® Megacampus in our Cambridge submarket aggregating 255,441 RSF, which

generates annualized rental revenue of $21.0 million and expires in March 2028. The tenant has leased the building since 2002 and has subsequently expanded and

consolidated its operations in Cambridge into a larger footprint. As a result, we do not expect the tenant to renew its lease upon expiration. We are actively marketing the

space for re-leasing and expect significant downtime following lease expiration to upgrade and re-lease the space.

(8)Altos Labs, Inc. is a private biotechnology company led by Hal Barron, M.D., former GlaxoSmithKline Chief Scientific Officer and President, R&D. Altos Labs launched with

$3.0 billion in private funding in 2022, and is backed by a group of prominent investors.

72

Locations of properties

Our properties are strategically located in AAA life science and advanced technology innovation cluster markets. The following

table sets forth the total RSF, number of properties, and annual rental revenue in effect as of September 30, 2026 in each of our

markets in North America (dollars in thousands, except per RSF amounts):

RSF

Number of

Properties

Annual Rental Revenue

Market

Operating

Development

Redevelopment

Total

% of Total

Total

% of Total

Per RSF

Greater Boston

10,338,586

—

600,652

10,939,238

28%

63

$740,938

39%

$88.46

San Diego

6,419,662

466,598

—

6,886,260

18

55

341,035

18

59.23

San Francisco Bay Area

5,469,953

212,657

50,377

5,732,987

16

39

300,013

17

70.79

Seattle

2,900,871

175,950

—

3,076,821

8

39

115,007

6

43.74

Maryland

3,676,755

—

—

3,676,755

10

47

151,322

8

45.77

Research Triangle

3,436,285

—

—

3,436,285

9

36

86,341

5

26.59

New York City

727,674

—

—

727,674

2

2

65,575

3

93.24

Texas

1,651,094

—

66,350

1,717,444

4

13

41,539

2

29.50

Non-cluster/other markets/

Canada

954,935

(1)

—

—

954,935

2

16

21,981

1

29.49

Properties held for sale

965,557

339,668

—

1,305,225

3

18

21,775

1

40.90

36,541,372

1,194,873

717,379

38,453,624

100%

328

$1,885,526

100%

$60.93

1,912,252

Summary of occupancy percentages in North America

The following table sets forth the occupancy percentages for our operating properties and our operating and redevelopment

properties in each of our North America markets, excluding properties held for sale, as of the following dates:

Operating Properties

Operating and Redevelopment Properties

Market

9/30/26

6/30/26

9/30/25

9/30/26

6/30/26

9/30/25

Greater Boston

81.0%

(2)

83.0%

86.8%

76.6%

73.7%

73.6%

San Diego

89.7

89.9

95.2

89.7

89.9

95.2

San Francisco Bay Area

87.1

83.1

90.4

86.3

81.9

86.4

Seattle

90.6

87.7

90.1

90.6

87.7

90.1

Maryland

91.5

91.5

93.9

91.5

91.5

93.9

Research Triangle

94.5

93.9

94.9

94.5

93.9

94.9

New York City

96.6

95.5

98.3

96.6

95.5

98.3

Texas

85.3

85.3

79.9

82.0

82.0

76.5

Subtotal

87.4

87.1

90.8

85.6

83.8

85.9

Non-cluster/other markets/

Canada

78.0

54.1

85.2

78.0

54.1

81.7

87.1%

(3)

86.9%

90.6%

85.4%

83.6%

85.8%

(1)Includes 779,842 RSF and $14.9 million of annual rental revenue located in Canada.

(2)Decline in occupancy was primarily due to 339,020 RSF at our 311 Arsenal Street redevelopment project in our Greater Boston market being placed back into operation

following the execution of leases aggregating 66,859 RSF, with additional leases aggregating 100,684 RSF under negotiation for advanced technology use as of

September 30, 2026. This activity enables us to pivot the redevelopment project to a lower-cost advanced technology use, reducing future construction spend by

approximately $220 million.

(3)Excludes leases aggregating 1.3 million RSF, or 3.7% of total operating RSF, executed as of September 30, 2026 and expected to be occupied upon completion of

building and/or tenant improvements. The weighted-average expected occupancy date is approximately June 2027, with expected annual rental revenue of

approximately $52 million. We expect 32% of the total RSF to be occupied by December 31, 2026.

73

Investments in real estate

A key component of our business model is our disciplined allocation of capital to the development and redevelopment of new

Class A/A+ properties, and property enhancements identified during the underwriting of certain acquired properties, primarily located in

collaborative Megacampus ecosystems in AAA life science and advanced technology innovation clusters. These projects are focused

on providing high-quality, generic, and reusable spaces that meet the real estate requirements of a wide range of tenants. Upon

completion, each development or redevelopment project is expected to generate increases in rental income, net operating income, and

cash flows. Our development and redevelopment projects are generally in locations that are highly desirable to high-quality entities,

which we believe may result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term

asset value. Our pre-construction activities are undertaken in order to prepare the property for its intended use and include entitlements,

permitting, design, site work, and other activities preceding commencement of construction of aboveground building improvements.

Our investments in real estate consisted of the following as of September 30, 2026 (dollars in thousands):

Development and Redevelopment

Under Construction

Operating

2027–2028

Stabilization

Evaluating

Business and

Financial

Strategy

Future

Subtotal

Total

Square footage

Operating

35,575,815

—

—

—

—

35,575,815

Future Class A/A+ development and redevelopment properties

—

905,582

667,002

18,912,303

20,484,887

20,484,887

Future development and redevelopment square feet currently

included in rental properties(1)

—

—

—

(935,031)

(935,031)

(935,031)

Total square footage, excluding properties held for sale

35,575,815

905,582

667,002

17,977,272

19,549,856

55,125,671

Properties held for sale

965,557

—

339,668

2,079,925

2,419,593

3,385,150

Total square footage

36,541,372

905,582

1,006,670

20,057,197

21,969,449

58,510,821

Investments in real estate

Gross book value as of September 30, 2026(2)

$30,198,713

$670,176

$611,311

$3,826,180

$5,107,667

(3)

$35,306,380

Properties held for sale

459,477

—

238,232

241,902

480,134

939,611

Total gross investment in real estate, excluding properties held

for sale

$29,739,236

$670,176

$373,079

$3,584,278

$4,627,533

$34,366,769

1649267441852

arrow.jpg

20%

17%

Development/

Redevelopment

Under Construction

Land/Future

Development

11% to 16%

12%

Non-Income-Producing Assets(4) as a Percentage of Gross Assets

(1)Refer to “Investments in real estate” under “Definitions and reconciliations” in Item 2 for additional details, including future development and redevelopment square feet

currently included in rental properties.

(2)Balances exclude accumulated depreciation and our share of the cost basis associated with our properties held by our unconsolidated real estate joint ventures, which is

classified as investments in unconsolidated real estate joint ventures in our consolidated balance sheet.

(3)Our share of investment in our development and redevelopment pipeline as of September 30, 2026 is $4.63 billion.

(4)Excludes land and development parcels classified as held for sale which represented approximately 1% of total non-income-producing assets as of September 30, 2026,

compared with approximately 1% as of December 31, 2025 and 2024.

74

Dispositions and sales of partial interests

The following table summarizes our 2026 sources of capital activity during the nine months ended September 30, 2026 and through the date of this report, and projections for the

remainder of 2026 (dollars in thousands):

Interest

Sold

Square Footage

Price

(Our Share)

Property

Submarket/Market

Date of

Transaction

Operating

Future

Development

Completed during the six months ended June 30, 2026

$7,350

Non-core and land dispositions completed during the three months ended September 30, 2026:

3825 and 3875 Fabian Way(1)

Palo Alto/San Francisco Bay Area

7/14/26

100%

228,000

250,000

163,000

One Hampshire Street(2)

Cambridge/Greater Boston

8/21/26

100%

104,956

—

44,900

3911, 3931, 4025, 4031, 4045, and 4075 Sorrento Valley Boulevard(3)

Sorrento Valley/San Diego

9/23/26

100%

95,814

144,000

26,500

Dispositions completed during the three months ended September 30, 2026

234,400

(4)

Total dispositions completed during the nine months ended September 30, 2026

241,750

Completed in October 2026:

Sales of partial interests:

Campus Point by Alexandria(5)

University Town Center/San Diego

10/23/26

(5)

1,586,697

366,816

475,000

Total completed 2026 dispositions and sales of partial interests as of October 26, 2026

716,750

Our share of pending dispositions and sales of partial interests subject to:

Non-refundable deposits

355,400

Signed letters of intent and/or purchase and sale agreement late-stage negotiations

1,547,850

2,620,000

Proceeds from dispositions and sales of partial interests in excess of 2026 guidance

midpoint which may be deferred into 2027(6)

(720,000)

2026 guidance midpoint for dispositions and sales of partial interests

$1,900,000

2026 guidance range for dispositions and sales of partial interests

$1,100,000 – $2,700,000

Weighted-average projected completion date of 2026 dispositions and sales of partial interests

November 2026

(7)

(1)Represents one future development project aggregating 250,000 SF at 3825 Fabian Way and one fully leased operating building aggregating 228,000 RSF at 3875 Fabian Way in our Palo Alto submarket. These assets were acquired in

2019 with the intent to develop them for life science use. However, due to the project’s macroeconomic outlook, the assets no longer aligned with our strategy and were sold to a residential developer.

(2)Represents one vacant office property that was originally acquired with the intent to redevelop for life science use and expand our Megacampus ecosystem. The asset was sold due to the macroeconomic outlook for the project and the

significant capital required to redevelop and lease the property.

(3)Represents five operating properties, primarily comprising non-laboratory space, and one land parcel. As of June 30, 2026, these operating properties were 30% occupied with a weighted-average lease term of 2.4 years and were sold due

to the significant capital that would have been required to convert these properties through redevelopment for laboratory use and their misalignment with our Megacampus strategy.

(4)Our share of dispositions completed during the three months ended September 30, 2026 had annual net operating income of $4.4 million (based on the three months ended June 30, 2026, annualized) with a weighted-average disposition

date of July 29, 2026.

(5)Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for additional details.

(6)Refer to “Key sources and uses of capital” under “Projected results” in Item 2 for additional details.

(7)Including the impact of the $1.0 billion junior subordinated notes issued during the three months ended September 30, 2026, the weighted-average projected completion date of these sources of capital is expected to be October 2026.

75

New Class A/A+ development and redevelopment properties: recent deliveries

99 Coolidge Avenue

50 and 60 Sylvan Road(1)

4135 Campus Point Court

Megacampus: 480 Arsenal Way, 446, 458, and

500 Arsenal Street, and 99 Coolidge Avenue

Megacampus: Alexandria Center® for Life

Science – Waltham

Megacampus: Campus Point by Alexandria

320,809 RSF

268,992 RSF

426,927 RSF

84% Occupancy

88% Occupancy

100% Occupancy

99Coolidge.jpg

60 Sylvan.jpg

Campuspoint4135.jpg

10075 Barnes Canyon Road

269 East Grand Avenue

701 Dexter Avenue North

Megacampus: SD Tech by Alexandria

Megacampus: Alexandria Center® for Advanced

Technologies – South San Francisco

Megacampus: Alexandria Center® for Advanced

Technologies – South Lake Union

253,079 RSF

33,780 RSF

51,627 RSF

80% Occupancy

100% Occupancy

100% Occupancy

barnescanyon10075 v2.jpg

269EGrand.jpg

701 Dexter - new construction.jpg

(1)Image represents 60 Sylvan Road on the Alexandria Center® for Life Science – Waltham Megacampus.

76

New Class A/A+ development and redevelopment properties: recent deliveries (continued)

Incremental Annual Net Operating Income Generated From YTD 3Q26 Deliveries

Aggregated $98 million(1), Including $40 million in 3Q26

The following table presents development and redevelopment of new Class A/A+ projects placed into service during the nine months ended September 30, 2026 (dollars in

thousands):

Property/Market/Submarket

3Q26

Delivery

Date(3)

Our

Ownership

Interest

RSF Placed in Service

Occupancy

Percentage(4)

Total Project

Unlevered Yields(2)

Prior to

1/1/26

1Q26

2Q26

3Q26

Total

Initial

Stabilized

Initial

Stabilized

(Cash Basis)

RSF

Investment

Development projects

99 Coolidge Avenue/Greater Boston/Cambridge/

Inner Suburbs

8/11/26

100%

129,413

16,734

—

174,662

320,809

84%

320,809

$446,000

5.8%

6.8%

4135 Campus Point Court/San Diego/University

Town Center

N/A

59.3%

—

—

426,927

—

426,927

100%

426,927

$524,000

10.8%

6.2%

10075 Barnes Canyon Road/San Diego/Sorrento

Mesa

N/A

50.0%

171,469

81,610

—

—

253,079

80%

253,079

$314,000

5.5%

5.7%

701 Dexter Avenue North/Seattle/Lake Union

7/9/26

100%

—

—

—

51,627

51,627

100%

227,577

TBD

Redevelopment projects

50 and 60 Sylvan Road/Greater Boston/Route 128

9/1/26

100%

—

—

—

268,992

268,992

88%

268,992

$432,000

6.3%

4.1%

(5)

269 East Grand Avenue/San Francisco Bay Area/

South San Francisco

8/21/26

100%

—

—

—

33,780

33,780

100%

84,157

TBD

8800 Technology Forest Place/Texas/Greater

Houston

N/A

100%

50,094

6,948

—

—

57,042

100%

123,392

$112,000

6.3%

6.0%

Weighted average/total

8/20/26

350,976

105,292

426,927

529,061

1,412,256

1,704,933

(1)Excludes future incremental annual net operating income from recently delivered spaces aggregating 134,767 RSF that were vacant and/or unleased at delivery.

(2)The delivered leases contain effective annual rent escalations of 3%, which are expected to contribute to growth in net operating income (cash basis) over the respective lease term.

(3)Represents the average delivery date for deliveries that occurred during the three months ended September 30, 2026, weighted by annual rental revenue.

(4)Occupancy reflects total operating RSF placed in service as of each respective delivery date when the space was placed into service. Subsequent occupancy changes are not reflected.

(5)The lease with Novo Nordisk, an investment-grade tenant, was executed in a highly competitive leasing environment and provides strong long-term value through a 15-year term and 3% annual rent escalations. The lower cash yield

relative to the original underwriting is primarily driven by higher development costs and lower rental assumptions than initially forecasted due to market changes.

77

New Class A/A+ development and redevelopment properties: under construction

10200 Campus Point Drive

1450 Owens Street

Megacampus: Campus Point by Alexandria

Megacampus: Alexandria Center® for Science and

Technology – Mission Bay

466,598 RSF

212,657 RSF

100% Leased

51% Leased/Negotiating

10210 Campus Point NovartisCP.jpg

owens1450.jpg

269 East Grand Avenue

701 Dexter Avenue North

Megacampus: Alexandria Center® for Advanced

Technologies – South San Francisco

Megacampus: Alexandria Center® for Advanced

Technologies – South Lake Union

50,377 RSF

175,950 RSF

40% Leased/Negotiating

69% Leased/Negotiating

269EGrand.jpg

701 Dexter - new construction.jpg

78

New Class A/A+ development and redevelopment properties: under construction

The following tables set forth a summary of our new Class A/A+ development and redevelopment properties under construction as of September 30, 2026 (dollars in thousands):

Property

Market/Submarket

Square Footage

Percentage

Occupancy(1)

Dev/

Redev

In Service

CIP

Total

Leased

Leased/

Negotiating

Initial

Stabilized

Under construction

2027–2028 stabilization

10200 Campus Point Drive(2)

San Diego/University Town Center

Dev

—

466,598

466,598

100%

100%

4Q28

4Q28

1450 Owens Street

San Francisco Bay Area/Mission Bay

Dev

—

212,657

212,657

51

51

2Q27

2028

269 East Grand Avenue

San Francisco Bay Area/South San Francisco

Redev

33,780

50,377

84,157

40

40

3Q26

2H27

701 Dexter Avenue North

Seattle/Lake Union

Dev

51,627

175,950

227,577

34

69

3Q26

2028

85,407

905,582

990,989

69%

77%

Evaluating business and financial strategy; earliest potential lab delivery in 2028(3)(4)

40 Sylvan Road

Greater Boston/Route 128

Redev

—

329,049

329,049

—%

—%

3000 Minuteman Road

Greater Boston/Other

Redev

—

271,603

271,603

—

—

8800 Technology Forest Place

Texas/Greater Houston

Redev

57,042

66,350

123,392

46

46

57,042

667,002

724,044

8%

8%

Our

Ownership

Interest

At 100%

Unlevered Yields

Property

Market/Submarket

In Service

CIP

Cost to

Complete

Total at

Completion

Initial

Stabilized

Initial Stabilized

(Cash Basis)

Under construction

2027–2028 stabilization(5)

10200 Campus Point Drive(2)

San Diego/University Town Center

59.3%

$—

$106,862

$553,138

$660,000

7.3%

6.5%

1450 Owens Street

San Francisco Bay Area/Mission Bay

25.0%

—

263,855

TBD

269 East Grand Avenue

San Francisco Bay Area/South San Francisco

100%

49,793

53,299

701 Dexter Avenue North

Seattle/Lake Union

100%

96,398

246,160

$146,191

$670,176

$780,000

(6)

$1,590,000

(6)

Our share of investment(6)(7)

$150,000

$420,000

$500,000

(6)

$1,070,000

(6)

Evaluating business and financial strategy; earliest potential lab delivery in 2028(3)(4)

40 Sylvan Road

Greater Boston/Route 128

100%

$—

$233,594

TBD

3000 Minuteman Road

Greater Boston/Other

100%

—

97,248

8800 Technology Forest Place

Texas/Greater Houston

100%

65,640

42,237

$65,640

$373,079

Refer to “Initial stabilized yield (unlevered)” under “Definitions and reconciliations” in Item 2 for additional information.

(1)Initial occupancy dates are subject to leasing and/or market conditions. Stabilized occupancy may vary depending on single tenancy versus multi-tenancy. Multi-tenant projects may increase in occupancy over time.

(2)Represents a single-tenant project that expands the existing Campus Point by Alexandria Megacampus, where we have a 59.3% ownership interest as of September 30, 2026. The project is fully leased to Novartis AG with 3% annual rent

escalations. The tenant currently occupies a building within the Megacampus aggregating 52,853 RSF that generated annual rental revenue of $4.1 million as of September 30, 2026. The tenant is expected to vacate this building during

2028. We expect to fund the majority of future construction costs at the Megacampus. Refer to “Dispositions and sales of partial interests” in Item 2 for additional information.

(3)We are evaluating multiple options, including whether to continue construction of laboratory improvements, pause construction, pursue lower-investment construction alternatives (including a pivot to advanced technology use), or pursue a

disposition, based upon future leasing interest. Under a lower-investment scenario, we would expect lower rent and tenant improvement requirements, and we would evaluate whether all or a portion of the property would be placed back

into operation. We would also expect stabilized yields under such alternatives to be lower than our initial underwriting assumptions. If we elect to continue to pursue construction of laboratory improvements for these projects, the earliest

deliveries of these projects are in 2028.

(4)As of June 30, 2026, 311 Arsenal Street and 421 Park Drive in our Greater Boston market were included in projects for which we were evaluating our business and financial strategy. During the three months ended September 30, 2026, we

reclassified the 339,020 RSF redevelopment project at 311 Arsenal Street to operating following the execution of leases aggregating 66,859 RSF, with additional leases aggregating 100,684 RSF under negotiation for advanced technology

use, which is expected to reduce future potential construction spending by approximately $220 million. We also entered into a purchase and sale agreement with an institutional user for the sale of 339,668 RSF at 421 Park Drive,

representing substantially all of our development project at this location. This portion of the project was classified as held for sale as of September 30, 2026. The transaction is anticipated to close in the fourth quarter of 2026 and is

expected to reduce future potential construction spending by approximately $136 million.

(5)We expect to provide total estimated costs and related yields for each project over the next several quarters.

(6)Represents dollar amount rounded to the nearest $10 million and includes preliminary estimated amounts for projects listed as TBD.

(7)Represents our share of investment based on our current ownership percentage upon completion of development or redevelopment projects, and will be adjusted as our ownership percentage increases at the Campus Point project.

79

New Class A/A+ development and redevelopment properties: summary of pipeline

80% of Our Total Development and Redevelopment Pipeline RSF

Is Within Our Megacampus Ecosystems

The following table summarizes the key information for all our development and redevelopment projects in North America as of September 30, 2026 (dollars in thousands):

Market

Property

Submarket

Our

Ownership

Interest

Book Value

Development and Redevelopment

Square Footage

Under

Construction

Future

Total(1)

Greater Boston

Megacampus: Alexandria Center® for Life Science – Waltham

Route 128

100%

$300,320

329,049

515,000

844,049

40 Sylvan Road and 35 Gatehouse Drive

Megacampus: 30, 200, and 3000 Minuteman Road

Other

100%

115,366

271,603

350,000

621,603

3000 Minuteman Road

Megacampus: 480 Arsenal Way, 446, 458, and 500 Arsenal Street, and 99

Coolidge Avenue

Cambridge/Inner Suburbs

100%

25,123

—

560,000

560,000

446, 458, and 500 Arsenal Street

Megacampus: Alexandria Center® at Kendall Square

Cambridge

100%

49,415

—

174,500

174,500

100 Edwin H. Land Boulevard

Megacampus: Alexandria Technology Square®

Cambridge

100%

9,176

—

100,000

100,000

10 Necco Street

Seaport Innovation District

100%

107,225

—

175,000

175,000

215 Presidential Way

Route 128

100%

6,816

—

112,000

112,000

Other development and redevelopment projects

100%

182,944

—

774,157

774,157

$796,385

600,652

2,760,657

3,361,309

Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional information.

(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have

future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “Investments in real estate” under

“Definitions and reconciliations” in Item 2 for additional information, including development and redevelopment square feet currently included in rental properties.

80

New Class A/A+ development and redevelopment properties: summary of pipeline (continued)

Market

Property

Submarket

Our

Ownership

Interest

Book Value

Development and Redevelopment

Square Footage

Under

Construction

Future

Total(1)

San Diego

Megacampus: Campus Point by Alexandria

University Town Center

59.3%

(2)

$288,339

466,598

866,816

1,333,414

10010(3), 10140(3), and 10200 Campus Point Drive and 4165, 4224, and 4275(3)

Campus Point Court

11255 and 11355 North Torrey Pines Road

Torrey Pines

100%

168,945

—

215,000

215,000

Megacampus: One Alexandria Square

Torrey Pines

100%

71,391

—

125,280

125,280

10975 and 10995 Torreyana Road

Megacampus: 5200 Illumina Way

University Town Center

51.0%

17,939

—

451,832

451,832

9625 Towne Centre Drive

University Town Center

30.0%

859

—

100,000

100,000

Megacampus: Sequence District by Alexandria

Sorrento Mesa

100%

51,110

—

1,661,915

1,661,915

6290, 6310, 6340, 6350, and 6450 Sequence Drive

Megacampus: SD Tech by Alexandria

Sorrento Mesa

50.0%

144,675

—

493,845

493,845

9805 Scranton Road and 10065 Barnes Canyon Road

Other development and redevelopment projects

(4)

—

—

50,000

50,000

743,258

466,598

3,964,688

4,431,286

San Francisco Bay Area

Megacampus: Alexandria Center® for Science and Technology – Mission Bay

Mission Bay

25.0%

263,855

212,657

—

212,657

1450 Owens Street

Megacampus: Alexandria Center® for Advanced Technologies – South San

Francisco

South San Francisco

100%

59,954

50,377

90,000

140,377

211(4) and 269 East Grand Avenue

Megacampus: Alexandria Center® for Advanced Technologies – Tanforan

South San Francisco

100%

471,396

—

1,930,000

1,930,000

1122, 1150, and 1178 El Camino Real

Alexandria Center® for Life Science – Millbrae

South San Francisco

48.6%

164,771

—

348,401

348,401

201 and 231 Adrian Road and 30 Rollins Road

Megacampus: Alexandria Center® for Life Science – San Carlos

San Carlos

100%

510,128

—

1,497,830

1,497,830

960 Industrial Road, 987 and 1075 Commercial Street, and 888 Bransten Road

$1,470,104

263,034

3,866,231

4,129,265

Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional details.

(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have

future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property subject to market conditions and leasing. Refer to “Investments in real estate” under

“Definitions and reconciliations” in Item 2 for additional details, including development and redevelopment square feet currently included in rental properties.

(2)In October 2026, we completed a partial sale of our interest in this joint venture for $475.0 million, which reduced our interest to approximately 30%. We expect to fund the majority of future construction costs at the Megacampus, which is

expected to increase our ownership interest over time to over 50%. Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for additional details.

(3)We have a 100% interest in this property.

(4)Includes a property in which we own a partial interest through a real estate joint venture. Refer to Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for

additional details.

81

New Class A/A+ development and redevelopment properties: summary of pipeline (continued)

Market

Property

Submarket

Our

Ownership

Interest

Book Value

Development and Redevelopment

Square Footage

Under

Construction

Future

Total(1)

Seattle

Megacampus: Alexandria Center® for Advanced Technologies – South Lake

Union

Lake Union

(2)

$548,166

175,950

1,057,400

1,233,350

601 and 701 Dexter Avenue North and 800 Mercer Street

1010 4th Avenue South

SoDo

100%

64,353

—

544,825

544,825

410 West Harrison Street

Elliott Bay

100%

27,147

—

91,000

91,000

Megacampus: Alexandria Center® for Advanced Technologies – Canyon Park

Bothell

100%

20,823

—

230,000

230,000

21660 20th Avenue Southeast

Other development and redevelopment projects

100%

161,663

—

706,087

706,087

822,152

175,950

2,629,312

2,805,262

Maryland

Megacampus: Alexandria Center® for Life Science – Shady Grove

Rockville

100%

25,968

—

296,000

296,000

9830 Darnestown Road

25,968

—

296,000

296,000

Research Triangle

Megacampus: Alexandria Center® for Life Science – Durham

Research Triangle

100%

170,969

—

2,060,000

2,060,000

Megacampus: Alexandria Center® for Advanced Technologies and AgTech –

Research Triangle

Research Triangle

100%

118,275

—

1,170,000

1,170,000

4 and 12 Davis Drive

Megacampus: Alexandria Center® for Sustainable Technologies

Research Triangle

100%

57,656

—

750,000

750,000

120 TW Alexander Drive, 2752 East NC Highway 54, and 10 South Triangle

Drive

Other development and redevelopment projects

100%

1,647

—

25,000

25,000

348,547

—

4,005,000

4,005,000

New York City

Megacampus: Alexandria Center® for Life Science – New York City

New York City

100%

185,936

—

550,000

(3)

550,000

$185,936

—

550,000

550,000

Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional information.

(1)Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF of buildings currently in operation at properties that also have

future development or redevelopment opportunities. Upon expiration of existing in-place leases, we intend to demolish or redevelop the existing property. Refer to “Investments in real estate” under “Definitions and reconciliations” for

additional details, including development and redevelopment square feet currently included in rental properties.

(2)We have a 100% interest in 601 and 701 Dexter Avenue North aggregating 364,350 RSF and a 60.0% interest in the future development project at 800 Mercer Street aggregating 869,000 RSF.

(3)In 2024, we filed a lawsuit against the New York City Health + Hospitals Corporation and the New York City Economic Development Corporation for fraud and breach of contract concerning our option to ground lease a land parcel to

develop a future world-class life science building within the Alexandria Center® for Life Science – New York City Megacampus. Refer to “Other” in Note 3 – “Investments in real estate” to our unaudited consolidated financial statements for

additional information.

82

New Class A/A+ development and redevelopment properties: summary of pipeline (continued)

Market

Property

Submarket

Our

Ownership

Interest

Book Value

Development and Redevelopment

Square Footage

Under

Construction

Future

Total(1)

Texas

Alexandria Center® for Advanced Technologies at The Woodlands

Greater Houston

100%

$45,351

66,350

116,405

182,755

8800 Technology Forest Place

1001 Trinity Street and 1020 Red River Street

Austin

100%

142,328

—

250,010

250,010

Other development and redevelopment projects

100%

—

—

—

—

187,679

66,350

366,415

432,765

Other development and redevelopment projects

100%

47,504

—

474,000

474,000

Total pipeline as of September 30, 2026, excluding properties held for sale

4,627,533

1,572,584

18,912,303

20,484,887

Properties held for sale

480,134

339,668

2,079,925

2,419,593

Total pipeline as of September 30, 2026

$5,107,667

(2)

1,912,252

20,992,228

22,904,480

Refer to “Megacampus” under “Definitions and reconciliations” in Item 2 for additional information.

(1)Total square footage includes 935,031 RSF of buildings currently in operation that we expect to demolish or redevelop and commence future construction subject to market conditions and leasing. Refer to “Investments in real estate” under

“Definitions and reconciliations” in Item 2 for additional details, including development and redevelopment square feet currently included in rental properties.

(2)Includes $1.04 billion of projects that are currently under construction.

83

Results of operations

Same properties

We supplement an evaluation of our results of operations with an evaluation of operating performance of certain of our

properties, referred to as “Same Properties.” For additional information on the determination of our Same Properties portfolio, refer to

“Same property comparisons” under “Definitions and reconciliations” in Item 2. The following table presents information regarding our

Same Properties for the three and nine months ended September 30, 2026:

September 30, 2026

Three Months Ended

Nine Months Ended

Percentage change in net operating income over comparable period from prior

year

(6.7)%

(1)

(9.2)%

(1)

Percentage change in net operating income (cash basis) over comparable

period from prior year

(2.8)%

(1)

(8.4)%

(1)

Operating margin

66%

66%

Number of Same Properties

288

284

RSF

32,250,516

31,629,122

Occupancy – current-period average

88.1%

88.6%

Occupancy – same-period prior-year average

91.7%

92.8%

(1)The decline was due to a decrease in same property occupancy, primarily driven by previously disclosed key lease expirations with expected downtime aggregating

282,878 RSF and 1.2 million RSF in the three and nine months ended September 30, 2026, respectively, with weighted-average lease expiration dates of August 2026

and April 2026, respectively.

The following table reconciles the number of Same Properties to total properties for the nine months ended

September 30, 2026:

Development and redevelopment – under construction

Properties

1450 Owens Street

1

701 Dexter Avenue North

1

10200 Campus Point Drive

1

40 Sylvan Road

1

269 East Grand Avenue

1

8800 Technology Forest Place

1

3000 Minuteman Road Building 4

1

7

Development and redevelopment – placed into service or reclassified into operating after January 1, 2025

230 Harriet Tubman Way

1

500 North Beacon Street and 4 Kingsbury Avenue

2

10935, 10945, and 10955 Alexandria Way

3

10075 Barnes Canyon Road

1

4135 Campus Point Court

1

99 Coolidge Avenue

1

50 and 60 Sylvan Road

2

311 Arsenal Street

1

3000 Minuteman Road Building 3

1

421 Park Drive

1

14

Acquisitions after January 1, 2025

Other

2

2

Unconsolidated real estate JVs

3

Properties held for sale

18

Total properties excluded from Same Properties

44

Same Properties

284

Total properties as of September 30, 2026

328

84

Comparison of results for the three months ended September 30, 2026 to the three months ended September 30, 2025

The following table presents a comparison of the components of net operating income for our Same Properties and Non-Same

Properties for the three months ended September 30, 2026, compared to the three months ended September 30, 2025 (dollars in

thousands). Refer to “Definitions and reconciliations” in Item 2 for definitions of “Tenant recoveries” and “Net operating income” and

their reconciliations from the most directly comparable financial measures presented in accordance with GAAP, income from rentals and

net income, respectively.

Three Months Ended September 30,

2026

2025

$ Change

% Change

Income from rentals:

Same Properties

$432,586

$454,624

$(22,038)

(4.8)%

Non-Same Properties

48,762

86,446

(37,684)

(43.6)

Rental revenues

481,348

541,070

(59,722)

(11.0)

Same Properties

167,825

175,145

(7,320)

(4.2)

Non-Same Properties

4,445

19,634

(15,189)

(77.4)

Tenant recoveries

172,270

194,779

(22,509)

(11.6)

Income from rentals

653,618

735,849

(82,231)

(11.2)

Same Properties

—

—

—

—

Non-Same Properties

17,564

16,095

1,469

9.1

Other income

17,564

16,095

1,469

9.1

Same Properties

600,411

629,769

(29,358)

(4.7)

Non-Same Properties

70,771

122,175

(51,404)

(42.1)

Total revenues

671,182

751,944

(80,762)

(10.7)

Same Properties

205,923

207,133

(1,210)

(0.6)

Non-Same Properties

22,008

32,101

(10,093)

(31.4)

Rental operations

227,931

239,234

(11,303)

(4.7)

Same Properties

394,488

422,636

(28,148)

(6.7)

Non-Same Properties

48,763

90,074

(41,311)

(45.9)

Net operating income

$443,251

$512,710

$(69,459)

(13.5)%

Net operating income – Same Properties

$394,488

$422,636

$(28,148)

(6.7)%

Straight-line rent revenue

480

(19,711)

20,191

(102.4)

Amortization of acquired below-market leases and deferred

revenue related to tenant-funded and -built landlord

improvements

(13,938)

(10,945)

(2,993)

27.3

Net operating income – Same Properties (cash basis)

$381,030

$391,980

$(10,950)

(2.8)%

85

Income from rentals

Total income from rentals for the three months ended September 30, 2026 decreased by $82.2 million, or 11.2%, to

$653.6 million, compared to $735.8 million for the three months ended September 30, 2025. The components of this change are

discussed below.

Rental revenues

Total rental revenues for the three months ended September 30, 2026 decreased by $59.7 million, or 11.0%, to $481.3 million,

compared to $541.1 million for the three months ended September 30, 2025. The decrease was primarily attributable to the factors

discussed below.

Same Properties’ rental revenues for the three months ended September 30, 2026 decreased by $22.0 million, or 4.8%, to

$432.6 million, compared to $454.6 million for the three months ended September 30, 2025. This decrease is primarily attributable to a

decrease in Same Properties’ average occupancy to 88.1% for the three months ended September 30, 2026 from 91.7% for the three

months ended September 30, 2025, and reflects the impact of previously disclosed key lease expirations aggregating 282,878 RSF and

1.2 million RSF in the three and nine months ended September 30, 2026, respectively, with weighted-average lease expiration dates of

August 2026 and April 2026, respectively.

Non-Same Properties’ rental revenues for the three months ended September 30, 2026 decreased by $37.7 million, or 43.6%,

to $48.8 million, compared to $86.4 million for the three months ended September 30, 2025, primarily due to the real estate dispositions

completed after July 1, 2025.

Tenant recoveries

Tenant recoveries for the three months ended September 30, 2026 decreased by $22.5 million, or 11.6%, to $172.3 million,

compared to $194.8 million for the three months ended September 30, 2025.

Same Properties’ tenant recoveries for the three months ended September 30, 2026 decreased by $7.3 million, or 4.2%, to

$167.8 million compared to $175.1 million for the three months ended September 30, 2025, primarily due to the decrease in Same

Property occupancy to 88.1% for the three months ended September 30, 2026, from 91.7% for the three months ended September 30,

2025, which reduced the proportion of expenses recoverable from tenants. As of September 30, 2026, 91% of our leases (on an annual

rental revenue basis) were triple net leases, which require tenants to pay substantially all real estate taxes, insurance, utilities, repairs

and maintenance, common area expenses, and other operating expenses (including increases thereto) in addition to base rent.

Non-Same Properties’ tenant recoveries for the three months ended September 30, 2026 decreased by $15.2 million, or

77.4%, to $4.4 million compared to $19.6 million for the three months ended September 30, 2025, primarily due to the dispositions of

real estate since July 1, 2025.

Rental operations

Total rental operating expenses for the three months ended September 30, 2026 decreased by $11.3 million, or 4.7%, to

$227.9 million, compared to $239.2 million for the three months ended September 30, 2025.

Same Properties’ rental operating expenses decreased by $1.2 million, or 0.6%, to $205.9 million during the three months

ended September 30, 2026, compared to $207.1 million for the three months ended September 30, 2025, primarily driven by a

decrease of $3.6 million in repairs and maintenance costs due to lower Same Properties’ average occupancy, partially offset by an

increase in property tax expense primarily resulting from the property tax rate increases in Boston and Cambridge in our Greater Boston

market.

Non-Same Properties’ rental operating expenses decreased by $10.1 million primarily due to real estate dispositions

completed since July 1, 2025.

86

General and administrative expenses

General and administrative expenses for the three months ended September 30, 2026 increased by $11.7 million, or 40.0%, to

$40.9 million, compared to $29.2 million for the three months ended September 30, 2025. The increase primarily reflects the timing of

the restructuring of compensation plans and other cost-control and efficiency initiatives during the three months ended September 30,

2025.

Notwithstanding this increase compared to the three months ended September 30, 2025, general and administrative expenses

for the three months ended September 30, 2026 decreased by $3.0 million, or 6.9%, compared to $43.9 million for the three months

ended September 30, 2024. The decrease relative to 2024 reflects the continued benefit from cost-efficiency initiatives implemented in

prior years. The increase relative to 2025 primarily reflects the expected return of a portion of the cost reductions achieved in 2025 that

were temporary in nature, while approximately half of the cost reductions achieved in 2025 have continued into 2026 and are expected

to continue through the remainder of 2026. We continue to expect approximately $76 million of cumulative general and administrative

expense savings in 2025 and 2026 compared to 2024 based on the midpoint of our 2026 guidance range.

As a percentage of net operating income, our general and administrative expenses for the trailing twelve months ended

September 30, 2026 and 2025 were 7.5% and 5.7%, respectively.

Depreciation and amortization

Depreciation and amortization expense for the three months ended September 30, 2026 decreased by $35.8 million, or 10.5%,

to $304.4 million, compared to $340.2 million for the three months ended September 30, 2025. The decrease was primarily a result of

real estate dispositions since July 1, 2025.

Impairment of real estate

During the three months ended September 30, 2026, we recognized impairment charges aggregating $637.9 million, classified

in impairment of real estate in our consolidated statement of operations. For additional information, refer to “Sales of real estate assets

and impairment of real estate” in Note 3 – “Investments in real estate” to our unaudited consolidated financial statements in Item 1.

During the three months ended September 30, 2025, we recognized real estate impairment charges aggregating

$323.9 million, primarily related to three operating properties in our Greater Boston, Research Triangle, and New York City markets and

land parcels in our San Diego market that met the criteria for classification as held for sale.

Interest expense

Interest expense for the three months ended September 30, 2026 and 2025 consisted of the following (dollars in thousands):

Three Months Ended September 30,

Component

2026

2025

Change

Gross interest

$142,609

$140,943

$1,666

Capitalized interest

(62,922)

(86,091)

23,169

Interest expense

$79,687

$54,852

$24,835

Average debt balance outstanding(1)

$12,860,229

$13,512,336

$(652,107)

Weighted-average annual interest rate(2)

4.4%

4.2%

0.2%

(1)Represents the average debt balance outstanding during the respective periods.

(2)Represents annualized total interest incurred divided by the average debt balance outstanding during the respective periods.

87

The net change in interest expense during the three months ended September 30, 2026, compared to the three months ended

September 30, 2025, resulted from the following (dollars in thousands):

Component

Interest Rate(1)

Effective Date

Change

Increases in interest incurred due to:

Issuances of debt:

$750 million of unsecured senior notes payable due 2036

5.41%

February 2026

$9,892

$1.0 billion of unsecured junior subordinated notes payable due 2057

7.37%

August 2026

8,056

Higher average outstanding balances under commercial paper program and/or

unsecured senior line of credit

2,803

Total increases

20,751

Decreases in interest incurred due to:

Repayments of debt:

$300 million of unsecured senior notes payable due 2026

4.50%

January 2026

(3,260)

$350 million of unsecured senior notes payable due 2026

3.96%

April 2026

(3,341)

Secured notes payable

7.18%

August 2025

(928)

Partial repurchases of debt:

Repaid $525 million of $1.0 billion of unsecured senior notes payable due 2052

3.70%

February 2026

(4,667)

Repaid $498 million of $850 million of unsecured senior notes payable due 2051

3.16%

February 2026

(3,744)

Repaid $309 million of $700 million of unsecured senior notes payable due 2050

3.95%

February 2026

(3,050)

Other decrease in interest

(95)

Total decreases

(19,085)

Change in gross interest

1,666

Decrease in capitalized interest

23,169

Total change in interest expense

$24,835

(1)Represents the weighted-average interest rate as of the end of the applicable period, including amortization of loan fees, amortization of debt premiums (discounts), and

other bank fees.

Investment income

During the three months ended September 30, 2026, we recognized investment income aggregating $24.0 million, which

consisted of $16.0 million of realized gains, $21.6 million of unrealized gains, and $13.6 million of impairment charges.

During the three months ended September 30, 2025, we recognized investment income aggregating $28.2 million, which

consisted of $34.8 million of realized gains, $18.5 million of unrealized gains, and $25.1 million of impairment charges.

For more information about our investments, refer to Note 7 – “Investments” and “Investments” in Note 2 – “Summary of

significant accounting policies” to our unaudited consolidated financial statements in Item 1.

Loss on early extinguishment of debt

During the three months ended September 30, 2026, we recognized a loss on early extinguishment of debt aggregating $3.3

million related to the partial write-off of unamortized loan fees in connection with the amendment and restatement of our unsecured

senior line of credit.

Gain on sales of real estate

During the three months ended September 30, 2026, no gain on sales of real estate was recognized. During the three months

ended September 30, 2025, we recognized a $9.4 million gain related to the disposition of our controlling interest in a consolidated joint

venture that owns Pacific Technology Park in our Sorrento Mesa submarket. The gain was classified in gain on sales of real estate

within our consolidated statement of operations for the three months ended September 30, 2025.

Other comprehensive loss

Total other comprehensive loss for the three months ended September 30, 2026 aggregating $664 thousand primarily related

to foreign currency translation losses related to our operations in Canada, resulting from the weakening of the Canadian dollar relative

to the U.S. dollar during this period. Refer to Note 11 – “Hedge Agreements” to our unaudited consolidated financial statements in Item

1 for additional information.

Total other comprehensive loss of $4.8 million for the three months ended September 30, 2025 was primarily due to unrealized

foreign currency translation loss of $7.8 million related to our operations in Canada, partially offset by $3.0 million of unrealized gains

related to the change in the fair value of our cross-currency swap agreements, resulting from the CAD’s weakening since the execution

of these agreements on July 29, 2025 through September 30, 2025.

88

Comparison of results for the nine months ended September 30, 2026 to the nine months ended September 30, 2025

The following table presents a comparison of the components of net operating income for our Same Properties and Non-Same

Properties for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025 (dollars in

thousands). Refer to “Definitions and reconciliations” in Item 2 for definitions of “Tenant recoveries” and “Net operating income” and

their reconciliations from the most directly comparable financial measures presented in accordance with GAAP, income from rentals and

net income, respectively.

Nine Months Ended September 30,

2026

2025

$ Change

% Change

Income from rentals:

Same Properties

$1,268,273

$1,361,022

$(92,749)

(6.8)%

Non-Same Properties

174,450

285,537

(111,087)

(38.9)

Rental revenues

1,442,723

1,646,559

(203,836)

(12.4)

Same Properties

478,425

498,454

(20,029)

(4.0)

Non-Same Properties

28,693

71,290

(42,597)

(59.8)

Tenant recoveries

507,118

569,744

(62,626)

(11.0)

Income from rentals

1,949,841

2,216,303

(266,462)

(12.0)

Same Properties

—

—

—

—

Non-Same Properties

55,147

55,839

(692)

(1.2)

Other income

55,147

55,839

(692)

(1.2)

Same Properties

1,746,698

1,859,476

(112,778)

(6.1)

Non-Same Properties

258,290

412,666

(154,376)

(37.4)

Total revenues

2,004,988

2,272,142

(267,154)

(11.8)

Same Properties

600,620

597,930

2,690

0.4

Non-Same Properties

58,789

92,132

(33,343)

(36.2)

Rental operations

659,409

690,062

(30,653)

(4.4)

Same Properties

1,146,078

1,261,546

(115,468)

(9.2)

Non-Same Properties

199,501

320,534

(121,033)

(37.8)

Net operating income

$1,345,579

$1,582,080

$(236,501)

(14.9)%

Net operating income – Same Properties

$1,146,078

$1,261,546

$(115,468)

(9.2)%

Straight-line rent revenue

(16,915)

(35,696)

18,781

(52.6)

Amortization of acquired below-market leases and deferred

revenue related to tenant-funded and -built landlord

improvements

(36,925)

(32,826)

(4,099)

12.5

Net operating income – Same Properties (cash basis)

$1,092,238

$1,193,024

$(100,786)

(8.4)%

89

Income from rentals

Total income from rentals for the nine months ended September 30, 2026 decreased by $266.5 million, or 12.0%, to

$1.95 billion, compared to $2.22 billion for the nine months ended September 30, 2025, due to a decrease in rental revenues, as

discussed below.

Rental revenues

Total rental revenues for the nine months ended September 30, 2026 decreased by $203.8 million, or 12.4%, to $1.44 billion,

compared to $1.65 billion for the nine months ended September 30, 2025. The decrease was primarily attributable to the factors

discussed below.

Same Properties’ rental revenues for the nine months ended September 30, 2026 decreased by $92.7 million, or 6.8%, to

$1.27 billion, compared to $1.36 billion for the nine months ended September 30, 2025. This decrease primarily reflects a decrease in

Same Properties’ average occupancy to 88.6% for the nine months ended September 30, 2026 from 92.8% for the nine months ended

September 30, 2025, primarily driven by previously disclosed key lease expirations aggregating 282,878 RSF and 1.2 million RSF in the

three and nine months ended September 30, 2026, respectively, with weighted-average lease expiration dates of August 2026 and April

2026, respectively.

Non-Same Properties’ rental revenues for the nine months ended September 30, 2026 decreased by $111.1 million, or 38.9%,

to $174.5 million, compared to $285.5 million for the nine months ended September 30, 2025, primarily due to the dispositions of real

estate since January 1, 2025.

Tenant recoveries

Tenant recoveries for the nine months ended September 30, 2026 decreased by $62.6 million, or 11.0%, to $507.1 million,

compared to $569.7 million for the nine months ended September 30, 2025.

Same Properties’ tenant recoveries for the nine months ended September 30, 2026 decreased by $20.0 million, or 4.0%, to

$478.4 million, compared to $498.5 million for the nine months ended September 30, 2025. The decrease described above in Same

Properties’ tenant recoveries resulted from a decrease in Same Properties’ average occupancy. As of September 30, 2026, 91% of our

leases (on an annual rental revenue basis) were triple net leases, which require tenants to pay substantially all real estate taxes,

insurance, utilities, repairs and maintenance, common area expenses, and other operating expenses (including increases thereto) in

addition to base rent.

Non-Same Properties’ tenant recoveries for the nine months ended September 30, 2026 decreased by $42.6 million, or 59.8%,

to $28.7 million, compared to $71.3 million for the nine months ended September 30, 2025, primarily due to the dispositions of real

estate since January 1, 2025.

Rental operations

Total rental operating expenses for the nine months ended September 30, 2026 decreased by $30.7 million, or 4.4%, to

$659.4 million, compared to $690.1 million for the nine months ended September 30, 2025. Non-Same Properties’ rental operating

expenses decreased by $33.3 million primarily as a result of dispositions of real estate assets since January 1, 2025.

Same Properties’ rental operating expenses increased by $2.7 million, or 0.4%, to $600.6 million during the nine months ended

September 30, 2026, compared to $597.9 million for the nine months ended September 30, 2025, primarily attributable to an increase

of $9.8 million in property tax expense resulting from the property tax rate increases in Boston and Cambridge in our Greater Boston

market. The increase was offset primarily by a decrease of $7.3 million in repairs and maintenance costs resulting from the lower Same

Properties’ average occupancy.

General and administrative expenses

General and administrative expenses for the nine months ended September 30, 2026 increased by $23.4 million, or 26.3%, to

$112.5 million, compared to $89.0 million for the nine months ended September 30, 2025. The increase primarily reflects the timing of

the restructuring of compensation plans and other cost-control and efficiency initiatives during the nine months ended September 30,

2025.

Notwithstanding this increase compared to the nine months ended September 30, 2025, general and administrative expenses

for the nine months ended September 30, 2026 decreased by $23.2 million, or 17%, compared to $135.6 million for the nine months

ended September 30, 2024. The decrease relative to 2024 reflects the continued benefit from cost-efficiency initiatives implemented in

prior years. The increase relative to 2025 primarily reflects the expected return of a portion of the cost reductions achieved in 2025 that

were temporary in nature, while approximately half of the cost reductions achieved in 2025 have continued into 2026 and are expected

to continue through the remainder of 2026. We continue to expect approximately $76 million of cumulative general and administrative

expense savings in 2025 and 2026 compared to 2024 based on the midpoint of our 2026 guidance range.

90

As a percentage of net operating income, our general and administrative expenses for the trailing twelve months ended

September 30, 2026 and 2025 were 7.5% and 5.7%, respectively.

Depreciation and amortization

Depreciation and amortization expense for the nine months ended September 30, 2026 decreased by $114.2 million, or 11.1%,

to $914.2 million, compared to $1.03 billion for the nine months ended September 30, 2025. The decrease was primarily a result of real

estate dispositions since January 1, 2025.

Impairment of real estate

During the nine months ended September 30, 2026, we recognized impairment charges aggregating $865.9 million, classified

in impairment of real estate in our consolidated statement of operations. For additional information, refer to “Sales of real estate assets

and impairment of real estate” in Note 3 – “Investments in real estate” to our unaudited consolidated financial statements in Item 1.

During the nine months ended September 30, 2025, we recognized real estate impairment charges aggregating $485.6 million,

which primarily related to (i) a ground lease entered into in 2021 for a future development site in our San Francisco Bay Area market, (ii)

three operating properties in our San Diego market and land parcels in our non-cluster market that met the criteria for classification as

held for sale, and (iii) three operating properties in our Greater Boston, Research Triangle, and New York City markets and land parcels

in our San Diego market that met the criteria for classification as held for sale.

Interest expense

Interest expense for the nine months ended September 30, 2026 and 2025 consisted of the following (dollars in thousands):

Nine Months Ended September 30,

Component

2026

2025

Change

Gross interest

$415,225

$409,603

$5,622

Capitalized interest

(206,612)

(248,579)

41,967

Interest expense

$208,613

$161,024

$47,589

Average debt balance outstanding(1)

$12,947,130

$13,200,441

$(253,311)

Weighted-average annual interest rate(2)

4.3%

4.1%

0.2%

(1)Represents the average debt balance outstanding during the respective periods.

(2)Represents annualized total interest incurred divided by the average debt balance outstanding during the respective periods.

91

The net change in interest expense during the nine months ended September 30, 2026, compared to the nine months ended

September 30, 2025, resulted from the following (dollars in thousands):

Component

Interest

Rate(1)

Effective Date

Change

Increases in interest incurred due to:

Issuances of debt:

$750 million of unsecured senior notes payable due 2036

5.41%

February 2026

$23,740

$550 million of unsecured senior notes payable due 2035

5.66%

February 2025

3,545

$1.0 billion of unsecured junior subordinated notes payable due 2057

7.37%

August 2026

8,056

Higher average outstanding balances under commercial paper program and/or

unsecured senior line of credit

28,549

Total increases

63,890

Decreases in interest incurred due to:

Repayments of debt:

$300 million of unsecured senior notes payable due 2026

4.50%

January 2026

(9,267)

$350 million of unsecured senior notes payable due 2026

3.96%

April 2026

(6,156)

$600 million of unsecured senior notes payable due 2025

3.62%

April 2025

(6,905)

Secured notes payable

7.18%

August 2025

(6,294)

Partial repurchases of debt:

Repaid $525 million of $1.0 billion of unsecured senior notes payable due 2052

3.70%

February 2026

(11,871)

Repaid $498 million of $850 million of unsecured senior notes payable due 2051

3.16%

February 2026

(9,522)

Repaid $309 million of $700 million of unsecured senior notes payable due 2050

3.95%

February 2026

(7,779)

Other decrease in interest

(474)

Total decreases

(58,268)

Change in gross interest

5,622

Decrease in capitalized interest

41,967

Total change in interest expense

$47,589

(1)Represents the weighted-average interest rate as of the end of the applicable period, including amortization of loan fees, amortization of debt premiums (discounts), and

other bank fees.

Investment income (losses)

During the nine months ended September 30, 2026, we recognized investment income aggregating $152.6 million, which

consisted of $44.5 million of realized gains, $143.2 million of unrealized gains, and $35.0 million of impairment charges.

During the nine months ended September 30, 2025, we recognized investment losses aggregating $52.5 million, which

consisted of $94.7 million of realized gains, $71.6 million of unrealized losses, and $75.5 million of impairment charges.

For additional information about our investments, refer to Note 7 – “Investments” to our unaudited consolidated financial

statements in Item 1. For our impairment accounting policy, refer to “Investments” in Note 2 – “Summary of significant accounting

policies” to our unaudited consolidated financial statements in Item 1.

Gain on early extinguishment of debt

During the nine months ended September 30, 2026, we recognized a gain on early extinguishment of debt aggregating $363.1

million, net of the write-off of unamortized debt issuance costs and other transaction-related costs, primarily related to the completion of

the February 2026 tender offers to repurchase $1.33 billion of debt principal across a portion of our outstanding 4.00% Senior Notes

due 2050, 3.00% Senior Notes due 2051, and 3.55% Senior Notes due 2052 for $952.2 million. The gain was partially offset by a loss

on early extinguishment of debt aggregating $3.3 million related to the partial write-off of unamortized loan fees in connection with the

amendment and restatement of our unsecured senior line of credit during the three months ended September 30, 2026.

92

Gain on sales of real estate

During the nine months ended September 30, 2026, no gain on sales of real estate was recognized. During the nine months

ended September 30, 2025, we recognized $22.5 million of gains classified in gain on sales of real estate within our consolidated

statement of operations. These gains included $12.7 million recognized during the three months ended March 31, 2025, in connection

with one sales-type lease for an operating property in our Seattle market, and $9.3 million recognized upon the disposition of our

controlling interest in a consolidated joint venture that owns Pacific Technology Park in our Sorrento Mesa submarket. The gains were

classified in gain on sales of real estate within our consolidated statement of operations for the nine months ended September 30,

2025.

Other comprehensive loss

Other comprehensive loss for the nine months ended September 30, 2026 aggregating $4.3 million includes $12.3 million of

foreign currency translation losses related to our operations in Canada, resulting from the weakening of the Canadian dollar relative to

the U.S. dollar during this period, partially offset by $8.0 million of unrealized gains related to the change in the fair value of our cross-

currency swap agreements. Refer to Note 11 – “Hedge Agreements” to our unaudited consolidated financial statements in Item 1 for

additional information.

Total other comprehensive income of $14.0 million for the nine months ended September 30, 2025 was primarily due to

unrealized foreign currency translation income of $11.1 million related to our operations in Canada and $3.0 million of unrealized gains

related to the change in the fair value of our cross-currency swap agreements, resulting from the CAD’s weakening since the execution

of these agreements on July 29, 2025 through September 30, 2025.

93

Construction spending

Our construction spending for the nine months ended September 30, 2026 and projected spending for the year ending

December 31, 2026 consisted of the following (in thousands):

Nine Months Ended

September 30,

2026

Projected Midpoint for

Year Ending

December 31, 2026

Construction of Class A/A+ properties:

Active construction projects

Development and redevelopment under construction(1)

$

1,039,228

$

1,555,000

Future pipeline pre-construction

Primarily Megacampus expansion pre-construction work (entitlement,

design, and site work)

140,645

210,000

(2)

Revenue- and non-revenue-enhancing capital expenditures(3)

430,365

510,000

(4)

Construction spending (before contributions from noncontrolling interests or

tenants)

1,610,238

2,275,000

Contributions from noncontrolling interests (consolidated real estate joint

ventures)

(50,727)

(100,000)

(5)

Tenant-funded and -built landlord improvements

(405,733)

(425,000)

Total construction spending

$

1,153,778

$

1,750,000

2026 guidance range for construction spending

$1,500,000 – $2,000,000

(1)Includes smaller conversions to laboratory space through redevelopment.

(2)Approximately 74% represents capitalized costs.

(3)Represents revenue- and non-revenue-enhancing capital expenditures before contributions from noncontrolling interests and tenant-funded and tenant-built landlord

improvements.

(4)The top two revenue- and non-revenue-enhancing capital expenditure projects in 2026 represent approximately 53% of the total spending within this category. The first

project relates to a property located at the Alexandria Center® for Advanced Technologies – South San Francisco Megacampus in our South San Francisco submarket,

which is leased to a new tenant and is undergoing its first major renovation in 12 years. The second project relates to two properties at the Alexandria Technology

Square® Megacampus in our Cambridge submarket, which are undergoing their first major renovation in 16 years.

(5)Represents contractual capital commitments from existing real estate joint venture partners to fund construction.

Projected capital contributions from partners in consolidated real estate joint ventures to fund construction

The following table summarizes projected capital contributions from partners in our existing consolidated joint ventures to fund

construction through 2027 and beyond (in thousands):

Projected timing

Amount(1)

Fourth quarter of 2026

$49,000

2027 and beyond

56,000

Total

$105,000

(1)Amounts represent reductions to our consolidated construction spending. 

94

Capitalization of interest

Our construction spending includes capitalized interest. The table below provides key categories of interest capitalized during

the three months ended September 30, 2026 (in thousands):

Key Categories of Average Real Estate Basis Qualifying for Capitalization

Three Months Ended

September 30, 2026

Total(1)

$5,866,853

Projects delivered in 3Q26 or other projects no longer requiring capitalization of interest

as of the end of 3Q26(2)

(1,402,235)

Projects continuing to qualify for capitalization of interest as of the end of 3Q26

$4,464,618

Components of average real estate basis of projects continuing to require capitalization of interest

as of the end of 3Q26

Class A/A+ development and redevelopment projects under construction and repositioning projects:

2027–2028 stabilization

$384,632

Repositioning and smaller redevelopment projects(3)

1,735,127

2,119,759

Land/future development projects with pre-construction milestones through 2028(4)

2,344,859

Average real estate basis of projects continuing to qualify for capitalization of interest

as of the end of 3Q26

$4,464,618

4Q26 projected range for average real estate capitalization basis

$3,400,000 – $4,900,000

(1)In addition to capitalized interest, we incur other capitalized project costs, including property taxes, insurance, and other costs directly related and essential to the

construction of Class A/A+ properties. If we cease activities necessary to prepare a project for its intended use, related costs are expensed as incurred. Annualized

capitalized operating expenses represent approximately 2% of the total average real estate basis subject to capitalization for the three months ended September 30,

2026.

(2)Primarily includes projects at 421 Park Drive on the Alexandria Center® for Life Science – Fenway Megacampus and Alexandria Stanford Life Science District, both of

which were classified as held for sale as of September 30, 2026, as well as a delivered project at Alexandria Center® for Life Science – Waltham Megacampus during the

three months ended September 30, 2026.

(3)Primarily consists of projects related to our operating assets that generally have shorter periods for which capitalization of interest is required, including executed leases

aggregating 1.3 million RSF as of September 30, 2026, with future occupancy expected after completion of building and/or tenant improvements by June 2027 on a

weighted-average basis. The balance also includes redevelopment projects for which we are evaluating business and financial strategy.

(4)Includes future pipeline projects expected to reach pre-construction milestones, including various phases of entitlement, design, site work, and other activities necessary

to begin aboveground vertical construction, with a weighted-average key construction milestone by 1H28. As projects progress, we will evaluate whether to proceed with

additional pre-construction and/or construction activities based on leasing demand and/or market conditions, pause future investments, or consider potential disposition.

These projects include, among others, future Megacampus development projects at (i) Alexandria Center® for Advanced Technologies – Tanforan, (ii) Alexandria Center®

for Life Science – San Carlos, where we have a letter of intent for approximately 235,600 RSF related to existing industrial buildings that were originally expected to be

demolished to allow for future development, (iii) Alexandria Center® for Life Science – New York City, and (iv) Campus Point by Alexandria, which represent

approximately 52% of the total real estate basis that continues to qualify for capitalization in this category as of September 30, 2026.

95

Projected results

Our 2026 guidance includes forward-looking non-GAAP financial measures, such as funds from operations as adjusted, net debt and preferred stock to Adjusted EBITDA –

fourth quarter 2026 annualized, fixed-charge coverage ratio – fourth quarter 2026 annualized, and net cash provided by operating activities, as adjusted, that differ from measures

calculated in accordance with GAAP. These non-GAAP measures are in addition to, and not a substitute for or superior to, financial measures prepared in accordance with GAAP

and should be considered in conjunction with our GAAP financial measures. We are unable to provide corresponding forward-looking GAAP measures or reconciliations to these

non-GAAP measures without unreasonable effort. This is due to the inherent difficulty of forecasting items that depend on market conditions outside of our control, including the

timing of dispositions, capital events, and financing decisions, as well as quarterly and annual components such as gain on sales of real estate, impairments of real estate and non-

real estate investments, and unrealized gains or losses on non-real estate investments. Our attempt to predict these amounts may produce significant but inaccurate estimates,

which would be potentially misleading for our investors. Refer to “Definitions and reconciliations” in Item 2 for additional details about these non-GAAP measures.

Projected 2026 Funds From Operations per Share Attributable to Alexandria’s Common Stockholders –

Diluted

As of 10/26/26

As of 8/3/26

Key Changes

Funds from operations per share, as adjusted(1)

$6.38 to $6.42

$6.35 to $6.45

No change to the midpoint,

range narrowed by 6 cents

Midpoint

$6.40

$6.40

Key Credit Metrics Targets

As of 10/26/26

As of 8/3/26

Key Changes

Net debt and preferred stock to Adjusted EBITDA – fourth quarter of 2026 annualized

5.6x to 6.2x

5.6x to 6.2x

No Change

Fixed-charge coverage ratio – fourth quarter of 2026 annualized

3.4x to 3.9x

3.6x to 4.1x

0.2x reduction(2)

We expect that our principal liquidity needs for the year ending December 31, 2026 will be satisfied by the following multiple sources of capital, as shown in the table below.

There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.

Key Sources and Uses of Capital

(In millions)

As of 10/26/26

Certain

Completed Items

As of 8/3/26

Midpoint

Range

Midpoint

Sources of capital:

Net cash provided by operating activities, as adjusted

475

575

525

525

Dispositions and sales of partial interests

1,100

2,700

1,900

(3)

2,900

Total sources of capital

$1,575

$3,275

$2,425

$3,425

Uses of capital:

Construction(4)

$1,500

$2,000

$1,750

$1,750

Reduction in unsecured debt

75

1,275

$675

See below

$1,675

Total uses of capital

$1,575

$3,275

$2,425

$3,425

Reduction in unsecured debt (included above):

Repayment of unsecured senior notes payable with 2026 maturities

$650

$650

$650

$650

650

Tender offers for partial principal repayments of unsecured senior notes payable

952

952

952

$952

952

Issuance of unsecured senior notes payable

(750)

(750)

(750)

$(750)

(750)

Issuance of junior subordinated notes payable(3)

(1,000)

(1,000)

(1,000)

$(1,000)

—

Unsecured senior line of credit, commercial paper, and other

223

1,423

823

823

Reduction in unsecured debt

$75

$1,275

$675

$1,675

(1)Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria Real Estate Equities, Inc.’s common stockholders” under “Definitions and reconciliations” in Item 2 for additional details.

(2)Reduction primarily reflects the $1.00 billion issuance of 7.250% Series A fixed-to-fixed reset rate junior subordinated notes due 2057, as further discussed in footnote 3 below.

(3)In August 2026, we issued $1.00 billion of 7.250% Series A fixed-to-fixed reset rate junior subordinated notes due 2057, allowing us to reduce the midpoint of our 2026 dispositions and sales of partial interests guidance by $1.0

billion. The proceeds from this issuance support our capital structure and deleveraging objectives, and the notes receive 50% equity treatment from key rating agencies for the computation of key credit metrics. We do not

anticipate the issuance of any common equity during 2026. As of October 26, 2026, completed dispositions and sales of partial interests aggregated $716.8 million, our share of pending dispositions and sales of partial interests

subject to non-refundable deposits aggregated $355.4 million and signed letters of intent and/or purchase and sale agreement late-stage negotiations aggregated $1.55 billion. These transactions aggregate approximately $2.62

billion, exceeding the $1.90 billion midpoint of our 2026 guidance and potentially providing advanced funding of our 2027 capital needs, whereby certain dispositions and sales of partial interests may be completed in 2026 with

proceeds deferred or available to be drawn in 2027, subject to timing and market conditions.

(4)We continue to apply a disciplined approach to reduce construction spending for 2027 and seek to prioritize leased projects with high incremental returns. We expect 2027 construction spending to primarily focus on: (i) revenue-

and non-revenue-enhancing capital expenditures, which are expected to represent the majority of spend, approximately half of which is associated with space that is already leased or under lease negotiations, in order to

support the leasing of vacant space and renewals and re-leasing of space at our operating properties and (ii) construction spending required to complete our development and redevelopment projects that are expected to

stabilize through 2028 and are 77% leased/negotiating.

96

The key assumptions behind the sources and uses of capital in the table on the previous page include favorable real estate transaction and capital market environments,

performance of our core operating properties, lease-up and delivery of current and future development and redevelopment projects, and leasing activity. Our expected sources and

uses of capital are subject to a number of variables and uncertainties, including those discussed as “Forward-looking statements” under Part I, “Item 1A. Risk factors”; and Part II,

“Item 7. Management’s discussion and analysis of financial condition and results of operations” in our annual report on Form 10-K for the year ended December 31, 2025; as well as

under “Trends that may affect our future results” in Part I, “Item 2.  Management’s discussion and analysis of financial condition and results of operations” of this quarterly report on

Form 10-Q. To the extent our full-year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such

guidance.

Key Assumptions

(Dollars in millions)

As of 10/26/26

As of 8/3/26

Key Changes

to Midpoint

Low

High

Low

High

Occupancy of operating properties as of December 31, 2026

86.2%

87.8%

86.2%

87.8%

No Change

Same property performance:

Net operating income changes

(10.5)%

(8.5)%

(10.5)%

(8.5)%

Net operating income changes (cash basis)

(10.5)%

(8.5)%

(10.5)%

(8.5)%

Lease renewals and re-leasing of space:

Rental rate changes

(9.0)%

(1.0)%

(9.0)%

(1.0)%

Rental rate changes (cash basis)

(15.0)%

(7.0)%

(15.0)%

(7.0)%

Straight-line rent revenue

$40

$70

$45

$75

$5 million reduction(1)

General and administrative expenses

$134

$154

$134

$154

No Change

Capitalization of interest

$220

$260

$220

$260

Interest expense

$260

$300

$260

$300

No Change(2)

Realized gains on non-real estate investments(3)

$50

$80

$60

$90

$10 million reduction(3)

(1)Reduction driven primarily by write-offs and reserves of deferred rent related to tenant wind-downs. Our 2026 guidance assumes a $30 million to $35 million reduction in funds from operations related to potential tenant wind-

downs, of which approximately $30 million was recognized during the nine months ended September 30, 2026, including approximately $16 million recognized during the three months ended September 30, 2026.

(2)We expect 2026 interest expense  to be near the high-end of the range, reflecting, in part, interest expense associated with the $1.0 billion issuance of junior subordinated notes in August 2026.

(3)Represents realized gains and losses included in funds from operations per share – diluted, as adjusted. Excludes unrealized gains and losses and significant gains and impairments realized on non-real estate investments, if

any. The midpoint of our revised guidance range for 2026 realized gains on non-real estate investments was reduced by $10 million, primarily due to certain transactions previously expected to close in 2026 that are now

expected to close in 2027. Refer to “Investments” in Item 2 for additional details.

97

Summary of key items that may impact 2026 and 2027 results

1)Potential tenant wind-downs

•Our 2026 guidance includes a $30 million to $35 million reduction in funds from operations for potential tenant wind-downs, of which approximately $30 million was recognized

during the nine months ended September 30, 2026, including approximately $16 million recognized during the three months ended September 30, 2026.

•Based upon current market conditions, we preliminarily estimate at least a similar level of reduction in funds from operations may be necessary in 2027.

•Depending on the timing and magnitude of the specific tenant wind-downs, we anticipate that 2027 occupancy may also be negatively impacted.

2)Development-related other income

•During the nine months ended September 30, 2026, we recognized development fees and other related revenues of approximately $8.0 million, or $11 million annualized, most

of which are expected to cease by the end of 2026 as we complete the respective projects.

3)Development and redevelopment projects under business and financial strategy evaluation

•We have three redevelopment projects for which the business and financial strategies continue to be evaluated, including whether to continue construction of laboratory

improvements, pause construction, pursue lower-investment construction alternatives (including a pivot to advanced technology use), or pursue a disposition. Refer to “New

Class A/A+ development and redevelopment properties: under construction” in Item 2 for additional details.

•If we elect to continue to pursue construction of laboratory improvements for these projects, the earliest deliveries of these projects are in 2028.

•If we elect to pursue lower-investment construction alternatives (including a pivot to advanced technology use), we expect these projects would have lower rental rates and

stabilized yields compared to our initial underwriting. The incremental capital required for alternative-use construction and corresponding rental rates earned are generally

lower than those associated with laboratory improvements.

•During the three months ended September 30, 2026, we have executed leases for 66,859 RSF and have additional leases under negotiation for 100,684 RSF for advanced

technology use at our project at 311 Arsenal Street in The Arsenal on the Charles Megacampus. This activity enables us to pivot the redevelopment project to a lower-cost

alternative use at lower rental rates and stabilized yields than our initial underwriting. Therefore, we placed this project, aggregating 339,020 RSF, into operation during the

three months ended September 30, 2026 and included it in our operating occupancy as of September 30, 2026. Refer to “Leasing activity” in Item 2 for additional details.

•In addition, we entered into a purchase and sale agreement with an institutional user for the sale of our development project at 421 Park Drive on the Alexandria Center® for

Life Science – Fenway Megacampus aggregating 339,668 RSF. The disposition is expected to close during the three months ended December 31, 2026, resulting in

significant sales proceeds and reducing future construction spending by approximately $136 million.

4)Capitalization of interest

•Our average real estate basis capitalized during the three months ended September 30, 2026 was $5.87 billion. As of September 30, 2026, real estate basis that continued to

qualify for capitalization declined to $4.46 billion, primarily driven by the cessation of capitalization on our projects at 421 Park Drive on the Alexandria Center® for Life Science –

Fenway Megacampus and Alexandria Stanford Life Science District, both of which were classified as held for sale as of September 30, 2026, as well as a delivered project at

Alexandria Center® for Life Science – Waltham Megacampus during the three months ended September 30, 2026. During the three months ended December 31, 2026, we

expect average real estate basis capitalized to range from $3.4 billion to $4.9 billion . Refer to “Capitalization of interest” in Item 2 for additional details.

•At each milestone date, we evaluate, on an asset-by-asset basis, whether to (i) proceed with additional pre-construction and/or construction activities based on leasing demand

and/or market conditions, (ii) pause future investments, or (iii) consider potential dispositions or sales of partial interests of these real estate assets. If we cease the activities

necessary to prepare a project for its intended use, costs related to such project, including interest, payroll, property taxes, insurance, and other costs directly related and

essential to the construction of Class A/A+ properties, are expensed as incurred. During the three months ended September 30, 2026, annualized capitalized operating

expenses represented approximately 2% of the total average real estate basis subject to capitalization.

5)2027 Key lease expirations

2027 Key Lease Expirations

RSF

Annual Rental

Revenue

Weighted-Average

Expiration Date

Weighted-Average

Downtime

1,377,960

$100.5 million

March 2027

9 to 24 months

•We estimate 1.4 million RSF of leases expiring in 2027, with approximately $100.5 million of annual

rental revenue, will have downtime after lease expiration. These 2027 expirations have a weighted-

average contractual lease expiration date in March 2027 and an expected weighted-average downtime

ranging from 9 to 24 months. Refer to “Contractual lease expirations” in Item 2 for additional details.

98

Summary of key items that may impact 2027 and 2028 results

The following key considerations for 2027 and 2028 reflect our preliminary expectations based on current market conditions.  These expectations could change materially and

are subject to a variety of factors, including industry, governmental, geopolitical, and macroeconomic conditions, including changes in interest rates, as well as other factors described in

our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

1)Operating occupancy

•For the year ending December 31, 2027, we expect average operating occupancy to temporarily decline relative to our projected operating occupancy as of December 31, 2026,

primarily due to expected downtime associated with the 1.4 million RSF 2027 key lease expirations disclosed in “Contractual lease expirations” in Item 2, as well as the potential

for tenant wind-downs. 

•For the year ending December 31, 2028, we expect average operating occupancy to improve relative to projected average operating occupancy for the year ending December

31, 2027, driven by the lease-up of temporary vacancy partially offset by approximately 718 thousand RSF of 2028 key lease expirations with expected downtime as disclosed in

“Contractual lease expirations” in Item 2.

2)Same property performance

•For the year ending December 31, 2027, we expect same property net operating income performance to improve compared with the midpoint of our guidance range for 2026 but

remain negative, primarily due to the expected temporary year-over-year decline in average operating occupancy, including the impact of expected downtime associated with 1.4

million RSF of 2027 key lease expirations.

•For the year ending December 31, 2028, we expect same property net operating income performance to improve compared with 2027, primarily driven by operating occupancy

growth and the lease-up of vacant space, subject to leasing and market conditions. 

3)Construction Spending

•For 2027, we continue to apply a disciplined approach to reduce construction spending and we seek to prioritize leased projects with high incremental returns. We expect 2027

construction spending to primarily focus on (i) revenue- and non-revenue-enhancing capital expenditures, which are expected to represent the majority of spend, approximately

half of which is associated with space that is leased or under lease negotiations, in order to support the leasing of vacant space and renewals and re-leasing of space at our

operating properties and (ii) construction spending required to complete our development and redevelopment projects that are expected to stabilize through 2028 and are 77%

leased/negotiating as of October 26, 2026.

•For 2028, we expect a further decline in construction spending relative to 2027, primarily driven by lower development and redevelopment spending. Construction spending on

revenue- and non-revenue-enhancing capital expenditures related to our operating portfolio is expected to continue to support the lease-up of temporary vacancy, subject to

leasing and market conditions.

4)Transactional and other capital sources

•For 2027, capital will be required to fund construction spending as we continue to prudently manage our key credit metrics, including net debt and preferred stock to Adjusted

EBITDA ratio. In general, we expect to rely on asset recycling transactions and other sources of cost-effective capital to support the achievement of our 2027 key credit metric

ratios targets, including net debt and preferred stock to Adjusted EBITDA.

•For 2028, if we have growth in Adjusted EBITDA, we may use incremental long-term debt to fund a portion of our capital needs on a leverage neutral basis. In addition, we may

use asset recycling and other sources of cost-effective capital to support the achievement of our 2028 key credit metric ratio targets, including net debt and preferred stock to

Adjusted EBITDA.

99

Consolidated and unconsolidated real estate joint ventures

We present components of balance sheet and operating results information for the noncontrolling interest share of our

consolidated real estate joint ventures and for our share of investments in unconsolidated real estate joint ventures to help investors

estimate balance sheet and operating results information related to our partially owned entities. These amounts are estimated by

computing, for each joint venture that we consolidate in our financial statements, the noncontrolling interest percentage of each financial

item to arrive at the cumulative noncontrolling interest share of each component presented. In addition, for our real estate joint ventures

that we do not control and do not consolidate, we apply our economic ownership percentage to the unconsolidated real estate joint

ventures to arrive at our proportionate share of each component presented. Refer to Note 4 – “Consolidated and unconsolidated real

estate joint ventures” to our unaudited consolidated financial statements in Item 1 for further discussion.

Consolidated Real Estate Joint Ventures

Property/Market/Submarket

Noncontrolling

Interest Share

Operating RSF

at 100%

50 and 60 Binney Street/Greater Boston/Cambridge/Inner Suburbs

66.0%

532,395

75/125 Binney Street/Greater Boston/Cambridge/Inner Suburbs

60.0%

388,270

100 and 225 Binney Street and 300 Third Street/Greater Boston/Cambridge/Inner Suburbs

70.0%

870,641

15 Necco Street/Greater Boston/Seaport Innovation District

43.3%

345,996

3215 Merryfield Row/San Diego/Torrey Pines

70.0%

170,523

Campus Point by Alexandria/San Diego/University Town Center(1)(2)

40.7%

(3)

1,586,697

5200 Illumina Way/San Diego/University Town Center

49.0%

792,687

9625 Towne Centre Drive/San Diego/University Town Center

70.0%

171,001

SD Tech by Alexandria/San Diego/Sorrento Mesa(1)(4)

50.0%

1,051,752

Summers Ridge Science Park/San Diego/Sorrento Mesa(5)

70.0%

316,531

Alexandria Center® for Science and Technology – Mission Bay/San Francisco Bay Area/

Mission Bay(6)

75.0%

551,845

211 and 213 East Grand Avenue/San Francisco Bay Area/South San Francisco

70.0%

300,930

500 Forbes Boulevard/San Francisco Bay Area/South San Francisco

90.0%

155,685

Alexandria Center® for Life Science – Millbrae/San Francisco Bay Area/South San Francisco

51.4%

285,346

1201 and 1208 Eastlake Avenue East/Seattle/Lake Union

70.0%

206,134

400 Dexter Avenue North/Seattle/Lake Union

70.0%

291,355

800 Mercer Street/Seattle/Lake Union(1)

40.0%

—

Unconsolidated Real Estate Joint Ventures

Property/Market/Submarket

Our Ownership

Share

Operating RSF

at 100%

1655 and 1725 Third Street/San Francisco Bay Area/Mission Bay

10.0%

586,208

101 West Dickman Street/Maryland/Beltsville

58.4%

(7)

135,958

Refer to “Joint venture financial information” under “Definitions and reconciliations” in Item 2 for additional information.

(1)Includes properties currently under construction or in our future development and redevelopment pipeline. Refer to “New Class A/A+ development and redevelopment

properties” in Item 2 for additional details.

(2)Includes 10200, 10290, and 10300 Campus Point Drive and 4135, 4155, 4165, 4224, and 4242 Campus Point Court.

(3)In October 2026, we completed a partial sale of our interest in this joint venture for $475.0 million which reduced our interest to approximately 30%. We expect to fund

the majority of future construction costs at the Megacampus, which is expected to reduce the ownership interests of our new joint venture partner and existing joint

venture partner over time to below 20.0% and 30.0%, respectively, and increase our ownership interest to over 50.0%. Refer to Note 4 – “Consolidated and

unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for additional details.

(4)Includes 9605, 9645, 9675, 9725, 9735, 9805, 9808, 9855, and 9868 Scranton Road and 10055, 10065, and 10075 Barnes Canyon Road.

(5)Includes 9965, 9975, 9985, and 9995 Summers Ridge Road.

(6)Includes 1450, 1500, and 1700 Owens Street and 455 Mission Bay Boulevard South.

(7)Represents a joint venture with a local real estate operator in which our joint venture partner manages the day-to-day activities that significantly affect the economic

performance of the joint venture.

100

The following table presents key terms related to our unconsolidated real estate joint ventures’ secured loans as of

September 30, 2026 (dollars in thousands):

As of September 30, 2026

Maturity Date

Stated Rate

Interest

Rate(1)

At 100%

Our

Share

Unconsolidated Joint Venture

Aggregate

Commitment

Debt Balance(2)

101 West Dickman Street

10/29/26

(3)

SOFR+1.95%

(4)

5.91%

$26,750

$19,354

58.4%

1655 and 1725 Third Street

2/10/35

6.37%

6.44%

500,000

497,138

10.0%

$526,750

$516,492

(1)Includes interest expense and amortization of loan fees.

(2)Represents outstanding principal, net of unamortized deferred financing costs, as of September 30, 2026.

(3)In October 2026, the unconsolidated real estate joint venture refinanced this debt with a new $22.5 million secured note payable bearing interest at SOFR+1.85% and

maturing in October 2030. As of September 30, 2026, our investment in this unconsolidated real estate joint venture was $9.9 million.

(4)This loan is subject to a SOFR floor of 0.75%.

The following tables present information related to the operating results and financial positions of our consolidated and

unconsolidated real estate joint ventures as of and for the three and nine months ended September 30, 2026 (in thousands):

Noncontrolling Interest Share of

Consolidated Real Estate Joint Ventures

Our Share of Unconsolidated

Real Estate Joint Ventures

September 30, 2026

September 30, 2026

Three Months Ended

Nine Months Ended

Three Months Ended

Nine Months Ended

Total revenues

$105,561

$301,634

$2,885

$8,895

Rental operations

(33,927)

(97,557)

(940)

(3,092)

71,634

204,077

1,945

5,803

General and administrative

(593)

(1,876)

(23)

(47)

Interest

(20)

(190)

(989)

(2,990)

Depreciation and amortization of real

estate assets

(32,458)

(93,449)

(858)

(2,577)

Gain on sale of interest in

unconsolidated JV

—

—

—

152

Fixed returns allocated to redeemable

noncontrolling interest(1)

191

730

—

—

$38,754

$109,292

$75

$341

Straight-line rent and below-market

lease revenue

$4,909

$9,034

$216

$550

Funds from operations(2)

$71,212

$202,741

$933

$2,918

Refer to “Joint venture financial information” under “Definitions and reconciliations” in Item 2 for additional details.

(1)Represents an allocation of joint venture earnings to redeemable noncontrolling interest for a property in the San Francisco Bay Area market. This redeemable

noncontrolling interest earns a fixed return on its investment rather than participating in the operating results of the property.

(2)Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria Real Estate Equities, Inc.’s common stockholders” under “Definitions

and reconciliations” in Item 2 for the definition and its reconciliation from the most directly comparable financial measure presented in accordance with GAAP.

As of September 30, 2026

Noncontrolling Interest

Share of Consolidated

Real Estate Joint Ventures

Our Share of

Unconsolidated

Real Estate Joint Ventures

Investments in real estate

$3,363,861

$85,927

Cash, cash equivalents, and restricted cash

136,379

2,514

Other assets

403,837

10,486

Secured notes payable

—

(61,016)

Other liabilities

(292,967)

(9,331)

Redeemable noncontrolling interests

(9,119)

—

$3,601,991

$28,580

During the nine months ended September 30, 2026 and 2025, our consolidated real estate joint ventures distributed an

aggregate of $171.2 million and $186.8 million, respectively, to our joint venture partners. Refer to our consolidated statements of cash

flows and Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in

Item 1 for additional information.

101

Investments

We hold investments in publicly traded companies and privately held entities primarily involved in the life science industry. The

tables below summarize components of our investment income (losses) and non-real estate investments (in thousands). Refer to Note

7 – “Investments” to our unaudited consolidated financial statements in Item 1 for additional information.

September 30, 2026

September 30, 2025

Three Months Ended

Nine Months Ended

Three Months Ended

Nine Months Ended

Realized gains:

Realized gains

$16,007

$44,497

$34,785

$94,650

Impairment of non-real estate investments

(13,580)

(1)

(35,026)

(25,139)

(75,535)

2,427

9,471

9,646

19,115

Unrealized gains (losses)

21,563

(2)

143,164

(2)

18,515

(3)

(71,568)

(4)

Investment income (losses)

$23,990

$152,635

$28,161

$(52,453)

September 30, 2026

December 31, 2025

Investments

Cost

Unrealized

Gains

Unrealized

Losses

Carrying

Amount

Carrying

Amount

Publicly traded companies

$105,921

$56,294

$(24,638)

$137,577

$94,928

Entities that report NAV

507,978

215,565

(43,100)

680,443

512,376

Entities that do not report NAV:

Entities with observable price changes

77,062

50,568

(10,785)

116,845

123,238

Entities without observable price changes

406,415

—

—

406,415

413,324

Investments accounted for under the equity method

N/A

N/A

N/A

394,393

357,383

September 30, 2026

$1,097,376

(5)

$322,427

$(78,523)

$1,735,673

$1,501,249

December 31, 2025

$1,010,488

$184,434

$(51,056)

$1,501,249

Public/Private Mix (Cost)

Tenant/Non-Tenant Mix (Cost)

1

13

7%

Public

18%

Tenant

93%

Private

82%

Non-Tenant

(1)Primarily relates to one non-real estate investment in a privately held entity that does not report NAV.

(2)Primarily relates to the increase in the fair value of our investments in privately held entities that report NAV during the three and nine months ended September 30,

2026.

(3)Primarily relates to the increase in fair values of our investments in publicly traded entities and investments in privately held entities that report NAV during the three

months ended September 30, 2025.

(4)Primarily relates to the accounting reclassifications of unrealized gains in prior periods into realized gains upon our realization of investments in publicly traded entities

and privately held entities that report NAV during the nine months ended September 30, 2025.

(5)Represents 2.7% of gross assets as of September 30, 2026. Refer to “Gross assets” under “Definitions and reconciliations” in Item 2 for additional details.

102

Liquidity

Liquidity

Limited Outstanding Borrowings and

Significant Availability on

Unsecured Senior Line of Credit

$4.6B

(in millions)

(In millions)

Availability under our unsecured senior line of credit, net of

amounts outstanding under our commercial paper program

$3,908

Cash, cash equivalents, and restricted cash

514

Investments in publicly traded companies

138

Liquidity as of September 30, 2026

$4,560

Net Debt and Preferred Stock

to Adjusted EBITDA(1)

Fixed Charge Coverage Ratio(1)

8246337208538

q326lineofcreditv3.jpg

$5,000

$5,000

$5,000

$1,091

$353

<$350

Remaining amounts available for

borrowing under our unsecured senior

line of credit

Outstanding balance under our

unsecured senior line of credit

and/or commercial paper

program

6.9x

8246337208321

6.6x(2)

5.6x to 6.2x

8246337208411

5.7x

Mid-5x Range

3.4x to 3.9x

3.7x

3.2x

(1)Quarter annualized.

(2)The pro forma amount reflects the October 23, 2026 sale of our partial interest in the Campus Point by Alexandria joint venture for  $475.0 million. Refer to Note 4 –

“Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for additional details.

We expect to meet certain long-term liquidity requirements, such as requirements for development, redevelopment, other

construction projects, capital improvements, tenant improvements, property acquisitions, equity repurchases, leasing costs, revenue-

and non-revenue-enhancing capital expenditures, scheduled debt maturities, distributions to noncontrolling interests, and payment of

dividends through net cash provided by operating activities, as adjusted, periodic asset dispositions, strategic real estate joint ventures,

long-term secured and unsecured indebtedness, borrowings under our unsecured senior line of credit, issuances under our commercial

paper program, and issuances of additional debt and/or equity securities.

We also expect to continue meeting our short-term liquidity and capital requirements, as further detailed in this section,

generally through our working capital and net cash provided by operating activities, as adjusted. We believe that the net cash provided

by operating activities, as adjusted, will continue to be sufficient to enable us to make the distributions necessary to continue qualifying

as a REIT.

For additional information on our liquidity requirements related to our contractual obligations and commitments, refer to

Note 5 – “Leases” and Note 10 – “Secured and unsecured senior debt” to our unaudited consolidated financial statements in Item 1.

103

Over the next several years, our balance sheet, capital structure, and liquidity objectives are as follows:

•Retain net cash provided by operating activities, as adjusted, for investment in development and redevelopment projects

and/or acquisitions;

•Maintain significant balance sheet liquidity;

•Maintain a strong credit profile and relative long-term cost of capital;

•Maintain diverse sources of capital, including sources from net cash provided by operating activities, as adjusted,

unsecured debt, secured debt, selective real estate asset sales, strategic real estate joint ventures, non-real estate

investment sales, and common stock;

•Maintain commitment to long-term capital to fund growth;

•Maintain prudent laddering of debt maturities;

•Maintain solid credit metrics;

•Prudently manage variable-rate debt exposure;

•Maintain a large, unencumbered asset pool to provide financial flexibility;

•Fund common stock dividends and distributions to noncontrolling interests from net cash provided by operating activities,

as adjusted;

•Manage a disciplined level of development and redevelopment projects as a percentage of our gross real estate assets;

and

•Maintain high levels of pre-leasing and percentage leased in development and redevelopment projects.

The following table presents the availability under our unsecured senior line of credit, net of amounts outstanding under our

commercial paper program; cash, cash equivalents, and restricted cash; and investments in publicly traded companies as of

September 30, 2026 (in thousands):

Description

Stated Rate

Aggregate

Commitments

Outstanding

Balance

Remaining

Commitments/

Liquidity

Availability under our unsecured senior line of credit, net of

amounts outstanding under our commercial paper program

SOFR+0.725%

$5,000,000

$1,092,450

$3,907,550

Cash, cash equivalents, and restricted cash

513,763

Investments in publicly traded companies

137,577

Liquidity as of September 30, 2026

$4,558,890

Cash, cash equivalents, and restricted cash

As of September 30, 2026 and December 31, 2025, we had $513.8 million and $553.8 million, respectively, of cash, cash

equivalents, and restricted cash. We expect existing cash, cash equivalents, and restricted cash, net cash provided by operating

activities, as adjusted, proceeds from real estate asset sales, sales of partial interests, strategic real estate joint ventures, non-real

estate investment sales, borrowings under our unsecured senior line of credit, issuances under our commercial paper program,

issuances of unsecured senior notes payable, and issuances of common stock to continue to be sufficient to fund our operating

activities and cash commitments for investing and financing activities, such as regular quarterly dividends, distributions to noncontrolling

interests, scheduled debt repayments, acquisitions, and certain capital expenditures, including expenditures related to construction

activities and any common stock repurchases.

Cash flows

We report and analyze our cash flows based on operating activities, investing activities, and financing activities. The following

table summarizes changes in our cash flows for the nine months ended September 30, 2026 and 2025 (in thousands):

Nine Months Ended September 30,

2026

2025

Change

Net cash provided by operating activities

$875,410

$1,101,668

$(226,258)

Net cash used in investing activities

$(1,165,939)

$(1,437,538)

$271,599

Net cash provided by financing activities

$251,067

$360,850

$(109,783)

104

Operating activities

Cash flows provided by operating activities are primarily dependent upon the occupancy level of our asset base, the rental

rates of our leases, the collectibility of rent and recovery of operating expenses from our tenants, the timing of completion of

development and redevelopment projects, and the timing of acquisitions and dispositions of operating properties. Net cash provided by

operating activities for the nine months ended September 30, 2026 decreased by $226.3 million, or 20.5%, to $0.88 billion, compared to

$1.10 billion for the nine months ended September 30, 2025, primarily reflecting the impact of real estate dispositions completed since

January 1, 2025 and the reduction in occupancy from 94.6% as of December 31, 2024 to 87.1% as of September 30, 2026. 

Investing activities

Cash used in investing activities for the nine months ended September 30, 2026 and 2025 consisted of the following (in

thousands):

Nine Months Ended September 30,

Change

2026

2025

Sources of cash from investing activities:

Proceeds from sales of real estate

$236,286

$227,105

$9,181

Sale of interests in unconsolidated real estate joint ventures

1,917

—

1,917

Sales of and distributions from non-real estate investments

123,660

77,067

46,593

Return of capital from unconsolidated real estate joint ventures

113

458

(345)

361,976

304,630

57,346

Uses of cash for investing activities:

Additions to real estate

1,328,092

1,538,613

(210,521)

Investments in unconsolidated real estate joint ventures

557

11,239

(10,682)

Change in escrow deposits

—

7,364

(7,364)

Additions to non-real estate investments

199,266

184,952

14,314

1,527,915

1,742,168

(214,253)

Net cash used in investing activities

$1,165,939

$1,437,538

$(271,599)

The change in net cash used in investing activities for the nine months ended September 30, 2026, compared to the nine

months ended September 30, 2025, was primarily due to a decrease in cash used for additions to real estate, and an increased source

of cash from sales of and distributions from non-real estate investments.

105

Financing activities

Cash flows provided by financing activities for the nine months ended September 30, 2026 and 2025 consisted of the following

(in thousands):

Nine Months Ended September 30,

2026

2025

Change

Borrowings under secured notes payable

$—

$4,031

$(4,031)

Repayments of borrowings under secured notes payable

(8,892)

(154,212)

145,320

Proceeds from issuance of unsecured senior notes payable

747,592

548,532

199,060

Repayments of unsecured senior notes payable

(1,602,203)

(600,000)

(1,002,203)

Proceeds from issuance of junior subordinated notes payable

1,000,000

—

1,000,000

Proceeds from issuances under commercial paper program

38,494,264

15,378,015

23,116,249

Repayments of borrowings under commercial paper program

(37,755,314)

(13,828,015)

(23,927,299)

Payments of loan fees

(57,893)

(5,307)

(52,586)

Changes related to debt

817,554

1,343,044

(525,490)

Contributions from and sales of noncontrolling interests

36,604

132,162

(95,558)

Distributions to noncontrolling interests

(171,248)

(186,725)

15,477

Purchases and redemptions of noncontrolling interests

(49,822)

(17,818)

(32,004)

Repurchase of common stock

—

(208,187)

208,187

Dividends on common stock

(371,427)

(684,419)

312,992

Taxes paid related to net settlement of equity awards

(10,594)

(17,207)

6,613

Net cash provided by financing activities

$251,067

$360,850

$(109,783)

106

Sources of capital

Net cash provided by operating activities, as adjusted

We expect to retain $475 million to $575 million of net cash provided by operating activities, as adjusted, for the year ending

December 31, 2026. Refer to “Net cash provided by operating activities, as adjusted” under “Definitions and reconciliations” in Item 2 for

the definition and reconciliation from the most directly comparable financial measure presented in accordance with GAAP. For the year

ending December 31, 2026, we expect our recently delivered projects, our development and redevelopment projects expected to be

delivered, and contributions from Same Properties to contribute to income from rentals, net operating income, and cash flows. We

anticipate contractual near-term growth in annual net operating income (cash basis) of $67 million related to the commencement of

contractual rents on the projects recently placed into service that are near the end of their initial free rent period, which has a weighted-

average remaining period of approximately four months. Refer to “Cash flows” in Item 2 for a discussion of cash flows provided by

operating activities for the nine months ended September 30, 2026.

Debt

We expect to fund a portion of our capital needs for 2026 and beyond from issuances under our commercial paper program,

issuances of unsecured senior notes payable, junior subordinated notes, and/or borrowings under our unsecured senior line of credit,

and/or borrowings under secured construction loans.

In September 2026, we amended and restated our $5.0 billion unsecured senior line of credit which, among other changes,

extended the maturity date from January 22, 2030 to January 22, 2032, including extension options that we control. The amendment

also reduced the applicable borrowing rate to SOFR plus 0.725% from SOFR plus 0.835% and eliminated the existing sustainability-

linked pricing adjustments. The facility fee was revised to 0.15% from 0.14%. In connection with the amendment, we recognized a loss

on early extinguishment of debt of approximately $3.3 million for the partial write-off of unamortized loan fees.

As of September 30, 2026, we had no outstanding balance on our unsecured senior line of credit.

Our commercial paper program provides us with the ability to issue up to $2.50 billion of commercial paper notes with a

maturity of generally 30 days or less and with a maximum maturity of 397 days from the date of issuance. Our commercial paper

program is back-stopped by our unsecured senior line of credit, and at all times we expect to retain a minimum undrawn amount of

borrowing capacity under our unsecured senior line of credit equal to any outstanding balance under our commercial paper program.

We use borrowings under the program to fund short-term capital needs. The notes issued under our commercial paper program are

sold under customary terms in the commercial paper market. They are typically issued at a discount to par, representing a yield to

maturity dictated by market conditions at the time of issuance. In the event we are unable to issue commercial paper notes or refinance

outstanding commercial paper notes under terms equal to or more favorable than those under the unsecured senior line of credit, we

expect to borrow under the unsecured senior line of credit. The commercial paper notes sold during the nine months ended

September 30, 2026 were issued at a weighted-average yield to maturity of 4.19%. As of September 30, 2026, we had $1.09 billion of

commercial paper notes outstanding.

In January 2026 and April 2026, we repaid, upon maturity, $300.0 million of 4.30% unsecured senior notes payable and

$350.0 million of 3.80% unsecured senior notes payable, respectively. These repayments were funded temporarily with borrowings

under our commercial paper program, which will be repaid through planned dispositions and sales of partial interests included in our

2026 guidance. No gain or loss was incurred in connection with these repayments.

In February 2026, we completed tender offers to repurchase an aggregate debt principal amount of $1.33 billion across a

portion of our outstanding 4.00% Senior Notes due 2050, 3.00% Senior Notes due 2051, and 3.55% Senior Notes due 2052. Cash

consideration paid was $952.2 million. The repurchase was primarily funded through the issuance of $750.0 million of 5.25% unsecured

senior notes due 2036, and approximately $200 million of short-term borrowings under our commercial paper program, which we expect

to repay through planned 2026 dispositions and sales of partial interests. In connection with the debt repurchase, we recognized a gain

on early extinguishment of debt aggregating $366.4 million, including the write-off of unamortized debt issuance costs and other

transaction-related costs.

107

In August 2026, we completed a public offering of $1.00 billion aggregate principal amount of 7.250% Series A fixed-to-fixed

reset rate junior subordinated notes due 2057. The notes will initially bear interest at 7.250% per year through, but excluding,

February 15, 2032. Thereafter, the interest rate will reset every five years to the five-year U.S. Treasury rate plus 2.889%, subject to a

minimum interest rate of 7.250%. We may elect to defer interest payments for up to five consecutive years, subject to the terms of the

notes, including certain restrictions on paying dividends and repurchasing equity. The notes may be redeemed at our option in whole or

in part at 100% of principal plus accrued and unpaid interest during the period beginning November 17, 2031 and ending on

February 15, 2032, and thereafter on any interest payment date. The notes may also be redeemed in whole, but not in part, at 100% of

principal plus accrued and unpaid interest upon certain tax events and at 102% of principal plus accrued and unpaid interest upon

certain rating agency events.

The following table presents our average debt outstanding and weighted-average interest rates during the three and nine

months ended September 30, 2026 (dollars in thousands):

Average Debt Outstanding

Weighted-Average Interest Rate

September 30, 2026

September 30, 2026

Three Months Ended

Nine Months Ended

Three Months Ended

Nine Months Ended

Long-term fixed-rate debt

$11,341,163

$11,239,142

4.15%

4.04%

Short-term variable-rate unsecured

senior line of credit and commercial

paper program debt

1,915,075

1,945,860

4.21

4.18

Blended average interest rate

13,256,238

13,185,002

4.16

4.06

Loan fee amortization and annual facility

fee related to unsecured senior line of

credit

N/A

N/A

0.13

0.13

Total/weighted average

$13,256,238

$13,185,002

4.29%

4.19%

Real estate dispositions and sales of partial interests

We expect to continue to focus on the disciplined execution of real estate dispositions and sales of partial interests, which will

provide an important source of capital to fund our development and redevelopment projects and potential opportunistic share

repurchases, and to reduce debt. For the year ending December 31, 2026, we expect real estate dispositions and sales of partial

interests to range from $1.10 billion to $2.70 billion. The amount of asset sales necessary to meet our forecasted sources of capital will

vary depending upon the amount of EBITDA associated with the assets sold. Refer to Note 3 – “Investments in real estate” and Note 4

– “Consolidated and unconsolidated real estate joint ventures,” and Note 14 – “Stockholders’ equity” to our unaudited consolidated

financial statements in Item 1 and to “Dispositions and sales of partial interests” in Item 2 for additional information.

As a REIT, we are generally subject to a 100% tax on the net income from real estate asset sales that the IRS characterizes as

“prohibited transactions.” We do not expect our sales will be categorized as prohibited transactions. However, unless we meet certain

“safe harbor” requirements, whether a real estate asset sale is a “prohibited transaction” will be based on the facts and circumstances

of the sale. Our real estate asset sales may not always meet such “safe harbor” requirements. Refer to “Item 1A. Risk factors” in our

annual report on Form 10-K for the year ended December 31, 2025 for additional information about the “prohibited transaction” tax.

Common equity transactions

During the three and nine months ended September 30, 2026, we did not issue any common stock under our ATM program.

As of September 30, 2026, the remaining aggregate amount available under our ATM program for future sales of common stock was

$1.47 billion.

Other sources

As a well-known seasoned issuer, we may, from time to time, issue securities, including preferred stock, subordinated debt,

convertible securities, and other forms of hybrid securities, at our discretion based on our needs and market conditions, including, as

necessary, to balance our use of incremental debt capital and our leverage profile.

Additionally, we, together with joint venture partners, hold interests in real estate joint ventures that we consolidate in our

financial statements. These existing joint ventures provide significant equity capital to fund a portion of our future construction spending,

and our joint venture partners may also contribute equity into these entities for financing-related activities. From October 1, 2026

through December 31, 2027 and beyond, we expect to receive capital contributions aggregating $105.0 million from existing

consolidated real estate joint venture partners to fund construction. During the year ending December 31, 2026, contributions from

noncontrolling interests from existing joint venture partners are expected to aggregate to approximately $100.0 million at the midpoint of

our guidance range for 2026 construction spending.

108

Uses of capital

Construction spending

One of our primary uses of capital relates to the development, redevelopment, pre-construction, and construction of properties.

We currently have projects in our development and redevelopment pipeline aggregating 1.9 million RSF of Class A/A+ properties

undergoing construction. We incur capitalized construction costs related to development, redevelopment, pre-construction, and other

construction activities. We also incur additional capitalized project costs, including interest, property taxes, insurance, and other costs

directly related and essential to the development, redevelopment, pre-construction, or construction of a project, during periods when

activities necessary to prepare an asset for its intended use are in progress. Refer to “New Class A/A+ development and redevelopment

properties: under construction” and “Construction spending” in Item 2 for additional information on our capital expenditures.

We capitalize interest cost as a cost of the project only during the period in which activities necessary to prepare an asset for

its intended use are ongoing, provided that expenditures for the asset have been made and interest cost has been incurred. Capitalized

interest, classified in investments in real estate in our consolidated balance sheets, aggregated $206.6 million for the nine months

ended September 30, 2026, a decrease from $248.6 million capitalized during the nine months ended September 30, 2025. This

reflects a lower weighted-average capitalized cost basis of $6.58 billion for the nine months ended September 30, 2026, as compared

to $8.18 billion for the nine months ended September 30, 2025. 

Property taxes, insurance on real estate, and indirect project costs, such as construction, administration, legal fees, and office

costs that clearly relate to projects under development or construction, are capitalized as incurred during the period an asset is

undergoing activities to prepare it for its intended use. We capitalized payroll and other indirect costs related to development,

redevelopment, pre-construction, and construction projects aggregating $55.4 million and $69.6 million, and property taxes, insurance

on real estate, and indirect project costs aggregating $98.4 million and $111.7 million during the nine months ended

September 30, 2026 and 2025, respectively.

Pre-construction activities include entitlements, permitting, design, site work, and other activities preceding commencement of

construction of aboveground building improvements. The advancement of pre-construction efforts is focused on reducing the time

required to deliver projects to prospective tenants. These critical activities add significant value for future ground-up development and

are required for the vertical construction of buildings. Should we cease activities necessary to prepare an asset for its intended use, the

interest, taxes, insurance, and certain other direct and indirect project costs related to the asset would be expensed as incurred.

Expenditures for repairs and maintenance are expensed as incurred.

Fluctuations in our development, redevelopment, and construction activities could result in significant changes to total

expenses and net income. For example, a 10% reduction in development, redevelopment, and construction activities without a

corresponding decrease in indirect project costs, including interest and payroll, would have resulted in an increase in total expenses of

approximately $36.0 million for the nine months ended September 30, 2026.

We use third-party brokers to assist in our leasing activity, who are paid on a contingent basis upon successful leasing. We are

required to capitalize initial direct costs related to successful leasing transactions that result directly from and are essential to the lease

transaction and would not have been incurred had that lease transaction not been successfully executed. During the nine months

ended September 30, 2026, we capitalized total initial direct leasing costs of $61.5 million. Costs that we incur to negotiate or arrange a

lease regardless of its outcome, such as fixed employee compensation, tax, or legal advice to negotiate lease terms, and other costs,

are expensed as incurred.

Dividends

During the nine months ended September 30, 2026 and 2025, we paid common stock dividends of $371.4 million and

$684.4 million, respectively. The decrease of $313.0 million in dividends paid on our common stock for the nine months ended

September 30, 2026, compared to the nine months ended September 30, 2025, was primarily due to a decrease in the related

dividends to $2.16 per common share paid for the nine months ended September 30, 2026 from $3.96 per common share paid during

the nine months ended September 30, 2025.

We have historically funded the payment of our common stock dividends using net cash provided by operating activities. We

expect to continue funding future quarterly common stock dividends from net cash provided by operating activities, which may be

supplemented by proceeds from periodic asset dispositions, issuances of additional debt and/or equity securities, and borrowings under

our unsecured senior line of credit and/or our commercial paper program. Future dividends are at the discretion of our Board and

subject to various considerations, including net income, cash flows, capital requirements, debt covenants, market conditions, dividend

yield, taxable income, payout ratios, and other factors. Accordingly, there can be no assurance that dividends will be maintained at the

current level, or that they will be increased or decreased in the future.

109

Unsecured senior notes payable and unsecured senior line of credit

The requirements of, and our actual performance with respect to, the key financial covenants under our unsecured senior

notes payable as of September 30, 2026 were as follows:

Covenant Ratios(1)

Requirement

September 30, 2026

Total Debt to Total Assets

Less than or equal to 60%

33%

Secured Debt to Total Assets

Less than or equal to 40%

—%

Consolidated EBITDA(2) to Interest Expense

Greater than or equal to 1.5x

5.6x

Unencumbered Total Asset Value to Unsecured Debt

Greater than or equal to 150%

295%

(1)All covenant ratio titles utilize terms as defined in the respective debt agreements.

(2)The calculation of consolidated EBITDA is based on the definitions contained in our loan agreements and is not directly comparable to the computation of EBITDA as

described in Exchange Act Release No. 47226.

In addition, the terms of the indentures, among other things, limit the ability of the Company, Alexandria Real Estate Equities,

L.P., and the Company’s subsidiaries to (i) consummate a merger, or consolidate, or sell all or substantially all of the Company’s assets

and (ii) incur certain secured or unsecured indebtedness.

The requirements of, and our actual performance with respect to, the key financial covenants under our unsecured senior line

of credit as of September 30, 2026 were as follows:

Covenant Ratios(1)

Requirement

September 30, 2026

Leverage Ratio

Less than or equal to 60.0%

35.5%

Secured Debt Ratio

Less than or equal to 45.0%

—%

Fixed-Charge Coverage Ratio

Greater than or equal to 1.50x

2.91x

Unsecured Interest Coverage Ratio

Greater than or equal to 1.75x

5.84x

(1)All covenant ratio titles utilize terms as defined in the credit agreement.

In managing our liquidity, we also consider the contractual interest payment obligations associated with our outstanding debt.

Interest payments on our fixed-rate debt are determined based on contractual interest rates, including interest payment dates and

scheduled maturity dates. As of September 30, 2026, 91.5% of our debt was fixed-rate debt. For additional information regarding our

debt, refer to Note 10 – “Secured and unsecured senior debt” to our unaudited consolidated financial statements in Item 1.

Ground lease obligations

Ground lease obligations as of September 30, 2026 included leases for 31 of our properties and accounted for approximately

9% of our total number of properties. Among these 31 properties, 17 properties are subject to ground leases with a weighted-average

remaining lease term of 53 years, including extension options that we are reasonably certain to exercise. These leases are with a single

lessor in our Palo Alto submarket with whom we have extended two ground leases over the past 10 years.

Our remaining 14 properties subject to ground leases are located across multiple submarkets and have remaining lease terms

ranging from approximately 44 to 80 years. The weighted-average remaining lease term of these ground leases is 72 years, including

extension options that we are reasonably certain to exercise.

In many cases, we seek to extend our ground leases well ahead of their scheduled contractual expirations. If we are

successful in extending ground leases, we could see significant up-front or increased recurring future payments to the ground lessor

and/or increased ground lease expense, which may require us to increase our capital funding needs.

110

Operating lease agreements

As of September 30, 2026, the remaining contractual payments under ground and office lease agreements in which we are the

lessee aggregated $739.1 million and $15.3 million, respectively. As of September 30, 2026, our operating lease liability, calculated as

the present value of the remaining payments aggregating $754.4 million under our operating lease agreements, including our extension

options that we are reasonably certain to exercise, was $354.0 million and was classified in accounts payable, accrued expenses, and

other liabilities in our consolidated balance sheet. As of September 30, 2026, the weighted-average remaining lease term of operating

leases in which we are the lessee was approximately 60 years, including extension options that we are reasonably certain to exercise,

and the weighted-average discount rate was 4.7%. Our corresponding operating lease right-of-use assets, adjusted for initial direct

leasing costs and other consideration exchanged with the landlord prior to the commencement of the lease, aggregated $686.2 million.

We classify the right-of-use asset in other assets in our consolidated balance sheets. Refer to “Lease accounting” in Note 2 –

“Summary of significant accounting policies” to our unaudited consolidated financial statements in Item 1 for additional information.

Commitments

As of September 30, 2026, remaining aggregate costs under contract for the construction of properties undergoing

development, redevelopment, and improvements under the terms of leases approximated $1.0 billion. We expect payments for these

obligations to occur over one to three years, subject to capital planning adjustments from time to time. We may have the ability to cease

the construction of certain projects, which would result in the reduction of our commitments. In addition, we have letters of credit and

performance obligations aggregating $5.3 million.

We are committed to funding approximately $340.6 million related to our non-real estate investments. These funding

commitments are primarily associated with our investments in privately held entities that report NAV and expire at various dates over

the next 11 years, with a weighted-average expiration of 7.8 years as of September 30, 2026. 

Our former joint venture partner in the Greater Boston market has an option, subject to certain conditions, to obtain a $30.0

million secured loan from us. If exercised, the loan would bear interest at SOFR plus 6.5%, subject to a floor of 9.0%, and a term not to

exceed five years. As of September 30, 2026, the option has not been exercised and is set to expire in July 2027.

In connection with the sale of a property in our San Diego market, we entered into a loan agreement with the buyer under

which we committed to provide up to $165.7 million of financing through December 30, 2029. As of September 30, 2026, $36.4 million

of the commitment remained available to be drawn by the borrower.

In October 2026, in connection with the sale of a partial noncontrolling interest in the joint venture that owns substantially all of

Campus Point by Alexandria Megacampus, the new joint venture partner has a put right exercisable beginning on the seventh

anniversary of the transaction. The put right allows the partner to require us to acquire its interest in exchange for shares of our

common stock, subject to a contractual share issuance limit, or, at our election, for cash, or a combination of cash and shares. Refer to

Note 4 – “Consolidated and unconsolidated real estate joint ventures” to our unaudited consolidated financial statements in Item 1 for

additional details.

Exposure to environmental liabilities

In connection with the acquisition of all of our properties, we have obtained Phase I environmental assessments to ascertain

the existence of any environmental liabilities or other issues. The Phase I environmental assessments of our properties have not

revealed any environmental liabilities that we believe would have a material adverse effect on our financial condition or results of

operations taken as a whole, nor are we aware of any material environmental liabilities that have occurred since the Phase I

environmental assessments were completed. In addition, we carry a policy of pollution legal liability insurance covering exposure to

certain environmental losses at substantially all of our properties.

111

Foreign currency translation gains and losses

The following table presents the change in accumulated other comprehensive loss attributable to Alexandria Real Estate

Equities, Inc.’s stockholders during the nine months ended September 30, 2026 primarily due to the changes in the foreign exchange

rates for our real estate investments in Canada (in thousands). We reclassify unrealized foreign currency translation gains and losses

into net income upon the sale or complete or substantially complete liquidation of the related investments.

Total

Balance as of December 31, 2025

$(29,395)

Other comprehensive loss before reclassifications

(4,273)

Reclassification adjustment for gain included in net income

(23)

Net other comprehensive loss

(4,296)

Balance as of September 30, 2026

$(33,691)

Inflation

As of September 30, 2026, approximately 91% of our leases (on an annual rental revenue basis) were triple net leases, which

require tenants to pay substantially all real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and

other operating expenses (including increases thereto) in addition to base rent. Approximately 97% of our leases (on an annual rental

revenue basis) contained effective annual rent escalations approximating 3% that were either fixed or indexed based on a consumer

price index or other indices. Accordingly, we do not believe that our cash flows or earnings from real estate operations are subject to

significant risks from inflation. A period of inflation, however, could cause an increase in the cost of issuing new unsecured senior notes

payable and our variable-rate borrowings, including borrowings under our unsecured senior line of credit and commercial paper

program, and secured loans held by our unconsolidated real estate joint ventures.

112

Issuer and guarantor subsidiary summarized financial information

Alexandria Real Estate Equities, Inc. (the “Issuer”) has sold certain debt securities registered under the Securities Act of 1933,

as amended, that are fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P. (the “LP” or the “Guarantor

Subsidiary”), an indirectly 100% owned subsidiary of the Issuer. The Issuer’s other subsidiaries, including, but not limited to, the

subsidiaries that own substantially all of its real estate (collectively, the “Combined Non-Guarantor Subsidiaries”), will not provide a

guarantee of such securities, including the subsidiaries that are partially or 100% owned by the LP. The following summarized financial

information presents, on a combined basis, balance sheet information as of September 30, 2026 and December 31, 2025, and results

of operations and comprehensive income for the nine months ended September 30, 2026 and year ended December 31, 2025 for the

Issuer and the Guarantor Subsidiary. The information presented below excludes eliminations necessary to arrive at the information on a

consolidated basis. In presenting the summarized financial statements, the equity method of accounting has been applied to (i) the

Issuer’s interests in the Guarantor Subsidiary, (ii) the Guarantor Subsidiary’s interests in the Combined Non-Guarantor Subsidiaries,

and (iii) the Combined Non-Guarantor Subsidiaries’ interests in the Guarantor Subsidiary, where applicable, even though all such

subsidiaries meet the requirements to be consolidated under GAAP. All assets and liabilities have been allocated to the Issuer and the

Guarantor Subsidiary generally based on legal entity ownership.

The following tables present combined summarized financial information as of September 30, 2026 and December 31, 2025

and for the nine months ended September 30, 2026 and year ended December 31, 2025 for the Issuer and Guarantor Subsidiary.

Amounts provided do not represent our total consolidated amounts (in thousands):

September 30, 2026

December 31, 2025

Assets:

Cash, cash equivalents, and restricted cash

$302,383

$127,100

Other assets

213,412

173,303

Total assets

$515,795

$300,403

Liabilities:

Unsecured senior notes payable

$10,820,687

$12,047,394

Unsecured senior line of credit and commercial paper

1,091,166

353,161

Junior subordinated notes payable

985,143

—

Other liabilities

462,507

433,707

Total liabilities

$13,359,503

$12,834,262

Nine Months Ended

September 30, 2026

Year Ended

December 31, 2025

Total revenues

$15,675

$48,748

Total expenses

(309,550)

(350,655)

Gain on early extinguishment of debt

363,112

—

Net income (loss)

69,237

(301,907)

Net income attributable to unvested restricted stock awards

(2,603)

(8,417)

Net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common

stockholders

$66,634

$(310,324)

As of September 30, 2026, all of our 328 properties were held indirectly by the REIT’s wholly owned consolidated subsidiary,

Alexandria Real Estate Equities, L.P.

Critical accounting estimates

Refer to our annual report on Form 10-K for the year ended December 31, 2025 for a discussion of our critical accounting

estimates related to recognition of real estate acquired, impairment of long-lived assets, impairment of non-real estate investments, and

monitoring of tenant credit quality.

113

Definitions and reconciliations

This section contains additional information on certain non-GAAP financial measures, including reconciliations from the most

directly comparable financial measure calculated and presented in accordance with GAAP and the reasons why we use these

supplemental measures of performance and believe they provide useful information to investors, as well as the definitions of other

terms used in this report.

Funds from operations and funds from operations, as adjusted, attributable to Alexandria Real Estate Equities, Inc.’s common

stockholders

GAAP-basis accounting for real estate assets utilizes historical cost accounting and assumes that real estate values diminish

over time. In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the

Nareit Board of Governors established funds from operations as an improved measurement tool. Since its introduction, funds from

operations has become a widely used non-GAAP financial measure among equity REITs. We believe that funds from operations is

helpful to investors as an additional measure of the performance of an equity REIT. Moreover, we believe that funds from operations, as

adjusted, allows investors to compare our performance to the performance of other real estate companies on a consistent basis, without

having to account for differences recognized because of real estate acquisition and disposition decisions, financing decisions, capital

structure, capital market transactions, variances resulting from the volatility of market conditions outside of our control, or other

corporate activities that may not be representative of the operating performance of our properties.

The 2018 White Paper published by the Nareit Board of Governors (the “Nareit White Paper”) defines funds from operations as

net income (computed in accordance with GAAP), excluding gains or losses on sales of real estate, and impairments of real estate, plus

depreciation and amortization of operating real estate assets, and after adjustments for our share of consolidated and unconsolidated

partnerships and real estate joint ventures. Impairments represent the write-down of assets when fair value over the recoverability

period is less than the carrying value due to changes in general market conditions and do not necessarily reflect the operating

performance of the properties during the corresponding period.

We compute funds from operations, as adjusted, as funds from operations calculated in accordance with the Nareit White

Paper, excluding significant gains, losses, and impairments realized on non-real estate investments, unrealized gains or losses on non-

real estate investments, impairments of real estate primarily consisting of right-of-use assets and pre-acquisition costs related to

projects that we decided to no longer pursue, gains or losses on early extinguishment of debt, changes in the provision for expected

credit losses on financial instruments, significant termination fees, acceleration of stock compensation expense due to the resignations

of executive officers, deal costs, the income tax effect related to such items, and the amount of such items that is allocable to our

unvested restricted stock awards. We compute the amount that is allocable to our unvested restricted stock awards with nonforfeitable

dividends using the two-class method. Under the two-class method, we allocate net income (after amounts attributable to noncontrolling

interests) to common stockholders and to unvested restricted stock awards with nonforfeitable dividends by applying the respective

weighted-average shares outstanding during each quarter-to-date and year-to-date period. This may result in a difference of the

summation of the quarter-to-date and year-to-date amounts. Neither funds from operations nor funds from operations, as adjusted,

should be considered as alternatives to net income (determined in accordance with GAAP) as indications of financial performance, or to

cash flows from operating activities (determined in accordance with GAAP) as measures of liquidity, nor are they indicative of the

availability of funds for our cash needs, including our ability to make distributions.

We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a

reconciliation for funds from operations on a forward-looking basis. This is due to the inherent difficulty of forecasting the timing and/or

amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and

financing decisions, as well as components such as gain on sales of real estate, unrealized gains or losses on non-real estate

investments, impairments of real estate, impairments of non-real estate investments, and changes in provision for expected credit

losses on financial instruments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would

potentially be misleading for our investors.

114

The following tables present a reconciliation of net income (loss) attributable to Alexandria Real Estate Equities, Inc.’s common

stockholders, the most directly comparable financial measure presented in accordance with GAAP, including our share of amounts from

consolidated and unconsolidated real estate joint ventures, to funds from operations attributable to Alexandria Real Estate Equities,

Inc.’s common stockholders – diluted, and funds from operations attributable to Alexandria Real Estate Equities, Inc.’s common

stockholders – diluted, as adjusted, and the related per share amounts for the three and nine months ended September 30, 2026 and

2025 (in thousands, except per share amounts). Per share amounts may not add due to rounding.

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Net loss attributable to Alexandria Real Estate Equities, Inc.’s

common stockholders – basic and diluted

$(638,452)

$(234,937)

$(351,419)

$(356,147)

Depreciation and amortization of real estate assets

302,240

338,182

907,774

1,021,292

Noncontrolling share of depreciation and amortization from

consolidated real estate JVs

(32,458)

(45,327)

(93,449)

(114,785)

Our share of depreciation and amortization from unconsolidated

real estate JVs

858

852

2,577

2,848

Gain on sales of real estate

—

(9,824)

—

(22,989)

Impairment of real estate – rental properties and land

637,904

(1)

323,870

865,873

454,960

Allocation to unvested restricted stock awards

(1,042)

(1,648)

(7,141)

(3,590)

Funds from operations attributable to Alexandria Real Estate

Equities, Inc.’s common stockholders – diluted(2)

269,050

371,168

1,324,215

981,589

Unrealized (gains) losses on non-real estate investments

(21,563)

(18,515)

(143,164)

71,568

Impairment of non-real estate investments

13,580

(3)

25,139

35,026

75,535

Impairment of real estate

—

—

—

39,343

Loss (gain) on early extinguishment of debt

3,323

107

(363,112)

107

Increase in provision for expected credit losses on financial

instruments

—

—

—

285

Allocation to unvested restricted stock awards

33

(74)

3,496

(2,156)

Funds from operations attributable to Alexandria Real Estate

Equities, Inc.’s common stockholders – diluted, as adjusted

$264,423

$377,825

$856,461

$1,166,271

(1)Refer to “Sales of real estate assets and impairment of real estate” in Note 3 – “Investments in real estate” to our unaudited consolidated financial statements in Item 1

for additional information.

(2)Calculated in accordance with standards established by the Nareit Board of Governors.

(3)Primarily relates to one non-real estate investment in a privately held entity that does not report NAV.

115

Three Months Ended

September 30,

Nine Months Ended

September 30,

(Per share)

2026

2025

2026

2025

Net loss per share attributable to Alexandria Real Estate

Equities, Inc.’s common stockholders – diluted

$(3.74)

$(1.38)

$(2.06)

$(2.09)

Depreciation and amortization of real estate assets

1.58

1.73

4.77

5.34

Gain on sales of real estate

—

(0.06)

—

(0.14)

Impairment of real estate – rental properties and land

3.74

1.90

5.07

2.67

Allocation to unvested restricted stock awards

(0.01)

(0.01)

(0.04)

(0.02)

Funds from operations per share attributable to Alexandria

Real Estate Equities, Inc.’s common stockholders – diluted

1.57

2.18

7.74

5.76

Unrealized (gains) losses on non-real estate investments

(0.13)

(0.11)

(0.84)

0.42

Impairment of non-real estate investments

0.08

0.15

0.20

0.45

Impairment of real estate

—

—

—

0.23

Loss (gain) on early extinguishment of debt

0.02

—

(2.12)

—

Allocation to unvested restricted stock awards

—

—

0.02

(0.01)

Funds from operations per share attributable to Alexandria

Real Estate Equities, Inc.’s common stockholders –

diluted, as adjusted

$1.54

$2.22

$5.00

$6.85

Weighted-average shares of common stock outstanding –

diluted(1)

Earnings per share – diluted

170,751

170,181

170,689

170,278

Funds from operations – diluted, per share

171,418

170,305

171,169

170,351

Funds from operations – diluted, as adjusted, per share

171,418

170,305

171,169

170,351

(1)Refer to “Weighted-average shares of common stock outstanding – diluted” in this section for additional information.

The following table reconciles net income (loss) to funds from operations for the share of consolidated real estate joint

ventures attributable to noncontrolling interests and our share of unconsolidated real estate joint ventures for the three and nine months

ended September 30, 2026 (in thousands):

Noncontrolling Interest Share of

Consolidated Real Estate Joint Ventures

Our Share of Unconsolidated

Real Estate Joint Ventures

September 30, 2026

September 30, 2026

Three Months Ended

Nine Months Ended

Three Months Ended

Nine Months Ended

Net income

$38,754

$109,292

$75

$341

Depreciation and amortization of

real estate assets

32,458

93,449

858

2,577

Funds from operations

$71,212

$202,741

$933

$2,918

116

Adjusted EBITDA and Adjusted EBITDA margin

We use Adjusted EBITDA as a supplemental performance measure of our operations, for financial and operational decision-

making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated

as earnings before interest, taxes, depreciation, and amortization (“EBITDA”), excluding stock compensation expense, gains or losses

on early extinguishment of debt, gains or losses on sales of real estate, impairments of real estate, changes in provision for expected

credit losses on financial instruments, and significant termination fees. Adjusted EBITDA also excludes unrealized gains or losses and

significant realized gains or losses and impairments that result from our non-real estate investments. These non-real estate investment

amounts are classified in our consolidated statements of operations outside of total revenues.

We believe Adjusted EBITDA provides investors with relevant and useful information as it allows investors to evaluate the

operating performance of our business activities without having to account for differences recognized because of investing and

financing decisions related to our real estate and non-real estate investments, our capital structure, capital market transactions, and

variances resulting from the volatility of market conditions outside of our control. For example, we exclude gains or losses on the early

extinguishment of debt to allow investors to measure our performance independent of our indebtedness and capital structure. We

believe that adjusting for the effects of impairments and gains or losses on sales of real estate, significant impairments and realized

gains or losses on non-real estate investments, changes in provision for expected credit losses on financial instruments, and significant

termination fees allows investors to evaluate performance from period to period on a consistent basis without having to account for

differences recognized because of investing and financing decisions related to our real estate and non-real estate investments or other

corporate activities that may not be representative of the operating performance of our properties.

In addition, we believe that excluding charges related to stock compensation and unrealized gains or losses facilitates

investors’ comparison of our business activities across periods without the volatility resulting from market forces outside of our control.

Adjusted EBITDA has limitations as a measure of our performance. Adjusted EBITDA does not reflect our historical expenditures or

future requirements for capital expenditures or contractual commitments. While Adjusted EBITDA is a relevant measure of performance,

it does not represent net income (loss) or cash flows from operations calculated and presented in accordance with GAAP, and it should

not be considered as an alternative to those indicators in evaluating performance or liquidity.

In order to calculate the Adjusted EBITDA margin, we divide Adjusted EBITDA by total revenues as presented in our

consolidated statements of operations. We believe that this supplemental performance measure provides investors with additional

useful information regarding the profitability of our operating activities.

We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a

reconciliation for Adjusted EBITDA on a forward-looking basis. This is due to the inherent difficulty of forecasting the timing and/or

amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and

financing decisions, as well as quarterly components such as gain on sales of real estate, unrealized gains or losses on non-real estate

investments, impairments of real estate, impairments of non-real estate investments, and changes in provision for expected credit

losses on financial instruments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would

potentially be misleading for our investors.

117

The following table reconciles net income (loss), the most directly comparable financial measure calculated and presented in

accordance with GAAP, to Adjusted EBITDA and calculates the Adjusted EBITDA margin for the three and nine months ended

September 30, 2026 and 2025 (dollars in thousands):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Net loss

$(598,932)

$(197,845)

$(239,524)

$(221,372)

Interest expense

79,687

54,852

208,613

161,024

Income taxes

2,609

3,737

7,679

5,902

Depreciation and amortization

304,419

340,230

914,244

1,028,415

Stock compensation expense

11,953

10,293

33,131

32,887

Loss (gain) on early extinguishment of debt

3,323

107

(363,112)

107

Gain on sales of real estate

—

(9,366)

—

(22,531)

Unrealized (gains) losses on non-real estate investments

(21,563)

(18,515)

(143,164)

71,568

Impairment of non-real estate investments

13,580

25,139

35,026

75,535

Impairment of real estate

637,904

323,870

865,873

485,630

Increase in provision for expected credit losses on financial

instruments

—

—

—

285

Adjusted EBITDA

$432,980

$532,502

$1,318,766

$1,617,450

Total revenues

$671,182

$751,944

$2,004,988

$2,272,142

Adjusted EBITDA margin

65%

71%

66%

71%

Advanced technology

Advanced technology space serves tech office and non-life-science users whose operations require building characteristics,

infrastructure, or systems beyond those typically found in traditional office space. Similar to laboratory space, advanced technology

space may require enhanced floor-loading capacity; increased electrical capacity, redundancy, and resilience; greater floor-to-floor

heights or clear heights; enhanced freight and loading access; enhanced security features; and specialized HVAC, exhaust, or other

critical building systems.

Annual rental revenue

Annual rental revenue represents the annualized fixed base rental obligations, calculated in accordance with GAAP. It includes

the amortization of deferred revenue related to tenant-funded and tenant-built landlord improvements for leases in effect as of the end

of the period, related to our operating RSF. Annual rental revenue is presented using 100% of the annual rental revenue from our

consolidated properties and our share of annual rental revenue for our unconsolidated real estate joint ventures. Annual rental revenue

per RSF is computed by dividing annual rental revenue by the sum of 100% of the RSF of our consolidated properties and our share of

the RSF of properties held in unconsolidated real estate joint ventures. As of September 30, 2026, approximately 91% of our leases (on

an annual rental revenue basis) were triple net leases, which require tenants to pay substantially all real estate taxes, insurance,

utilities, repairs and maintenance, common area expenses, and other operating expenses (including increases thereto) in addition to

base rent. Annual rental revenue excludes these operating expenses recovered from our tenants. Amounts recovered from our tenants

related to these operating expenses, along with base rent, are classified in income from rentals in our consolidated statements of

operations.

Capitalization rates

Capitalization rates are calculated based on net operating income and net operating income (cash basis) annualized,

excluding lease termination fees, on stabilized operating assets for the quarter preceding the date on which the property is sold, or

near-term prospective net operating income.

Capitalized interest

We capitalize interest cost as a cost of a project during periods for which activities necessary to develop, redevelop, or

reposition a project for its intended use are ongoing, provided that expenditures for the asset have been made and interest cost has

118

been incurred. Activities necessary to develop, redevelop, or reposition a project include pre-construction activities such as

entitlements, permitting, design, site work, and other activities preceding commencement of construction of aboveground building

improvements. The advancement of pre-construction efforts is focused on reducing the time required to deliver projects to prospective

tenants. These critical activities add significant value for future ground-up development and are required for the vertical construction of

buildings. If we cease activities necessary to prepare a project for its intended use, interest costs related to such project are expensed

as incurred.

Cash interest

Cash interest is equal to interest expense calculated in accordance with GAAP plus capitalized interest, less amortization of

loan fees, debt premiums (discounts) and interest expense associated with the equity treatment of junior subordinated notes payable.

Refer to “Fixed-charge coverage ratio” in this section for a reconciliation of interest expense, the most directly comparable financial

measure calculated and presented in accordance with GAAP, to cash interest.

Class A/A+ properties and AAA locations

Class A/A+ properties are properties clustered in AAA locations that provide innovative tenants with highly dynamic and

collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity,

efficiency, creativity, and success. These properties are typically well-located, professionally managed, and well-maintained, offering a

wide range of amenities and featuring premium construction materials and finishes. Class A/A+ properties are generally newer or have

undergone substantial redevelopment and are generally expected to command higher annual rental rates compared to other classes of

similar properties. AAA locations are in close proximity to concentrations of specialized skills, knowledge, institutions, and related

businesses. It is important to note that our definition of property classification may not be directly comparable to other equity REITs.

Credit rating

Represents the credit ratings assigned by S&P Global Ratings or Moody’s Ratings as of September 30, 2026. A credit rating is

not a recommendation to buy, sell, or hold securities and may be subject to revision or withdrawal at any time.

Development, redevelopment, and pre-construction

A key component of our business model is our disciplined allocation of capital to the development and redevelopment of new

Class A/A+ properties, as well as property enhancements identified during the underwriting of certain acquired properties. These efforts

are primarily concentrated in collaborative Megacampus ecosystems within AAA life science and advanced technology innovation

clusters, as well as other strategic locations that support innovation and growth. These projects are generally focused on providing high-

quality, generic, and reusable spaces that meet the real estate requirements of a wide range of tenants. Upon completion, each

development or redevelopment project is expected to generate increases in rental income, net operating income, and cash flows. Our

development and redevelopment projects are generally in locations that are highly desirable to high-quality entities, which we believe

results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Development projects generally consist of the ground-up development of generic and reusable laboratory facilities.

Redevelopment projects generally consist of the permanent change in use of acquired office, warehouse, or shell space into facilities

designed for life science innovation or advanced technology. We generally will not commence new development projects for

aboveground construction of new Class A/A+ laboratory space without first securing significant pre-leasing for such space, except when

there is solid market demand for high-quality Class A/A+ properties.

Pre-construction activities include entitlements, permitting, design, site work, and other activities preceding commencement of

construction of aboveground building improvements. The advancement of pre-construction efforts is focused on reducing the time

required to deliver projects to prospective tenants. These critical activities add significant value for future ground-up development and

are required for the vertical construction of buildings. Ultimately, these projects will provide high-quality facilities and are expected to

generate significant revenue and cash flows.

Development, redevelopment, and pre-construction spending also includes the following costs: (i) amounts to bring certain

acquired properties up to market standard and/or other costs identified during the acquisition process (generally within two years of

acquisition) and (ii) permanent conversion of space for highly flexible, move-in-ready laboratory space to foster the growth of promising

early- and growth-stage life science companies.

Revenue-enhancing and repositioning capital expenditures represent spending to reposition or significantly change the use of

a property, including through improvement in the asset quality from Class B to Class A/A+.

Non-revenue-enhancing capital expenditures represent costs required to maintain the current revenues of a stabilized

property, including the associated costs for renewed and re-leased space.

119

Dividend payout ratio (common stock)

Dividend payout ratio (common stock) is the ratio of the absolute dollar amount of dividends on our common stock (shares of

common stock outstanding on the respective record dates multiplied by the related dividend per share) to funds from operations

attributable to Alexandria’s common stockholders – diluted, as adjusted.

Dividend yield

Dividend yield for the quarter represents the annualized quarterly dividend per share divided by the closing common stock

price at the end of the quarter.

Fixed-charge coverage ratio

Fixed-charge coverage ratio is a non-GAAP financial measure representing the ratio of Adjusted EBITDA to cash interest and

fixed charges. We believe that this ratio is useful to investors as a supplemental measure of our ability to satisfy fixed financing

obligations and preferred stock dividends. Fixed charges equal interest expense calculated in accordance with GAAP plus capitalized

interest, plus preferred stock dividends, less amortization of loan fees and debt premiums (discounts), and less any portion of interest

expense or preferred stock dividends incurred from any corresponding portion of any hybrid instrument that is treated as equity,

generally consistent with the treatment by key rating agencies, as excluding such amounts provides investors with useful supplemental

information regarding the effect of that equity-credit treatment on our credit profile and fixed-charge coverage.

The following table reconciles interest expense, the most directly comparable financial measure calculated and presented in

accordance with GAAP, to cash interest and computes fixed-charge coverage ratio for the three and nine months ended September 30,

2026 and 2025 (dollars in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

2026

2025

2026

2025

Adjusted EBITDA

$432,980

$532,502

$1,318,766

$1,617,450

Interest expense

$79,687

$54,852

$208,613

$161,024

Capitalized interest

62,922

86,091

206,612

248,579

Amortization of loan fees

(4,422)

(4,505)

(13,267)

(13,811)

Amortization of debt discounts

(353)

(325)

(1,025)

(1,009)

Interest expense associated with the equity

treatment of junior subordinated notes

payable(1)

(4,028)

—

(4,028)

—

Cash interest and fixed charges

$133,806

$136,113

$396,905

$394,783

Fixed-charge coverage ratio:

– period annualized

3.2x

3.9x

3.3x

4.1x

– trailing 12 months

3.4x

4.1x

3.4x

4.1x

(1)Represents 50% of the interest expense associated with our junior subordinated notes payable, corresponding to the portion of the related amount that key rating

agencies treat as equivalent to a common dividend for credit-analysis purposes.

We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a

reconciliation for fixed-charge coverage ratio on a forward-looking basis. This is due to the inherent difficulty of forecasting the timing

and/or amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and

financing decisions, as well as quarterly components such as gain on sales of real estate, unrealized gains or losses on non-real estate

investments, impairments of real estate, impairments of non-real estate investments, and changes in provision for expected credit

losses on financial instruments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would

potentially be misleading for our investors.

120

Gross assets

Gross assets are calculated as total assets plus accumulated depreciation as of September 30, 2026 and December 31, 2025

(in thousands):

September 30, 2026

December 31, 2025

Total assets

$34,051,722

$34,081,835

Accumulated depreciation

6,879,381

6,127,525

Gross assets

$40,931,103

$40,209,360

Incremental annual net operating income on development and redevelopment projects

Incremental annual net operating income represents the annualized net operating income expected to be realized upon a

project being placed into service and achieving stabilized occupancy. For projects placed into service during the period, the incremental

annual net operating income disclosed excludes future incremental annual net operating income from space that was vacant or

unleased at delivery. Incremental annual net operating income is calculated as the initial stabilized yield multiplied by the project’s total

cost at completion.

Initial stabilized yield (unlevered)

Initial stabilized yield is calculated as the estimated amounts of net operating income at stabilization divided by our investment

in the property. For this calculation, we exclude any tenant-funded and tenant-built landlord improvements from our investment in the

property. Our initial stabilized yield excludes the benefit of leverage. Our cash rents related to our development and redevelopment

projects are generally expected to increase over time due to contractual annual rent escalations. Our estimates for initial stabilized

yields, initial stabilized yields (cash basis), and total costs at completion represent our initial estimates at the commencement of the

project. We expect to update this information upon completion of the project, or sooner if there are significant changes to the expected

project yields or costs.

•Initial stabilized yield reflects rental income, including contractual rent escalations and any rent concessions over the

term(s) of the lease(s), calculated on a straight-line basis, and any amortization of deferred revenue related to tenant-

funded and tenant-built landlord improvements.

•Initial stabilized yield (cash basis) reflects cash rents at the stabilization date after initial rental concessions, if any, have

elapsed and our total cash investment in the property.

Investment-grade or publicly traded large cap tenants

Investment-grade or publicly traded large cap tenants represent tenants that are investment-grade rated or publicly traded

companies with an average daily market capitalization greater than $10 billion for the twelve months ended September 30, 2026, as

reported by Bloomberg Professional Services. Credit ratings from Moody’s Ratings and S&P Global Ratings reflect credit ratings of the

tenant’s parent entity, and there can be no assurance that a tenant’s parent entity will satisfy the tenant’s lease obligation upon such

tenant’s default. We monitor the credit quality and related material changes of our tenants. Material changes that cause a tenant’s

market capitalization to decrease below $10 billion, which are not immediately reflected in the twelve-month average, may result in their

exclusion from this measure.

Investments in real estate

The following table presents our new Class A/A+ development and redevelopment pipeline, excluding properties held for sale,

as a percentage of gross assets and as a percentage of annual rental revenue as of September 30, 2026 (dollars in thousands):

Book Value

Percentage of

Gross Assets

Projects under active construction

$1,043,255

3%

Future development projects(1) and land parcels primarily located in Megacampuses

3,584,278

9

Total Class A/A+ development and redevelopment pipeline, excluding properties held for

sale

4,627,533

12

Properties held for sale – land and development parcels

480,134

1

Total Class A/A+ development and redevelopment pipeline

$5,107,667

13%

(1)Includes projects with existing buildings that are generating or can generate operating cash flows. Also includes development rights associated with existing operating

campuses.

121

The square footage presented in the table below is classified as operating as of September 30, 2026, and excludes properties

classified as held for sale. These lease expirations or vacant space at recently acquired properties represent future opportunities for which

we intend, subject to market conditions and leasing, to commence first-time conversion from non-laboratory space to laboratory space,

or to commence future ground-up development:

Dev/Redev

RSF of Lease Expirations Targeted for

Development and Redevelopment

Property/Submarket

2026

2027

Thereafter(1)

Total

Future projects:

446, 458, and 500 Arsenal Street/Cambridge/Inner Suburbs

Dev

—

—

116,623

116,623

Campus Point by Alexandria/University Town Center

Dev

—

—

96,805

96,805

Sequence District by Alexandria/Sorrento Mesa

Dev/Redev

—

—

457,013

457,013

1150 El Camino Real/South San Francisco

Dev

—

—

152,000

152,000

960 Industrial Road/San Carlos

Dev

—

—

112,590

112,590

Total

—

—

935,031

935,031

(1)Includes vacant square footage as of September 30, 2026.

Joint venture financial information

We present components of balance sheet and operating results information related to our real estate joint ventures, which are

not presented, or intended to be presented, in accordance with GAAP. We present the proportionate share of certain financial line items

as follows: (i) for each real estate joint venture that we consolidate in our financial statements, which are controlled by us through

contractual rights or majority voting rights, but of which we own less than 100%, we apply the noncontrolling interest economic

ownership percentage to each financial item to arrive at the amount of such cumulative noncontrolling interest share of each component

presented; and (ii) for each real estate joint venture that we do not control and do not consolidate, which are instead controlled jointly or

by our joint venture partners through contractual rights or majority voting rights, we apply our economic ownership percentage to each

financial item to arrive at our proportionate share of each component presented.

The components of balance sheet and operating results information related to our real estate joint ventures do not represent

our legal claim to those items. For each entity that we do not wholly own, the joint venture agreement generally determines what equity

holders can receive upon capital events, such as sales or refinancing, or in the event of a liquidation. Equity holders are normally

entitled to their respective legal ownership of any residual cash from a joint venture only after all liabilities, priority distributions, and

claims have been repaid or satisfied.

We believe that this information can help investors estimate the balance sheet and operating results information related to our

partially owned entities. Presenting this information provides a perspective not immediately available from consolidated financial

statements and one that can supplement an understanding of the joint venture assets, liabilities, revenues, and expenses included in

our consolidated results.

The components of balance sheet and operating results information related to our real estate joint ventures are limited as an

analytical tool as the overall economic ownership interest does not represent our legal claim to each of our joint ventures’ assets,

liabilities, or results of operations. In addition, joint venture financial information may include financial information related to the

unconsolidated real estate joint ventures that we do not control. We believe that, to facilitate investors’ clear understanding of our

operating results and our total assets and liabilities, joint venture financial information should be examined in conjunction with our

consolidated statements of operations and balance sheets. Joint venture financial information should not be considered an alternative

to our consolidated financial statements, which are presented and prepared in accordance with GAAP.

122

Megacampus™

A Megacampus ecosystem is a cluster campus that consists of approximately 1 million RSF or greater, including operating,

active development/redevelopment, and land RSF less operating RSF expected to be demolished. The following table reconciles our

annual rental revenue and development and redevelopment pipeline RSF, excluding properties classified as held for sale, as of

September 30, 2026 (dollars in thousands):

Annual Rental

Revenue

Development and

Redevelopment

Pipeline RSF

Megacampus

$1,485,494

15,575,865

Core and non-core

378,257

3,973,991

Total

$1,863,751

19,549,856

Megacampus as a percentage of annual rental revenue and of total development and

redevelopment pipeline RSF

80%

80%

Net cash provided by operating activities, as adjusted

We use net cash provided by operating activities, as adjusted, as a supplemental measure for financial and operational

decision-making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Net cash provided by

operating activities, as adjusted, is calculated as net cash provided by operating activities as shown in our consolidated statements of

cash flows, adjusted for changes in operating assets and liabilities (as they represent timing differences), and reduced by dividends and

distributions to noncontrolling interests (excludes liquidating distributions from asset sales).

We believe net cash provided by operating activities, as adjusted, provides investors with relevant and useful information as it

allows investors to evaluate our operating cash flows on a more consistent basis that excludes period-to-period timing differences in

operating assets and liabilities (working capital) and reflects cash dividends and distributions paid quarterly.

The following table reconciles net cash flows from operating activities, the most directly comparable financial measure

presented in accordance with GAAP, to net cash provided by operating activities, as adjusted:

Nine Months Ended September 30,

(in thousands)

2026

2025

Net cash provided by operating activities

$875,410

1,101,668

Changes in operating assets and liabilities

154,064

188,563

Common stock dividends paid

(371,427)

(684,419)

Distributions to noncontrolling interests

(171,248)

(186,725)

Net cash provided by operating activities, as adjusted

$486,799

$419,087

Net debt and preferred stock to Adjusted EBITDA

Net debt and preferred stock to Adjusted EBITDA is a non-GAAP financial measure that we believe is useful to investors as a

supplemental measure for evaluating our balance sheet leverage. Net debt and preferred stock is calculated at the end of the applicable

period and equals total consolidated debt (including secured debt, unsecured senior debt, and junior subordinated debt) plus preferred

stock, less cash, cash equivalents, restricted cash, and the portion of any hybrid instrument included in debt or preferred stock that is

treated as equity, generally consistent with the treatment by key rating agencies, as excluding such amounts provides investors with

useful supplemental information regarding the effect of that equity-credit treatment on our leverage. Refer to “Adjusted EBITDA and

Adjusted EBITDA margin” in this section for further information on the calculation of Adjusted EBITDA.

We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a

reconciliation for net debt and preferred stock to Adjusted EBITDA on a forward-looking basis. This is due to the inherent difficulty of

forecasting the timing and/or amount of items that depend on market conditions outside of our control, including the timing of

dispositions, capital events, and financing decisions, as well as quarterly components such as gain on sales of real estate, unrealized

gains or losses on non-real estate investments, impairments of real estate, impairments of non-real estate investments, and changes in

provision for expected credit losses on financial instruments. Our attempt to predict these amounts may produce significant but

inaccurate estimates, which would potentially be misleading for our investors.

123

The following table reconciles debt to net debt and preferred stock and computes the ratio to Adjusted EBITDA as of

September 30, 2026 and December 31, 2025 (dollars in thousands):

September 30, 2026

December 31, 2025

Unsecured senior notes payable

$10,820,687

$12,047,394

Junior subordinated notes payable

985,143

—

Unsecured senior line of credit and commercial paper

1,091,166

353,161

Unamortized deferred financing costs

79,954

74,314

Cash and cash equivalents

(508,855)

(549,062)

Restricted cash

(4,908)

(4,693)

Equity treatment of junior subordinated notes payable(1)

(500,000)

—

Preferred stock

—

—

Net debt and preferred stock

$11,963,187

$11,921,114

Adjusted EBITDA:

– quarter annualized

$1,731,920

$2,097,444

– trailing 12 months

$1,843,127

$2,141,811

Net debt and preferred stock to Adjusted EBITDA:

– quarter annualized

6.9x

5.7x

– trailing 12 months

6.5x

5.6x

(1)Represents the 50% equity treatment assigned by key rating agencies to the $1.0 billion principal amount of our junior subordinated notes payable.

124

Net operating income, net operating income (cash basis), and operating margin

The following table reconciles net income (loss) to net operating income and net operating income (cash basis) and computes

operating margin for the three and nine months ended September 30, 2026 and 2025 (dollars in thousands):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Net loss

$(598,932)

$(197,845)

$(239,524)

$(221,372)

Equity in (earnings) losses of unconsolidated real estate joint

ventures

(75)

(201)

(341)

9,327

General and administrative expenses

40,915

29,224

112,461

89,027

Interest expense

79,687

54,852

208,613

161,024

Depreciation and amortization

304,419

340,230

914,244

1,028,415

Impairment of real estate

637,904

323,870

865,873

485,630

Loss (gain) on early extinguishment of debt

3,323

107

(363,112)

107

Gain on sales of real estate

—

(9,366)

—

(22,531)

Investment (income) losses

(23,990)

(28,161)

(152,635)

52,453

Net operating income

443,251

512,710

1,345,579

1,582,080

Straight-line rent revenue

(2,466)

(18,821)

(21,229)

(59,380)

Amortization of deferred revenue related to tenant-funded

and -built landlord improvements

(11,992)

(5,455)

(24,881)

(9,507)

Amortization of acquired below-market leases

(8,233)

(6,456)

(22,229)

(31,874)

Provision for expected credit losses on financial instruments

—

—

—

285

Net operating income (cash basis)

$420,560

$481,978

$1,277,240

$1,481,604

Net operating income (cash basis) – annualized

$1,682,240

$1,927,912

$1,702,987

$1,975,472

Net operating income (from above)

$443,251

$512,710

$1,345,579

$1,582,080

Total revenues

$671,182

$751,944

$2,004,988

$2,272,142

Operating margin

66%

68%

67%

70%

Net operating income is a non-GAAP financial measure calculated as net income (loss), the most directly comparable financial

measure calculated and presented in accordance with GAAP, excluding equity in the earnings of our unconsolidated real estate joint

ventures, general and administrative expenses, interest expense, depreciation and amortization, impairments of real estate, gains or

losses on early extinguishment of debt, gains or losses on sales of real estate, and investment income or loss. We believe net operating

income provides useful information to investors regarding our financial condition and results of operations because it primarily reflects

those income and expense items that are incurred at the property level. Therefore, we believe net operating income is a useful measure

for investors to evaluate the operating performance of our consolidated real estate assets. Net operating income on a cash basis is net

operating income adjusted to exclude the effect of straight-line rent, amortization of acquired above- and below-market lease revenue,

amortization of deferred revenue related to tenant-funded and tenant-built landlord improvements, and changes in the provision for

expected credit losses on financial instruments required by GAAP. We believe that net operating income on a cash basis is helpful to

investors as an additional measure of operating performance because it eliminates straight-line rent revenue and the amortization of

acquired above- and below-market leases and tenant-funded and tenant-built landlord improvements.

125

Furthermore, we believe net operating income is useful to investors as a performance measure of our consolidated properties

because, when compared across periods, net operating income reflects trends in occupancy rates, rental rates, and operating costs,

which provide a perspective not immediately apparent from net income or loss. Net operating income can be used to measure the initial

stabilized yields of our properties by calculating net operating income generated by a property divided by our investment in the property.

Net operating income excludes certain components from net income in order to provide results that are more closely related to the

results of operations of our properties. For example, interest expense is not necessarily linked to the operating performance of a real

estate asset and is often incurred at the corporate level rather than at the property level. In addition, depreciation and amortization,

because of historical cost accounting and useful life estimates, may distort comparability of operating performance at the property level.

Impairments of real estate have been excluded in deriving net operating income because we do not consider impairments of real estate

to be property-level operating expenses. Impairments of real estate relate to changes in the values of our assets and do not reflect the

current operating performance with respect to related revenues or expenses. Our impairments of real estate represent the write-down in

the value of the assets to the estimated fair value less cost to sell for assets held for sale or to their estimated fair value for assets held

and used. These impairments result from investing decisions or a deterioration in market conditions or changes in the intended use of a

property. We also exclude realized and unrealized investment gain or loss, which results from investment decisions that occur at the

corporate level related to non-real estate investments in publicly traded companies and certain privately held entities. Therefore, we do

not consider these activities to be an indication of operating performance of our real estate assets at the property level. Our calculation

of net operating income also excludes charges incurred from changes in certain financing decisions, such as losses on early

extinguishment of debt and changes in provision for expected credit losses on financial instruments, as these charges often relate to

corporate strategy. Property operating expenses included in determining net operating income primarily consist of costs that are related

to our operating properties, such as utilities, repairs, and maintenance; rental expense related to ground leases; contracted services,

such as janitorial, engineering, and landscaping; property taxes and insurance; and property-level salaries. General and administrative

expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, rent, and supplies that

are incurred as part of corporate office management. We calculate operating margin as net operating income divided by total revenues.

We believe that, to facilitate investors’ clear understanding of our operating results, net operating income should be examined

in conjunction with net income or loss as presented in our consolidated statements of operations. Net operating income should not be

considered as an alternative to net income or loss as an indication of our performance, nor as an alternative to cash flows as a measure

of our liquidity or our ability to make distributions.

We are not able to forecast the net income of future periods without unreasonable effort, and therefore do not provide a

reconciliation for net operating income on a forward-looking basis. This is due to the inherent difficulty of forecasting the timing and/or

amount of items that depend on market conditions outside of our control, including the timing of dispositions, capital events, and

financing decisions, as well as components such as gain on sales of real estate, unrealized gains or losses on non-real estate

investments, impairments of real estate, impairments of non-real estate investments, and changes in provision for expected credit

losses on financial instruments. Our attempt to predict these amounts may produce significant but inaccurate estimates, which would

potentially be misleading for our investors.

Operating statistics

We present certain operating statistics related to our properties, including number of properties, RSF, occupancy percentage,

leasing activity, and contractual lease expirations as of the end of the period. We believe these measures are useful to investors

because they facilitate an understanding of certain trends for our properties. We compute the number of properties, RSF, occupancy

percentage, leasing activity, and contractual lease expirations at 100%, excluding RSF at properties classified as held for sale, for all

properties in which we have an investment, including properties owned by our consolidated and unconsolidated real estate joint

ventures. For operating metrics based on annual rental revenue, refer to “Annual rental revenue” in this section.

Same property comparisons

As a result of changes within our total property portfolio during the comparative periods presented, including changes from

assets acquired or sold, properties placed into development or redevelopment, and development or redevelopment properties recently

placed into service, the consolidated total income from rentals, as well as rental operating expenses in our operating results, can show

significant changes from period to period. In order to supplement an evaluation of our results of operations over a given quarterly or

annual period, we analyze the operating performance for all consolidated properties that were fully operating for the entirety of the

comparative periods presented, referred to as same properties. We separately present quarterly and year-to-date same property results

to align with the interim financial information required by the SEC in our management’s discussion and analysis of our financial

condition and results of operations. These same properties are analyzed separately from properties acquired subsequent to the first day

in the earliest comparable quarterly or year-to-date period presented, properties that underwent development or redevelopment at any

time during the comparative periods, unconsolidated real estate joint ventures, properties classified as held for sale, and corporate

entities (legal entities performing general and administrative functions), which are excluded from same property results. Additionally,

termination fees, if any, are excluded from the results of same properties. Refer to “Same properties” in Item 2 for additional information.

126

Stabilized occupancy date

The stabilized occupancy date represents the estimated date on which a development or redevelopment project is expected to

reach occupancy of 95% or greater.

Tenant collections

Tenant collections represent the percentage of recognized rental income billed during the respective quarter that has been

collected as of the date of this report. Rental income from tenants for whom collection is considered not probable is recognized only

upon receipt of cash and, accordingly, is included in this calculation only to the extent recognized and collected.

Tenant recoveries

Tenant recoveries represent revenues comprising reimbursement of real estate taxes, insurance, utilities, repairs and

maintenance, common area expenses, and other operating expenses and are earned in the period during which the applicable

expenses are incurred and the tenant’s obligation to reimburse us arises.

We classify rental revenues and tenant recoveries generated through the leasing of real estate assets within revenues in

income from rentals in our consolidated statements of operations. We provide investors with a separate presentation of rental revenues

and tenant recoveries in “Results of operations” in Item 2 because we believe it promotes investors’ understanding of our operating

results. We believe that the presentation of tenant recoveries is useful to investors as a supplemental measure of our ability to recover

operating expenses under our triple net leases, including recoveries of utilities, repairs and maintenance, insurance, property taxes,

common area expenses, and other operating expenses, and of our ability to mitigate the effect on net income of any significant

variability in components of our operating expenses.

The following table reconciles income from rentals to tenant recoveries for the three and nine months ended September 30,

2026 and 2025 (in thousands):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Income from rentals

$653,618

$735,849

$1,949,841

$2,216,303

Rental revenues

(481,348)

(541,070)

(1,442,723)

(1,646,559)

Tenant recoveries

$172,270

$194,779

$507,118

$569,744

127

Total debt and preferred stock, as adjusted

Total debt and preferred stock, as adjusted, is calculated at the end of the applicable period and equals total consolidated debt

(including secured debt, unsecured senior, and junior subordinated debt) plus preferred stock, less the portion of any hybrid instrument

included in debt or preferred stock that is treated as equity, generally consistent with the treatment by key rating agencies, as excluding

such amounts provides investors with useful supplemental information regarding the effect of that equity-credit treatment on our

leverage.

The following table reconciles total debt and preferred stock, as adjusted (in thousands):

September 30, 2026

December 31, 2025

Unsecured senior notes payable

$10,820,687

$12,047,394

Junior subordinated notes payable

985,143

—

Unsecured senior line of credit and commercial paper

1,091,166

353,161

Equity treatment of junior subordinated notes payable(1)

(500,000)

—

Total debt and preferred stock, as adjusted

$12,396,996

$12,400,555

(1)Represents the 50% equity treatment assigned by key rating agencies to the $1.0 billion principal amount of our junior subordinated notes payable.

Total equity capitalization

Total equity capitalization is equal to the outstanding shares of common stock multiplied by the closing price on the last trading

day at the end of each period presented.

Total market capitalization

Total market capitalization is equal to the sum of total equity capitalization and total debt.

Unencumbered net operating income as a percentage of total net operating income

Unencumbered net operating income as a percentage of total net operating income is a non-GAAP financial measure that we

believe is useful to investors as a performance measure of the results of operations of our unencumbered real estate assets as it

reflects those income and expense items that are incurred at the unencumbered property level. Unencumbered net operating income is

derived from assets classified in continuing operations, which are not subject to any mortgage, deed of trust, lien, or other security

interest, as of the period for which income is presented.

The following table summarizes unencumbered net operating income as a percentage of total net operating income for the

three and nine months ended September 30, 2026 and 2025 (dollars in thousands):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Unencumbered net operating income

$443,251

$512,710

$1,345,579

$1,579,167

Encumbered net operating income

—

—

—

2,913

Total net operating income

$443,251

$512,710

$1,345,579

$1,582,080

Unencumbered net operating income as a percentage of total

net operating income

100.0%

100.0%

100.0%

99.8%

128

Weighted-average shares of common stock outstanding – diluted

From time to time, we enter into capital market transactions, including forward equity sales agreements (“Forward

Agreements”), to fund acquisitions, to fund construction of our development and redevelopment projects, and for general working

capital purposes. While the Forward Agreements are outstanding, we are required to consider the potential dilutive effect of our Forward

Agreements under the treasury stock method. Under this method, we also include the dilutive effect of unvested restricted stock awards

(“RSAs”) with forfeitable dividends in the calculation of diluted shares. Refer to Note 13 – “Earnings per share” and Note 14 –

“Stockholders’ equity” to our unaudited consolidated financial statements in Item 1 for additional information.

The weighted-average shares of common stock outstanding used in calculating EPS – diluted, funds from operations per

share – diluted, and funds from operations per share – diluted, as adjusted, for the three and nine months ended September 30, 2026

and 2025 are calculated as follows. Also shown are the weighted-average unvested RSAs with nonforfeitable dividends used in

calculating the amounts allocable to these awards pursuant to the two-class method for each of the respective periods presented below

(in thousands):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2026

2025

2026

2025

Basic shares for earnings per share

170,751

170,181

170,689

170,278

Unvested RSAs with forfeitable dividends

—

—

—

—

Diluted shares for earnings per share

170,751

170,181

170,689

170,278

Basic shares for funds from operations per share and funds

from operations per share, as adjusted

170,751

170,181

170,689

170,278

Unvested RSAs with forfeitable dividends

667

124

480

73

Diluted shares for funds from operations per share and funds

from operations per share, as adjusted

171,418

170,305

171,169

170,351

Weighted-average unvested RSAs with nonforfeitable

dividends used in the allocations of net income, funds from

operations, and funds from operations, as adjusted

1,224

1,917

1,280

1,989

129

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest rate risk

The primary market risk to which we believe we may be exposed is interest rate risk, which may result from many factors,

including government monetary and tax policies, domestic and international economic and political considerations, and other factors

that are beyond our control.

In order to modify and manage the interest rate characteristics of our outstanding debt and to limit the effects of interest rate

risks on our operations, we may utilize a variety of financial instruments, including interest rate hedge agreements, caps, floors, and

other interest rate exchange contracts. The use of these types of instruments to hedge a portion of our exposure to changes in interest

rates may carry additional risks, such as counterparty credit risk and the legal enforceability of hedge agreements. As of September 30,

2026, we did not have any outstanding interest rate hedge agreements.

Our future earnings and fair values relating to our outstanding debt are primarily dependent upon prevailing market interest

rates. The following tables illustrate the effect of a 1% change in interest rates, assuming a zero percent interest rate floor, on our fixed-

and variable-rate debt as of September 30, 2026 (in thousands):

As of

September 30, 2026

December 31, 2025

Annualized effect on future earnings due to variable-rate debt:

Rate increase of 1%

$(4,986)

$(1,259)

Rate decrease of 1%

$4,986

$1,259

Effect on fair value of total consolidated debt:

Rate increase of 1%

$(697,783)

$(746,058)

Rate decrease of 1%

$794,148

$852,698

These amounts are determined by considering the effect of the hypothetical interest rates on our borrowings as of

September 30, 2026 and December 31, 2025. These analyses do not consider the effects of the reduced level of overall economic

activity that could exist in such an environment. Furthermore, in the event of a change of such magnitude, we would consider taking

actions to further mitigate our exposure to the change. Because of the uncertainty of the specific actions that would be taken and their

possible effects, the sensitivity analyses assume no changes in our capital structure.

Equity price risk

We have exposure to equity price market risk because we hold equity investments in publicly traded companies and privately

held entities. All of our investments in actively traded public companies are reflected in our consolidated balance sheets at fair value.

Our investments in privately held entities that report NAV per share are measured at fair value using NAV as a practical expedient to fair

value. Our equity investments in privately held entities that do not report NAV per share are measured at cost less impairments,

adjusted for observable price changes during the period. Changes in fair value of public investments, changes in NAV per share

reported by privately held entities, and observable price changes of privately held entities that do not report NAV per share are

classified as investment income (losses) in our consolidated statements of operations. There is no assurance that future declines in

value will not have a material adverse effect on our future results of operations. The following table illustrates the effect that a 10%

change in the value of our equity investments would have on earnings as of September 30, 2026 and December 31, 2025 (in

thousands):

As of

September 30, 2026

December 31, 2025

Equity price risk:

Fair value increase of 10%

$134,128

$114,387

Fair value decrease of 10%

$(134,128)

$(114,387)

130

Foreign currency exchange rate risk

We have exposure to foreign currency exchange rate risk related to our operations in Canada. The functional currency of our

Canadian subsidiaries is the Canadian dollar. Gains or losses resulting from the translation of these subsidiaries’ balance sheets and

statements of operations are classified in accumulated other comprehensive income (loss) as a separate component of total equity and

are excluded from net income (loss). Gains or losses will be reflected in our consolidated statements of operations when there is a sale

of our investment in these operations or upon a complete or substantially complete liquidation of the investment. The following tables

illustrate the effect that a 10% change in Canadian dollar exchange rates relative to the USD would have on our potential future

earnings and on the fair value of our net investment in Canadian subsidiaries, based on our current operating assets outside the U.S.

as of September 30, 2026 and December 31, 2025 (in thousands):

As of

September 30, 2026

December 31, 2025

Effect on potential future earnings due to foreign currency exchange rate:

Rate increase of 10%

$292

$182

Rate decrease of 10%

$(292)

$(182)

Effect on the fair value of net investment in foreign subsidiaries due to foreign currency

exchange rate:

Rate increase of 10%

$35,005

$35,306

Rate decrease of 10%

$(35,005)

$(35,306)

Change in the fair value of cross-currency swap agreements designated as a net

investment hedge(1):

Rate increase of 10% (USD weakening)

$(18,232)

$(24,600)

Rate decrease of 10% (USD strengthening)

$18,232

$24,600

(1)Refer to Note 11 – “Hedge agreements” to our unaudited consolidated financial statements for additional information.

Our exposure to market risk elements for the nine months ended September 30, 2026 was consistent with the risk elements

presented above, including the effects of changes in interest rates, equity prices, and foreign currency exchange rates.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

As of September 30, 2026, we had performed an evaluation, under the supervision of our principal executive officers and

principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. These controls and

procedures have been designed to ensure that information required for disclosure is recorded, processed, summarized, and reported

within the requisite time periods. Based on our evaluation, the principal executive officers and principal financial officer concluded that

our disclosure controls and procedures were effective as of September 30, 2026.

Changes in internal control over financial reporting

There has not been any change in our internal control over financial reporting during the three months ended September 30,

2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

131

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Stockholder Matters

On November 25, 2025, a securities class action was filed against the Company and certain of its officers and directors in the

United States District Court for the Central District of California. The amended complaint alleged violations of the federal securities laws

based on alleged material misrepresentations and omissions related to the Company’s business performance and real estate

impairment charges. The amended complaint sought damages and other relief on behalf of investors who acquired the Company’s

securities between January 30, 2024 and December 5, 2025. On September 10, 2026, the Court granted defendants’ motion to dismiss

the amended complaint with leave to amend. On October 15, 2026, the plaintiffs filed a second amended complaint. 

On February 3, 2026, March 25, 2026, and June 25, 2026, stockholder derivative actions were filed against certain officers and

directors of the Company, with the Company named as a nominal defendant, in the United States District Court for the District of

Maryland and the United States District Court for the Central District of California. The derivative complaints assert claims under the

federal securities laws and state law based on allegations similar to those in the securities class action and seek damages and other

relief on behalf of the Company. The first two derivative actions were stayed on April 8, 2026 and June 23, 2026, respectively, pending

the dismissal of the securities class action with prejudice or the denial of any motion to dismiss in the securities class action.

The Company does not believe the complaints state any meritorious claims and intends to defend these cases vigorously. 

At this time, we cannot predict the outcome of these matters or reasonably estimate the amount or range of any possible loss,

if any, and therefore we have not recorded an accrual related to these matters.

Option Parcel Development at Alexandria Center® for Life Science – New York City Campus

Refer to “Other” in Note 3 – “Investments in real estate” to our unaudited consolidated financial statements for information

regarding litigation involving our subsidiary in connection with an option and ground lease for a development parcel at the Alexandria

Center® for Life Science – New York City campus.

ITEM 1A. RISK FACTORS

In addition to the information set forth in this quarterly report on Form 10-Q, one should also carefully review and consider the

information contained in the other reports and periodic filings that we make with the SEC, including, without limitation, the information

contained under the caption “Item 1A. Risk factors” in our annual report on Form 10-K for the year ended December 31, 2025. Those

risk factors could materially affect our business, financial condition, and results of operations. The risks that we describe in our public

filings are not the only risks that we face. Additional risks and uncertainties not currently known to us, or that we presently deem to be

immaterial, also may materially adversely affect our business, financial condition, and results of operations.

There have been no material changes in our risk factors from those disclosed under the caption “Item 1A. Risk factors” in our

annual report on Form 10-K for the year ended December 31, 2025.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Purchases of equity securities

On December 8, 2025, we announced that our Board of Directors authorized a new share repurchase program that allows the

repurchase of shares with an aggregate value of up to $500.0 million through December 31, 2026 in the open market, through privately

negotiated transactions, or otherwise, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the

Exchange Act. This new program replaced our prior stock repurchase program. As of the date of this report, no repurchases have been

made under the new program and $500.0 million remains available for future share repurchases.

ITEM 5. OTHER INFORMATION

Disclosure of 10b5-1 plans

During the three months ended September 30, 2026, none of our officers or directors adopted or terminated any contract,

instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of

Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

132

ITEM 6. EXHIBITS

Exhibit

Number

Exhibit Title

Incorporated by

Reference to:

Date Filed

3.1

Articles of Amendment and Restatement of the Company, dated May 21, 1997

Form 10-Q

August 14, 1997

3.2

Certificate of Correction of the Company, dated June 20, 1997

Form 10-Q

August 14, 1997

3.3

Articles of Amendment of the Company, effective as of May 10, 2017

Form 8-K

May 12, 2017

3.4

Articles of Amendment of the Company, effective as of May 18, 2022

Form 8-K

May 19, 2022

3.5

Articles Supplementary, dated June 9, 1999, relating to the 9.50% Series A

Cumulative Redeemable Preferred Stock

Form 10-Q

August 13, 1999

3.6

Articles Supplementary, dated February 10, 2000, relating to the election to be

subject to Subtitle 8 of Title 3 of the Maryland General Corporation Law

Form 8-K

February 10, 2000

3.7

Articles Supplementary, dated February 10, 2000, relating to the Series A Junior

Participating Preferred Stock

Form 8-K

February 10, 2000

3.8

Articles Supplementary, dated January 18, 2002, relating to the 9.10% Series B

Cumulative Redeemable Preferred Stock

Form 8-A

January 18, 2002

3.9

Articles Supplementary, dated June 22, 2004, relating to the 8.375% Series C

Cumulative Redeemable Preferred Stock

Form 8-A

June 28, 2004

3.10

Articles Supplementary, dated March 25, 2008, relating to the 7.00% Series D

Cumulative Convertible Preferred Stock

Form 8-K

March 25, 2008

3.11

Articles Supplementary, dated March 12, 2012, relating to the 6.45% Series E

Cumulative Redeemable Preferred Stock

Form 8-K

March 14, 2012

3.12

Articles Supplementary, effective as of May 10, 2017, relating to Reclassified

Preferred Stock

Form 8-K

May 12, 2017

3.13

Articles Supplementary, effective as of March 31, 2026, relating to Subtitle 8 of

Title 3 of the Maryland General Corporation Law

Form 8-K

March 31, 2026

3.14

Amended and Restated Bylaws of the Company (Amended December 6, 2024)

Form 8-K

December 9, 2024

4.1

Indenture, dated as of February 13, 2025, among Alexandria Real Estate

Equities, Inc., as Issuer, Alexandria Real Estate Equities, L.P., as Guarantor, and

U.S. Bank Trust Company, National Association, as Trustee

Form 8-K

February 13, 2025

4.2

Supplemental Indenture No. 3, dated as of August 21, 2026, by and among

Alexandria Real Estate Equities, Inc., as Issuer, Alexandria Real Estate Equities,

L.P., as Guarantor, and U.S. Bank Trust Company, National Association, as

Trustee

Form 8-K

August 21, 2026

4.3

Form of 7.250% Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes

due 2057 (included in Exhibit 4.2 above)

Form 8-K

August 21, 2026

10.1

Fourth Amended and Restated Credit Agreement, dated as of September 24,

2026, among the Company, as Borrower, Alexandria Real Estate Equities, L.P.,

as a Guarantor, Citibank, N.A., as Administrative Agent, and the lenders and

other parties thereto

N/A

Filed herewith

22.1

List of Guarantor Subsidiaries of the Company

N/A

Filed herewith

31.1

Certification of Principal Executive Officer Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

N/A

Filed herewith

31.2

Certification of Principal Executive Officer Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

N/A

Filed herewith

31.3

Certification of Principal Financial Officer Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

N/A

Filed herewith

32.0

Certification of Principal Executive Officers and Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002

N/A

Filed herewith

101.1

The following materials from the Company’s quarterly report on Form 10-Q for

the quarterly period ended September 30, 2026, formatted in iXBRL (Inline

eXtensible Business Reporting Language): (i) Consolidated Balance Sheets as

of September 30, 2026 and December 31, 2025 (unaudited), (ii) Consolidated

Statements of Operations for the three and nine months ended September 30,

2026 and 2025 (unaudited), (iii) Consolidated Statements of Comprehensive

Income for the three and nine months ended September 30, 2026 and 2025

(unaudited), (iv) Consolidated Statements of Changes in Stockholders’ Equity

and Noncontrolling Interests for the three and nine months ended September 30,

2026 and 2025 (unaudited), (v) Consolidated Statements of Cash Flows for the

nine months ended September 30, 2026 and 2025 (unaudited), and (vi) Notes to

Consolidated Financial Statements (unaudited)

N/A

Filed herewith

104

Cover Page Interactive Data File – the cover page from this Quarterly Report on

Form 10-Q for the quarter ended September 30, 2026 is formatted in Inline

XBRL and contained in Exhibit 101.1

N/A

Filed herewith

133

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed

on its behalf by the undersigned, thereunto duly authorized, on October 26, 2026.

ALEXANDRIA REAL ESTATE EQUITIES, INC.

/s/ Joel S. Marcus

Joel S. Marcus

Executive Chairman

(Principal Executive Officer)

/s/ Peter M. Moglia

Peter M. Moglia

Chief Executive Officer and Chief Investment Officer

(Principal Executive Officer)

/s/ Marc E. Binda

Marc E. Binda

Chief Financial Officer and Treasurer

(Principal Financial Officer)

来源:SEC EDGAR · 本站存档